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Abstract 
The increasing occurrence of diabetes in the general population as a result of over 
nutrition and increasingly inactive lifestyle has led to an obesity epidemic which is set 
to grow over time. With an ever increasing obese population type 2 diabetes and 
cardiovascular complications are set to become the major causes of human mortality. 
Chronic non healing wounds are a major cause of mortality and morbidity in patients 
with type 2 diabetes. They are predominantly caused by macrophage dysfunction and 
a lack of migration of fibroblasts into the wound. 
This study aimed to investigate diabetic wound healing through development of an 
artificial scratch assay. An in vitro scratch assay developed in WS1 cells. The effect of 
heat shock treatments from 39°C to 45° was tested to determine if cell migration 
increased; however, no significant difference was seen. Mitomycin C was used to 
determine if wound closure occurred as a result of cell proliferation and migration or 
migration alone. 10μg/ml of mitomycin C inhibited cell division by 79.9% without 
exhibiting cytotoxicity over a 12h period. The effect of hyperglycaemia and heat shock 
was also tested and showed no significant difference when compared to control 
conditions, suggesting that fibroblast migration in vivo is hindered through other 
factors such as debridement or macrophage dysfunction in the wound. 
GLUT4 is present in insulin sensitive organs (liver, adipose and muscle) and is the 
major glucose transporter responsible for the clearance of glucose from the blood after 
a meal, thus playing a central role in glucose homeostasis. Monocytes are precursors to 
macrophages and can easily be isolated from whole blood. They have also been shown 
to express GLUT4 in response to insulin and could be used as model to assess 
inflammation in diabetes. A glucose uptake assay was developed in U937 cells using a 
fluorescent glucose analogue, 2NBDG. 2NBDG fluorescence was shown to be 
competitively inhibited by increasing concentrations of glucose suggesting that 
2NBDG enters the cell through glucose transporters. 2NBDG uptake was also assessed 
at different pH and in presence of membrane fluidizers (DMSO, benzyl alcohol and 
phenethyl alcohol). Extremes of pH significantly reduced cell viability and only at pH 
4 was 2NBDG fluorescence significantly reduced.  Treatment with DMSO showed that 
at high concentrations (≤ 1.56%) cell viability was reduced with a concurrent reduction 
in 2NBDG fluorescence. The effect of benzyl alcohol and phenethyl alcohol was found 
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to be insignificant at the concentrations and time points tested. The presence of GLUT4 
was also determined by flow cytometry and Western blotting and found to be situated 
in the cytoplasmic region of the cell. This study indicates that monocytes and 
macrophages could be a potential therapeutic target to improve diabetic wound 
healing as they are a source of growth factors and cytokines that can bring about 
resolution of inflammation and it is their dysfunction in diabetic wounds that causes 
poor clinical outcomes.  
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Chapter 1  General Introduction 
 
1.0 Introduction 
The condition of diabetes has been known recorded as early as 1500 BC by the 
Egyptians (Kirchhof, Popat, & Malowany, 2009). Diabetes is a metabolic syndrome 
characterised by the breakdown of insulin signal transduction leading to impaired 
glucose homeostasis. It can be caused when the patient does not produce insulin (type 
1) or when the patient develops resistance to insulin (type 2).  As of 2013, 382 million 
people have been diagnosed with diabetes (International diabetes federation, 2014). In 
the UK the number people suffering from diabetes has nearly doubled over the last two 
decades; from 1.8 million in 1996 to 3.4 million in 2014 (Diabetes UK, 2014).   
Faults in the immune system have a role to play in both type 1 and type 2 diabetes. Type 
1 diabetes is an autoimmune disease where the insulin producing cells of the islets of 
Langerhans are targeted by the host immune system and as a result insulin production 
is lost (Van Belle, Coppieters, & Von Herrath, 2011). In type 2 diabetes cells lose 
sensitivity to insulin and therefore fail to transport glucose into the cell (McGarry, 
2002). Type 2 diabetes is closely linked to a chronic inflammation induced by excessive 
nutrient intake coupled with unhealthy lifestyle choices. This thesis focused principally 
on type 2 diabetes and the role of fibroblast and monocytes in diabetic wound healing. 
 Impaired wound healing: Patients with diabetes have poor wound healing 
which could be attributed to a lack of growth factors and viable fibroblasts in 
the wound (Lerman, Galiano, Armour, Levine, & Gurtner, 2003). 
 Monocyte responses: In diabetic wounds monocyte and macrophage 
recruitment has been shown to be delayed, moreover they have been shown to 
secrete high levels of inflammatory cytokines and very little growth factors 
(Brem & Tomic-Canic, 2007).  
 
1.1  Glucose Homeostasis 
Glucose is main source of carbohydrate in the body and in some organs it is the only 
source of metabolic energy (e.g. brain) (Thorens, 2014). This makes glucose 
homeostasis a very important regulatory mechanism for overall energy homeostasis in 
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the body. Consumption of carbohydrates is the main source of glucose in the body and 
organs such as liver and muscles store glucose in the form of glycogen. Adipose tissue 
converts glucose into lipids and stores fat, a long term fuel source. Additionally the 
liver can breakdown proteins and generate glucose through gluconeogenesis. The liver 
and muscle can also breakdown their glycogen stores to generate glucose for the brain. 
These systems are regulated by hormones and ensure a constant supply of glucose 
within the body at all times. Normal glucose levels are maintained at approximately 
5mM/L within the blood. After a meal glucose levels within the blood are raised to 
about 7.9mM/L and is brought down within 2 to three hours back to 5mM/L  (Ceriello, 
Colagiuri, Gerich, & Tuomilehto, 2008). Blood glucose is maintained at all times 
through co-ordination of hormones secreted by pancreas, adipose tissue and small 
intestine and the subsequent binding of these hormones to their receptors. 
 
1.1.1  Hormones 
Blood glucose levels are generally maintained and regulated by the action of hormones 
secreted by the pancreas, adipose tissue and gut. The major hormones are: 
Insulin: Insulin is secreted by pancreatic β cells in the islets of Langerhans of the 
pancreas promotes glucose uptake, inhibits gluconeogenesis, promotes glycogen 
synthesis, promotes lipogenesis and inhibits lipolysis in insulin target tissues by 
binding to the insulin receptor and translocating the insulin sensitive glucose 
transporter GLUT 4 (Kotas & Medzhitov, 2015).  Insulin secretion is also increased in 
response to amino acids and glucose-independent insulinotropic polypeptide (GIP) 
and glucagon like peptide-1 (GLP-1) (Drucker, 2001; Drucker, 2007). Insulin receptors 
are present on muscle, liver, adipose and immune cells.   
Glucagon: Glucagon is secreted by pancreatic α cells and has opposing action to insulin 
and promotes lipolysis, glycogenosis and promotes gluconeogenesis. It maintains 
plasma glucose levels during fasting periods through its action on the liver (Aronoff, 
Berkowitz, Shreiner, & Want, 2004).   
Amylin: Amylin is secreted by the β cells of the pancreas when post-prandial glucose is 
high. One of its main functions is to inhibit arginine-induced glucagon secretion by α 
cells of the pancreas in a paracrine manner after a meal (Aronoff et al., 2004). It is 
responsible for delaying gastric emptying in a dose dependent manner (Schmitz, Brock, 
 3 | P a g e  
 
& Rungby, 2004). This gastric emptying has been shown to inhibited by hypoglycaemia 
in rats  (Gedulin & Young, 1998). It primarily acts through the nervous system were 
receptors for amylin are present in the postrema, a region that can induce vomiting 
(Aronoff et al., 2004) 
GLP-1: Glucagon like peptide-1 (GLP-1) is secreted by intestinal epithelial L cells located 
in colon and distal ileum and is an incretin which promotes insulin secretion of β cells 
and enhances β cell survival by promoting cell proliferation. It is stimulated by glucose 
and monounsaturated fatty acids. It promotes satiety, weight loss and improves cardiac 
output (Drucker, 2007; Lim et al., 2009).   
GIP: Glucose-dependent insulinotropic polypeptide or gastric inhibitory polypeptide 
(GIP) is another incretin produced in the stomach and proximal small intestine. It 
promotes insulin secretion fat deposition and bone formation. It is rapidly induce by 
the ingestion of proteins. (Seino, Fukushima, & Yabe, 2010). 
Leptin: leptin is secreted by adipose tissue and was discovered in (ob/ob) mice that had 
abnormally high feeding rates where it was found to inhibit nutrient intake and reduce 
weight gain in the long term (Guerre-Millo, 2002) . Leptin acts on the hypothalamus 
and reports the energy status of the body. Leptins levels have been shown to increase 
with increasing body mass index (BMI)  (Ouchi et al., 2011) 
Ghrelin: Ghrelin is secreted in the stomach and levels seem to rise before meal and 
drop immediately after the meal. Increased ghrelin levels have been shown to correlate 
with hunger. Like leptin it acts on the hypothalamus but stimulates nutrient intake 
(Klok, Jakobsdottir, & Drent, 2007).  
ASP: Acyl stimulating protein (ASP) is a hormone that is produced within the adipose 
tissue and inhibits lipolysis, promotes lipogenesis and promotes glucose uptake in 
adipocytes (Yang et al., 2006). ASP has also been shown to stimulate insulin secretion 
in in vitro studies. Increasing levels of adiposity correlate with increased production of 
the hormone (Havel, 2014).   
Adiponectin: Adiponectin is a hormone that has been implicated in preventing insulin 
resistance and promoting insulin sensitivity in animals. Adiponectin levels are reduced 
with increasing adiposity (Ouchi et al., 2011). Administration of adiponectin has been 
shown to promote glucose clearance without stimulating insulin secretion, however 
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the mechanism remains unknown (Havel, 2014). Table 1.1 summarises all the hormones 
involved in glucose homeostasis.   
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Table 1.1 Hormones involved in glucose homeostasis 
Organ Cells Hormone Function Reference 
Pancreas: 
Islets of 
Langerhans 
β-cells 
Insulin 
Promotes glucose uptake by cells 
Kotas and Medzhitov, 2015 
Promotes protein and fat synthesis 
Promotes use of glucose as an energy source 
 
Suppresses postprandial glucagon secretion 
Amylin, or islet 
amyloid polypeptide 
(IAPP) 
Supresses postprandial glucagon secretion Schmitz, Brock, & Rungby, 2004 and 
Slows gastric emptying Gedulin and Young, 1998 
α-cells Glucagon 
Stimulates the breakdown of stored liver 
glycogen 
Aronoff, Berkowitz, Shreiner, & Want, 
2004 Promotes hepatic gluconeogenesis 
Promotes hepatic ketogenesis 
Intestine L-cells GLP-1 
Enhances glucose-dependent insulin 
secretion 
Drucker, 2007; Lim et al., 2009 
Suppresses postprandial glucagon secretion 
Slows gastric emptying 
Reduces food intake and body weight 
Promotes cell health 
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Organ Cells Hormone Function Reference 
  
K-cells GIP-1 
 Enhances glucose-dependent insulin 
secretion 
Seino, Fukushima, & Yabe, 2010 
  Promotes bone formation 
       Promotes fat deposition 
Stomach  Ghrelin cells Ghrelin Promotes hunger Klok, Jakobsdottir, & Drent, 2007 
Adipose 
Tissue 
  
Leptin 
  Decrease nutrient intake 
Guerre-Millo, 2002 and Ouchi et al., 
2011 
Increase energy expenditure 
Regulates weight gain 
  
Acyl simulation 
protein 
 Increased glucose uptake by adipocytes 
Yang et al., 2006 and Havel, 2014    Increased lipogenesis 
 Decreased lipolysis 
  Adiponectin Insulin sensitizing hormone Ouchi et al., 2011 and Havel, 2014  
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1.1.2  Glucose Transporters 
Hormones described earlier act on cells and tissues to bring about the expression and 
activity of glucose transporters. Glucose transport in the body is carried out 2 types of 
glucose transporters (Table 1.2), facultative glucose transporters (GLUT) and sodium 
dependent glucose transporters (SGLT) (Wood & Trayhurn, 2003). 
The GLUT family of proteins are encoded by SLC2 genes and belong to the major 
facilitator superfamily (MFS) of evolutionary related proteins and have 12 
transmembrane helices and carry out glucose transport through facilitated diffusion 
(Wood & Trayhurn, 2003). 14 GLUT isoforms have been identified and are divided into 
3 classes based on sequence homology. SGLT are encoded for SLC5 genes, have 14 
transmembrane helices and carryout glucose transport against an electrochemical 
gradient (Harada & Inagaki, 2012; Thorens & Mueckler, 2014; Wood & Trayhurn, 
2003). 
SGLTs are usually found in luminal walls of the small intestine and in proximal tubules 
of the kidney where they bring about glucose transport from the gastrointestinal (GI) 
tract into tissues (Harada & Inagaki, 2012; Wood & Trayhurn, 2003). SGLT1 is also 
thought to promote incretin secretion. SGLT1 also works in conjunction with GLUT2 
in enterocytes of the small intestine to remove glucose from the GI tract (Gorboulev et 
al., 2012). SGLT2 is expressed in kidneys where it is thought to be responsible for the 
majority of glucose clearance in S1 and S2 cells (Harada & Inagaki, 2012). SGLT3 has 
been thought to act as a glucose sensor (Bianchi & Dez-Sampedro, 2010). Other SGLTs 
have been identified but their role remains yet to be identified.  
The major GLUT proteins that have been studied belong to class 1: 
GLUT1: GLUT1 is predominantly expressed in brain and erythrocytes but is present on 
most cells in conjunction with other GLUT proteins. It has a very high affinity of 
glucose but can also transport galactose, glucosamine and mannose (Thorens, 2014; 
Young et al., 2011). 
GLUT2: GLUT2  has low affinity for glucose and is expressed in hepatocytes, pancreatic 
β where it is thought to play a role in glucose sensing and insulin secretion, intestinal 
enterocytes and in kidneys (Thorens, 2014; Thorens & Mueckler, 2014). 
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GLUT3: GLUT3 is expressed in many brains cell and is thought to be a neuronal 
transporter but is also found in heart, sperm, pre-implantation embryo (Simpson et al., 
2008) 
GLUT4: GLUT4 is the major glucose transporter in insulin target tissue and is 
responsible for the majority of glucose clearance after a meal. It is expressed in muscle, 
adipose and liver; however it has recently been shown to be expressed on the 
membrane of monocytes (Dimitriadis et al., 2005). GLUT4 expression has also been 
shown to increase in muscle of athletes while its expression has been shown to be 
reduced in obese individuals (Timothy Garvey et al., 1991). 
GLUT5: GLUT5 is a transporter of fructose and is found in kidney, testis, muscle, 
adipose tissue and brain. With an increasing rise in fructose consumption GLUT5 has 
now been implicated to induce breast cancer (Douard & Ferraris, 2008). 
GLUT8: GLUT8 is a glucose transporter found in testis, brain and in differentiating 
spermatocytes (Roth et al., 2002). It has a high affinity for glucose and has been shown 
in blastocysts to play an important role in survival suggesting its importance in 
development (Pinto, Carayannopoulos, Hoehn, Dowd, & Moley, 2002; Thorens & 
Mueckler, 2014). 
GLUT9: GLUT9 is expressed in liver and kidney and thought to be a urate transporter 
(Anzai et al., 2008). 
GLUT10 to GLUT 14: GLUT10 to GLUT14 have been identified through sequencing of 
the human genome but their physiological relevance remains to be elucidated (Thorens 
& Mueckler, 2014). 
Table 1.2 summarises all the glucose transporters involved in glucose homeostasis  
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Table 1.2  Glucose transporters 
Protein Km (mM) location  Function Reference 
Facultative Glucose transporters (GLUT) SCL2 genes 
GLUT1 3-7 Ubiquitous Basal glucose uptake (Young et al., 2011) 
GLUT2 17 Liver, islets, kidney, 
small intestine 
High capacity/low affinity (Thorens, 2014) 
GLUT3 1.4 Brain, nerve cells Neuronal transport (Simpson et al., 2008) 
GLUT4 6.6 Muscle, fat, heart Insulin-regulated transport (Garvey et al., 1998; Wood & 
Trayhurn, 2003) 
GLUT5  Testis, brain, kidney, 
muscle and adipose 
tissue 
Fructose transporter and has been 
implicated in breast cancer 
(Douard & Ferraris, 2008) 
GLUT8 ~2 testis, brain and 
differentiating 
spermatocytes 
Role in embryonic developments of 
the blastocyst 
(Pinto et al., 2002) 
GLUT9   Urate transporter (Anzai et al., 2008) 
Na+/glucose cotransporters (SGLT) SLC5 genes 
SGLT1 0.2 Kidney, intestine Glucose reabsorption  (Gorboulev et al., 2012) 
SGLT2 10 Kidney Low affinity glucose reabsorption  (Harada & Inagaki, 2012) 
SGLT3 2 Small intestine, skeletal 
muscle 
Glucose activated Na+ transport (Bianchi & Dez-Sampedro, 2010) 
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As this study investigated diabetes, GLUT4 expression was the main focus as it is the 
major insulin sensitive glucose transporter.  
 
1.1.3 Insulin Signalling 
Insulin secreted by the β cell of the pancreas binds to insulin receptors (IR) on insulin 
target tissues. Binding of insulin to IR causes auto-phosphorylation of the IR on 
tyrosine residues (Nystrom & Quon, 1999; Saltiel & Kahn, 2001). IR then activates two 
major insulin signalling cascades namely Phosphotidyl Inositol 3 Kinase/ Akt 
(PI3K/Akt) (Akt is also known as protein kinase B (PKB)) and the RAS-mitogen 
activated protein kinase (RAS/MAPK) cascade (de Luca & Olefsky, 2008; Nystrom & 
Quon, 1999). PI3k/Akt brings about the translocation of GLUT4 from internal vesicles, 
supress gluconeogenesis while the RAS/MAPK brings about gene expression (Chang, 
Chiang, & Alan, 2006). All these process are mediated by the insulin receptor substrate 
(IRS). Two isoforms of IRS are known; IRS-1 is thought to play a role in glucose 
metabolism whilst IRS-2 is thought to play a role in lipid metabolism (de Luca & 
Olefsky, 2008). Activated IR phosphorylates IRS on tyrosine residues and activates IRS 
and allows phosphotidyl inositol 3 phosphate kinase (PI3K) to bind to IRS via its SH2 
domain and then activates Akt/PKB (Björnholm & Zierath, 2005; Nystrom & Quon, 
1999). It also translocate to the membrane and binds to RAS to bring about gene 
expression. Akt phosphorylates GSK-3 and deactivates it which in turn prevents the 
phosphorylation of glycogen synthase kinase which is un-phosphorylated by protein 
phosphatase 1 and brings about glycogen synthesis (Fröjdö, Vidal, & Pirola, 2009).  
These pathways are activated by tyrosine phosphorylation of IR and IRS and down 
regulated by serine phosphorylation. Serine phosphorylation is carried out by various 
signalling serine kinases such as Inhibitor kappa B kinase β (IKKβ), protein kinase C 
(PKC) and c-Jun N terminal kinase (JNK). Serine phosphorylation of IRS1 inhibits signal 
transduction while tyrosine phosphorylation promotes insulin signal transduction 
(Boura-Halfon & Zick, 2009). Heat shock proteins (HSP) inhibit serine 
phosphorylation of IRS-1 through down regulation of IKKβ and JNK (Simar, Jacques, & 
Caillaud, 2012). In diabetes there is a lack of HSP and has been thought to prolong 
inflammation and increase insulin resistance. Several studies have shown induction of 
 2 | P a g e  
 
HSP through hyperthermia or through treatment with membrane fluidizer can 
improve insulin sensitivity (Chung et al., 2008; Hargitai et al., 2003; Karpe & Tikoo, 
2014). 
 
1.2  Diabetes 
Diabetes is a condition where there is loss of control in glucose homeostasis. This leads 
to impaired glucose disposal by insulin target tissues. Type 1 diabetes is considered an 
autoimmune disease where pancreatic β cells are targeted by the host immune system 
and destroyed; while type 2 diabetes is caused by excessive nutrient intake coupled 
with unhealthy lifestyle choices. The complications that arise as a result of impaired 
glucose homeostasis affects both type 1 and type 2 diabetic patients and is caused by 
low level chronic inflammation in the patient.  Impaired glucose homeostasis causes 
several clinical complications throughout the body such as:  
 Nephropathy: Diabetic patients have a higher risk of developing end stage renal 
failure characterised by protein urea and are the single most reason for kidney 
transplant in patients (Marshal 2004). 
 Retinopathy:  Diabetic retinopathy is the leading cause of blindness in patients 
aged between 20-74 years (Davey et al., 2014).  
 Neuropathy: Hyperglycaemic conditions cause the loss and dysfunction of 
somatic, autonomic and motor neurons which undermine the patient’s ability 
to feel pain or move the limb. This is brought about by local ischemic conditions 
that have occurred over time due to the systemic loss of peripheral capillaries 
which cut of blood supply and consequent supply of oxygen and nutrients to 
peripheral tissues (Yagihashi, Mizukami, & Sugimoto, 2011). Other 
compounding factors such as chronic inflammation, oxidative damage to 
endothelial cells and neurones by advanced glycated end products (AGE), 
presence of inflammatory cytokines in peripheral tissue bring about the loss of 
neurons and blood vessels in peripheral tissues (Brownlee, 2005). This 
eventually leads to the formation of non-healing chronic wounds, infection of 
the limb and its subsequent amputation (Davey et al., 2014). 
 Cardiovascular complications: type 2 diabetes patients often suffer from cardiac 
complications such as cardiovascular disease, stroke, and myocardial 
infractions (Davey et.al, 2014).  
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A dramatic rise in cases of diabetes has been brought about by the obesity epidemic. 
Almost 80%-90% of all cases have been of type 2 diabetes (Van Greevenbroek, 
Schalkwijk, & Stehouwer, 2013).  The onset of insulin resistance is the main cause of 
type 2 diabetes. Insulin is a peptide hormone that regulates blood glucose and 
transports glucose into insulin target organs namely liver, muscle and adipose. Insulin 
is secreted by the β cells present on the islets of Langerhans in the pancreas in response 
to high circulating blood glucose (Björnholm & Zierath, 2005). In muscle tissue it 
promotes the translocation of insulin sensitive glucose transporter GLUT 4; in 
hepatocytes it promotes glycogen synthesis and down regulates gluconeogenesis and 
in adipose tissue it promotes uptake of free flowing fatty acids, downregulates lipolysis 
and promotes lipid synthesis (Dimitriadis, Mitrou, Lambadiari, Maratou, & Raptis, 
2011).  
 
1.3 Diabetes: a chronic inflammatory disease 
The main feature of type 2 diabetes is insulin resistance. Inflammation was first linked 
to insulin resistance when a study showed that there were high circulating levels of 
tumour necrosis factor-α (TNF-α) in obese individuals when compared to healthy 
controls (Hotamisligil, Arner, Caro, Atkinson, & Spiegelman, 1995). Investigators also 
found high levels TNF-α being expressed in adipose tissue of obese individuals when 
compared to healthy controls. Furthermore dietary control and resulting weight 
reduction improved insulin sensitivity and reduced circulating levels of TNF-α in obese 
patients (Hotamisligil et al., 1995).  This discovery lead to a plethora of research that 
showed that adipose tissue could produce interleukin-6 (IL-6), macrophage 
chemoattractant protein (MCP-1) and other pro-inflammatory cytokines and other 
molecules that have collectively been referred to as adipokines (Fried, Bunkin, & 
Greenberg, 1998; Kamei et al., 2006; Ouchi et al., 2011).  These pro-inflammatory 
cytokines are produced in response to adipocyte stress due to over nutrition and 
increasing adiposity and appear to create low level inflammation in obese individuals.  
Production of pro-inflammatory cytokines by adipose tissue, binding of non-esterified 
free fatty acids (FFA) to toll-like receptors (TLR) and production of advance glycated 
end products (AGE), recruits immune cells such as macrophages to the site which then 
secrete other cytokines and add to the underlying inflammation in adipose tissue. 
Inflammatory cytokine production activates intracellular signalling cascades in insulin 
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sensitive tissue namely PKC, IKK-NFκB and JNK (Shoelson, Lee, & Goldfine, 2006). 
These signalling cascades act either directly or indirectly to promote insulin resistance 
in insulin sensitive tissue by causing the phosphorylation of insulin receptor substrate 
(IRS) on serine residues as opposed to tyrosine residues and inhibit the insulin 
signalling cascade (Aguirre et al., 2002; Griffin et al., 1999). Inhibition of the insulin 
signalling cascade creates an excess of FFA and sugar in blood which raises fasting 
glucose concentration. The role of each of these signalling cascades in insulin 
resistance is discussed below. 
 
1.3.1 The role of PKC in insulin resistance 
Protein kinase C are a family of serine  kinases that  are activated by diacyl glycerol 
(DAG) and act on several signal transduction pathways that act on cell regulation and 
tumour development (Blobe, Khan, & Hannun, 1995). Evidence of insulin resistance 
caused by PKC isoforms comes from studies performed in muscles using euglycaemic-
hyperinsulinemic clamps and nuclear magnetic resonance of C13 and P31. Researchers 
have demonstrated that increasing concentration of free flowing fatty acids (FFA) in 
blood inhibits the transport of glucose or the phosphorylation of glucose in muscle 
tissue (Roden et al., 1996). This in turn reduces intermuscular glucose 6 phosphate 
levels which would account for the low activity of glycogen synthase (Roden et al., 
1996). GLUT4 translocation was also shown be retained in dense intracellular vesicles 
of insulin-resistant and diabetic patient muscle biopsies (Garvey et al., 1998). In rat 
soleus muscle biopsies phosphorylation of IRS1 on Ser307 instead of tyrosine has been 
shown to cause a decrease in the activity of PI3K in the presence of high intracellular 
lipid metabolites (linoleoyl CoA). An isozyme of novel protein kinase C (PKCθ), a 
serine-threonine kinase activated by diacylglycerol, catalysed the phosphorylation of 
Ser307; however the authors also noted that total concentration of PKCθ reduced after 
5 hours of lipid infusion(Yu et al., 2002). They along with Griffin et al., (1999) have also 
demonstrated that PKCθ translocated to the membrane and cytoplasmic levels of PKCθ  
were lower than controls  (Griffin et al., 1999; Yu et al., 2002). A similar study in 
humans found that the enzymes PKCβll and were raised in healthy non-diabetics in 
response to raised lipid concentrations (Itani, Ruderman, Schmieder, & Boden, 2002). 
The study also confirmed that levels of PKCδ dropped in a time dependent manner as 
described earlier but the levels of total PKC, PKCβll and PKCδ in both membrane and 
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cytosolic fractions increased (Itani et al., 2002). In vitro studies using rat hepatic cell 
line H4IIE, have demonstrated that PKCδ phosphorylates IRS-1 on serine residues 
(Greene, Morrice, Garofalo, & Roth, 2004). 
The role of novel PKC isoforms in insulin resistance has come into question as 
knockout studies in mice have only shown mild and short term protection to insulin 
resistance when given a high fat diet. A short term euglycaemic-hyperinsulinemic 
clamp study in PKCθ knockout mice showed that PKCθ knockout mice were protected 
from insulin resistance when fed a high fat diet (Kim et al., 2004) while long term 
studies have shown that PKCθ knockout mice had increased susceptibility of obesity 
and insulin resistance (Gao et al., 2007). Studies using transgenic mice models 
expressing a dominant negative form of PKCθ have shown that even before the onset 
of obesity they show increased insulin resistance and by 6 to 7 months showed 
increased visceral adiposity when compared to the wild type control (Serra et al., 2003)  
A problem with clamp studies is that the results only show a correlation to what is 
being tested and are conducted over a small period of time and so cannot represent 
long term implications which are more characteristic of  diabetes and its related 
complications. The studies have usually been carried out in muscle tissue where PKC 
is the dominant kinase (Schmitz-Peiffer & Biden, 2008).  
 
1.3.2 The role of JNK in insulin resistance 
The c-Jun NH2-terminal kinase (JNK) cascade is a sub group of mitogen activated 
kinases that are specifically activated by environmental stress and inflammation.  TNF-
α and FFA have been shown to activate the cell stress signalling cascades (Shoelson et 
al., 2006). Aguirre et al. (2000) first showed that JNK1 phosphorylates IRS-1 at Ser307 in 
CHO cells upon stimulation with anisomycin. This group also showed that substitution 
of serine to alanine inhibited the phosphorylation of IRS-1 at position 307 (Aguirre et 
al., 2000). The link between JNK and insulin resistance was confirmed in mouse 
models where both diet induced and genetic ob/ob mice expressed high levels of JNK 
in all insulin sensitive tissues. They also showed that gene knockout of JNK1 (JNK-/-) in 
both diet induced and genetic models of obesity decreased adiposity, improved glucose 
tolerance, lowered body weight and lowered circulating levels of insulin when 
compared to JNK1  controls (Hirosumi et al., 2002).  Interestingly JNK2 knockout had 
no protective effect on insulin resistance. JNK has also been shown to be activated by 
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production of reactive oxygen species in the cell and endoplasmic reticulum (ER) stress 
(Back & Kaufman, 2012).  
JNK has also been implicated in in β cell dysfunction and cell death (Kaneto et al., 
2005). An in vitro study using the transfected cell line, AN-ins cells which are derived 
from AN-glu and produce insulin showed higher susceptibility to IL-1β when compared 
glucagon producing AN-glu (Ammendrup et al., 2000). NO synthesis was found to be 
similar in both cells, however JNK phosphorylation and activation were significantly 
increased in AN-ins cells and lead to increased cytotoxicity of these cells to IL-1β 
(Ammendrup et al., 2000). Inhibition of JNK, with JNK binding protein improved cell 
survival and confirmed that JNK1 was associated with β cell cytotoxicity (Ammendrup 
et al., 2000). A novel inhibitory peptide has been developed based on the binding 
domain of JNK interacting protein-1 (JIP1) (Bonny, Oberson, Negri, Sauser, & 
Schorderet, 2001; Kaneto et al., 2004). JIP1 also known as islet-brain 1 (IB1) has been 
shown to competitively inhibit JNK signal transduction and prevent IL-1β induced 
apoptosis in vitro studies using AN-ins cells when conjugated to HIV-TAT, a 10 amino 
acid peptide that allows proteins to be imported into cells  (Bonny et al., 2001).   These 
results were confirmed in both diet induced and genetic mouse (db/db) models studies 
where the inhibitory peptide was tagged with a fluorophore (FITC) and delivered to 
the mice via intraperitoneal injection. Treated mice showed improved glucose 
homeostasis, reduced IRS-1 serine phosphorylation and reduced JNK1 phosphorylation 
in insulin target tissue when compared to untreated mice and mice that received a 
scramble peptide, thus confirming that JNK1 plays an important role in insulin 
resistance (Kaneto et al., 2004).  
 
1.3.3 The role of IKK in insulin resistance 
The IKK-NFκB signalling cascade is normally activated by inflammatory signals in 
response to free radicals, stress, ultraviolet light, and viral and bacterial antigens (Patel 
& Santani, 2009).  NFκB is ubiquitously expressed in all cells where their action is 
tightly regulated by the formation of complexes with its inhibitor called inhibitor of κB 
(IκB). The NFκB.IκB complexes and their activating kinases, inhibitor of κB kinase 
(IKK) (classical activation) and NIK (alternative activation) translocate freely from 
cytoplasm and nucleus leading to low level constitutive expression of NFκB 
transcriptional genes (Birbach et al., 2002). This also enables the signalling cascade to 
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be modulated rapidly in response to changes in the extracellular environment. High 
dose of sodium salicylate and aspirin exhibit their anti-inflammatory effect on cells by 
inhibiting the activity of IKK. Inhibition by the competitive binding of these 
compounds to IKK and reducing its ATP binding efficiency and has been shown in both 
purified proteins and cells (Yin, Yamamoto, & Gaynor, 1998).  Aspirin and salicylate 
have been used for years by clinicians to treat type 2 diabetes and the finding that they 
inhibit IKK-NFκB signalling implicated the role of NFκB in type 2 diabetes (Shoelson, 
Lee, & Yuan, 2003).   
Streptozotocin induced diabetic mice showed poor recovery and increased neuropathy 
when compared to healthy controls following an ischemic insult (Wang, Schmeichel, 
Iida, Schmelzer, & Low, 2006). Diabetic mice showed an increased levels of NFκB when 
compared to controls after seven days of reperfusion suggesting that underlying 
chronic inflammation brought about by IKK-NFκB lead to poor recovery (Wang et al., 
2006). Studies in mouse models overexpressing NFκB have shown that while the mice 
are resistant to diet induced obesity as NKκB was shown to inhibit lipid accumulation 
and adipocyte differentiation, there was an increase in inflammatory cytokine 
production of TNF-α, IL-1, IL-6 and MCP-1 and an increase in adipocyte macrophages 
(Tang et al., 2010). Global gene knockout of (Ikbkb-/-) is lethal in the embryonic stage, 
thus studies in conditional knock outs have been used to investigate the role of NFκB 
in insulin resistance. Hepatocyte knockout (IkbkbΔhep) and myeloid cell knockout  
(IkbkbΔmye) of IKK in mice have improved insulin sensitivity and glucose tolerance in 
response to diet induced insulin resistance when compared to controls; however in 
hepatocyte knockout mice only the hepatocytes retained their insulin resistance whist 
other tissue such as muscle and adipocyte became insulin resistant (Arkan et al., 2005). 
Interestingly myeloid cell knockout mice were completely protected from insulin 
resistance when compared to controls suggesting that myeloid cells such as neutrophils 
and macrophages were key to maintain insulin sensitivity. Induction of inflammation 
by lipopolysaccharide (LPS) injection induced hyperglycaemia in both models but 
hepatocyte knockout mice and myeloid cell knockout mice were more tolerant to 
hyperglycaemia when compared to controls. Treatment of control mice with IL-1 
antagonist prior to LPS injection improved glucose tolerance (Arkan et al., 2005).  This 
study has shown that NFκB signalling plays an important role in insulin resistance and 
that NFκB signalling in immune cells has a larger impact on glucose homeostasis than 
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in insulin sensitive tissue linking inflammation to insulin resistance and diabetes 
(Shoelson, Lee, & Yuan, 2003). 
 
1.4 Factors that cause insulin resistance through inflammation 
Inflammation is brought about by various factors in type 2 diabetes. Insulin resistance 
always manifests in tissue through either one or all 3 signalling cascades described 
above and can be seen in both insulin sensitive and non-sensitive tissue. The major 
factors and their roles in the prognosis of type 2 diabetes are discussed below.   
 
1.4.1  Inflammation induced by FFA binding to TLR 
One mechanism for insulin resistance is brought about by the binding of fatty acids to 
toll-like receptor (TLR) on cells which activate pro-inflammatory responses in cells and 
enable them to secrete cytokines such as TNF-α (Martins et al., 2012). TLR are pattern 
recognising receptors on cell membranes that activate the innate immune system. TLR 
binds to LPS from gram negative bacteria which contain saturated fatty acids (Kim & 
Sears, 2010). Several studies have demonstrated that saturated fatty acids bind to TLR2 
and TLR4 and activate the stress kinase cascade JNK and inflammatory cascade IKK- 
NFκB and bring about insulin resistance. Gene knockout studies in mice have shown 
that knock out mice have better tolerance to high fat diets and protection from insulin 
resistance. They also have shown a preference for fat metabolism and lower pro-
inflammatory cytokine profile compared to controls  (Ehses et al., 2010; Tsukumo et 
al., 2007). These studies were carried out in germ free conditions, however TLR2 
knockout mice when kept under normal conditions have been shown to exhibit 
diseased phenotypic symptoms of insulin resistance implying that gut microbes and 
environment may also play a role in insulin sensitivity (Caricilli et al., 2011). They 
further demonstrated that treatment with antibiotics returned gut microbes 
population to ones found in the wild type control and returned glucose tolerance to 
that of wild type controls. They also showed that transplantation of gut microflora from 
TLR2-/- mice to wild type controls yielded insulin resistance in wild type mice (Caricilli 
et al., 2011). TLR4 knockout Sprague Dawley rats showed a reduction in calorie intake 
but were not protected from insulin resistance and development of fatty liver compared 
to the controls when gavage (force-feeding via a tube) fed a high fat diet (Galbo et al., 
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2013).  The binding of saturated fatty acids to TLR forms a very plausible mechanism 
linking insulin resistance to inflammation as high levels of saturated fatty acids are 
present type 2 diabetes which is thought to be the cause of chronic low level 
inflammation in insulin target tissues. 
Another issue with studies that suggest saturated fatty acids bind to TLR do not 
account for the LPS contamination present in the experiments that could give them 
false positive results (Kim & Sears, 2010; Martins et al., 2012). LPS or endotoxin levels 
can be directly measured but often render the sample unusable moreover, they are 
designed to measure endotoxin levels in water and not cell culture components.  Some 
studies have measured endotoxin levels indirectly (Kim & Sears, 2010). From these 
studies it can be concluded that high fat and fructose diets change the gut microflora 
and increase the levels of LPS in blood causing endotoxemia which in turn is recognised 
by TLR present on cells and brings about chronic low level inflammation and insulin 
resistance in type 2 diabetes; thus saturated fatty acids are indirectly responsible for 
TLR activation and insulin resistance. A second mechanism for FFA binding to TLR 4 
has also been identified through a the binding of FFA to fetuin A (Fet A), a glycoprotein 
secreted by liver that has been shown in vitro to act as a carrier for the incorporation 
of FFA into cells (Cayatte, Kumbla, & Subbiah, 1990). Raised circulating Fet A levels 
have been shown in in the serum of obese diabetic humans, in diet induced insulin 
resistant and genetically modified murine models (Pal et al., 2012). Furthermore they 
have demonstrated that gene knockdown of either Fet A or TLR 4 in mice, reduced 
levels of TNF-α IL-6 and phosphorylated NF B and protected them form insulin 
resistance induced by a high fat diet (Pal et al., 2012). 
 
1.4.2  Oxidative stress 
Oxidative stress is brought about by the presence of high circulating glucose levels and 
FFA in blood that are not disposed of by insulin target tissue. These form permanent 
complexes with plasma proteins, lipids and nucleic acids through Maillard reaction and 
become advanced glycated end products (AGE) (Singh, Barden, Mori, & Beilin, 2001). 
The formation of AGE is a slow process catalysed by metal ions and thus targets long 
lived proteins such as connective tissue and collagen in the extracellular matrix, myelin 
and tubulin (Singh et al., 2001). This random glycoxidation of sugar moieties to 
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proteins and the subsequent formation of AGE yields a heterogeneous  mixture of 
chemically modified proteins (Boyer et al., 2015).  
Production of AGE has been implicated in the development of diabetic retinopathy and 
nephropathy in a dose dependent manner and the amount of AGE reflected the 
oxidative stress within the patient (McCance et al., 1993). Nε-[carboxymethyl]-lysine 
(CML) is one the most well characterised AGE and can be formed from both lipid and 
glucose oxidation and is thought to be an important biomarker for oxidative stress (Fu 
et al., 1996). Another feature of AGE is to form cross links with matrix proteins which 
increase their resistance to proteolytic degradation and decrease flexibility of support 
proteins. In vitro studies show that treatment of collagen plates with methylglyoxal 
resulted in decreased adhesion of MG63 and HT1080 in a dose depended manner when 
compared to untreated control plates (Paul & Bailey, 1999). These findings are 
confirmed in post-mortem studies of human aortae where arterial stiffness had a direct 
correlation to increased cross-link formation by NFC-1 (an AGE formed from glucose 
and lysine) in collagen and was associated with increased denaturation temperature, 
resistance to enzymatic degradation and decreased solubility in aortae of diabetic 
individuals when compared to age matched non diabetic controls (Sims, Rasmussen, 
Oxlund, & Bailey, 1996). 
AGE can also bind to its receptor, receptor for advanced glycated end products (RAGE) 
and bring about inflammatory responses in tissue. Several receptors have been 
identified and are expressed in monocytes, macrophages, endothelial cells, astrocytes, 
microglia and pericytes (Singh et al., 2001). Binding of AGE to its receptor (RAGE) has 
been shown to activate IKK-NFκB signalling cascade and bring about the transduction 
of inflammatory signals whilst the binding of AGE to AGER-1, another receptor for AGE 
has been shown to be protective (Boyer et al., 2015; Ott et al., 2014). 
 
1.4.3 ER stress 
Before the onset of obesity and insulin resistance pancreatic β cell increase in size and 
number as compensatory response to over nutrition (Back & Kaufman, 2012). This has 
been shown in Zucker (fa/fa) rats to occur at 5 weeks and preceded insulin resistance 
which began between 7 to 10 weeks (Jetton et al., 2005). As insulin resistance increases 
and results in overt type 2 diabetes pancreatic β cells can no longer compensate for the 
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increasing demand for insulin in response to hyperglycaemic and hyperlipidaemia and 
eventually fail and begin to die through apoptosis (Back & Kaufman, 2012).  
Insulin is the major protein synthesised and stored in pancreatic β cells and its 
synthesis occurs in a dose dependent manner in response to glucose (Schuit, In’t Veld, 
& Pipeleers, 1988). This imposes a large metabolic load on its endoplasmic reticulum 
(ER). The ER is the site of all synthesis within the cell and changes to cell cycle or the 
response to external stimuli can have significant impact of the ER of a cell. When the 
homeostasis of the ER is hindered the unfolded protein response (UPR) is activated 
and cell chaperones assist in the refolding and clearance of protein aggregates from the 
ER lumen. Failure of the UPR results in the activation of pro-apoptotic signals and leads 
to cell death (Morimoto, RI, Christen, Shen, & Frydman, 2013).  
FFA and inflammatory cytokines have been shown to induce apoptosis in β cells, 
however their mode of action is different. Cytokines such as IL-1β induce apoptosis 
through ER stress by the production of iNOS, activation of NFκB genes and increase 
expression of MCP-1, whilst FFA (palmitate and oleate) induce ER stress but do not 
activate iNOS or NFκB (Kharroubi et al., 2004). It remains unclear as to the exact 
mechanisms by which saturated FFA induce apoptosis in β cells, however long chain 
FFA have been shown to induce a mild ER stress in pancreaticβcells (Back & Kaufman, 
2012). Studies in CHO cells that have been induced to produce human coagulation 
factor 8 (FVIII) but are unable to secrete it have demonstrated that UPR produces ROS 
and that treatment with antioxidants improves cell survival and promotes FVIII 
secretion (Malhotra et al., 2008). Pancreatic β cells have been shown to have very little 
antioxidant enzymes such as glutathione peroxidase and they do not produce catalase, 
thus they are susceptible to oxidative damage (Back & Kaufman, 2012). Treatment of β 
cells with lard oil and oleate promoted insulin secretion but delayed proinsulin 
synthesis in both in vivo and in vitro models, suggesting that prolonged exposure of 
FFA would not allow β cells to regenerate their insulin stores and would invariably 
affect cell function in the long run and cause ER stress (Bollheimer, Skelly, Chester, 
McGarry, & Rhodes, 1998). It is unclear as to exactly how ER stress is induced in β cells, 
increasing evidence points to both lipotoxicity and glucotoxicity interfere with 
proinsulin synthesis and induces UPR that eventually leads to ROS generation and β 
cell death (Back & Kaufman, 2012).  
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The resulting insulin resistance only progresses the inflammation over time and leads 
to β cell death the development of type 2 diabetes and their complications. These 
conditions are fully reversible in early to middle stages by exercise and diet control and 
reduce complications that arise later stages of the disease. 
 
1.5 Wound healing 
Wound healing or repairing damage to maintain cell or tissue integrity is one of the 
most important facets of survival and can be seen in every living organism studied 
(Sonnemann & Bement, 2011; Velnar, Bailey, & Smrkolj, 2009). It is also one of the most 
intensive areas of research as chronic (non-healing) wounds and complicated wounds 
present a clinical problem and are a major cause for patient mortality and morbidity. 
They also have a huge impact on healthcare systems; for instance in the UK the cost of 
caring for chronic wounds for the year 2005-2006 was conservatively estimated to be 
between £2.3-3.1billon (Posnett & Franks, 2010).   
Any disruption in the normal anatomical structure and function of tissue can be 
defined as a wound. They can be caused by physical injury, disease, age and stress. 
Wound healing irrespective of the source of the wound is a dynamic physiological 
response to the wound to restore tissue structure and cell integrity (Velnar et al., 2009).  
Dermal wound healing process is a dynamic process and most stages overlap each 
other; but for the ease of understanding can be divided in to 4 phases 
 Haemostasis phase: Here the wound closed by the rapid formation of a clot. 
Haemostasis is initiated immediately post injury (Eming, Martin, & Tomic-
Canic, 2014). The clot also provides scaffolding for the recruitment of other 
cells that would initiate the healing cascade (J. Li, Chen, & Kirsner, 2007).  
 Inflammatory phase: Immune cells such as neutrophils and monocytes move 
in to the site to kill invading microorganisms and clear up cell debris. This 
phase begins immediately post injury and is also brought in by platelets that 
secrete cytokines that act as chemo-attractants and recruit leukocytes to the 
wound. This phase usually lasts for 24h to 48h but in some cases can lasts for 
up to 2 weeks (Bielefeld, Amini-Nik, & Alman, 2013; J. Li et al., 2007). The 
appearance of neutrophils can be seen within the first hour of the wound and 
are peak at 24h whilst macrophages begin to appear at 24h and peak at 48h-
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72h and lymphocytes begin to appear after 72h (Harper, Young, & McNaught, 
2014)  
 Proliferative phase: Growth factors released by macrophages and 
surrounding cells allow for migration of fibroblasts, endothelial and epithelial 
cells into the wound and form a temporary extra cellular matrix known as 
granulation tissue. Fibroblasts are one of the cells that be seen during the 
proliferative phase which begins at 120h post injury (Harper et al., 2014). 
They laydown new extra cellular matrix (ECM) and degrade the old and 
damaged ECM. The cells differentiate at wound edge to form myofibroblasts 
and initiate wound contraction(Darby, Laverdet, Bonte, & Desmouliere, 
2014).  
 Remodelling phase. Removal of scar tissue and signs of an injury that 
occurred. This phase can last for a long time and is thought to be regulated 
by T lymphocytes (Guo & Dipietro, 2010; Velnar et al., 2009).   
Upon coming into contact with collagen and damaged vessels platelets begin to 
aggregate, adhere and release fibrinogen, fibronectin, vitronectin and several growth 
factors such as platelet derived growth factor (PDGF), vascular endothelial growth 
factor(VEDGF),  transforming growth factor-α (TGF-α) and transforming growth 
factor-β (TGF-β) (Sonnemann & Bement, 2011; Velnar et al., 2009). They also ensure 
the sufficient exsanguination of the wound site which in turn provides a matrix for 
immune cells, fibroblasts and keratinocytes cells (Velnar et al., 2009). These growth 
factors allow immune cells to migrate to the wound site through chemotaxis. The 
platelets themselves allow prothrombin to be converted to thrombin which in turn 
converts fibrinogen to fibrin and results in clot formation (Olczyk, Mencner, & 
Komosinska-vassev, 2014).  The first immune cells to appear at the wound site are 
neutrophils which begin to appear  and their primary function is phagocytosis of the 
cell debris and invading microbes (Guo & Dipietro, 2010). They also release several 
proteases and reactive oxygen species (ROS) such as nitric oxide (NO) which can cause 
damage to surrounding cells.  
Monocytes and macrophages are the next cells that move in to the wound site. 
Monocytes undergo maturation and become resident tissue macrophages and are an 
important source of cytokines for the healing wound such as TNF-α and IL-1 (Guo & 
Dipietro, 2010). They release matrix metalloproteinase such as collagenases and 
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elastases and perform debridement of the wound through phagocytosis of microbes 
and neutrophils in the early inflammatory phase (Olczyk et al., 2014). In the late 
inflammatory phase they become an important sources of growth factors that promote 
fibroblast migration and proliferation and pave the way for the proliferative phase 
(Velnar et al., 2009). Studies in guinea pig models have shown that removal of 
macrophages by hydrocortisone acetate injection and treatment with anti-macrophage 
serum resulted in delayed wound healing, poor wound debridement and delayed and 
reduced fibroblast migration after 10 ten days (Leibovich & Ross, 1975). 
In the proliferative phase fibroblasts migrate into the wound bed in response to the 
growth factors secreted by macrophages and begin to divide rapidly and produce 
collagen and major components of the extracellular matrix (ECM) collectively called 
granulation tissue. Fibroblasts at the wound edge differentiate into myo-fibroblasts 
that begin to close the wound and from a scar (Darby et al., 2014). Endothelial cells 
divide and bring about angiogenesis in response to vascular endothelial growth factor 
(VEGF) and nitric oxide (NO) to alleviate the temporary hypoxic conditions that were 
present in haemostasis and inflammatory phases. With the ECM restored epithelial 
cells migrate in to the wound through cell division and migration and bring about the 
restoration of function to the wound. The eventual outcome is the formation of scar 
tissue. Once a scar is formed the remodelling phase begins and can last for a long 
period. Here the scar tissue is strengthened and replaced with collagen I fibres and the 
tissue is remodelled to restore it closely to its original form. The remodelling phase id 
brought about by lymphocytes (Bielefeld et al., 2013). Embryonic wound healing has 
been shown to heal completely without the development of scar tissue while adult 
wound healing scar tissue (Sonnemann & Bement, 2011). Some cells such a sebaceous 
glands and hair follicles are lost and are never replaced in post wound repair (Bielefeld 
et al., 2013). 
The process described here was for an acute wound and depends on several cell types 
working in conjunction to bring about wound healing. Complications in wound healing 
arise when one of the cells do not carry out their function in lieu of other compounding 
factors such as diabetes. In diabetes wound healing is impaired and the wound remains 
in a quasi-inflammatory phase (Blakytny & Jude, 2006).     
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1.5.1 Diabetic wound healing 
Inflammation in insulin sensitive organs caused by excessive circulating nutrients bring 
about chronic inflammation and cause insulin resistance in type 2 diabetes. Peripheral 
neuropathy causes a delay in the healing of both acute and chronic wounds in diabetic 
patients. Diabetic wounds are characterised by low production of growth factors, lack 
of macrophages, presence of high matrix metalloproteinase, little to no migration and 
proliferation of keratinocytes and fibroblasts, poor angiogenesis, prolonged hypoxia 
and poor debridement of necrotic tissue by immune cells (Brem & Tomic-Canic, 2007). 
Chronic diabetic wounds such as diabetic foot ulcers present a major problem as they 
significantly affect patient mortality, morbidity and have a huge cost implication on 
the health care system.  With an increasing ageing population in the west, treatment 
of chronic diabetic wounds is set to put even more pressure on health care systems, 
therefore understanding the molecular mechanisms behind poor clinical outcomes and 
research into new therapies is very important in order to improve patient mortality and 
morbidity. 
Studies form both murine models and human wound biopsies have shown that there 
is a consistent delay of immune cell recruitment (Blakytny & Jude, 2006). This could 
be attributed to the presence of a large number of free radicals produced by nitric oxide 
(NO). NO is produced by endothelial cells, keratinocytes, melanocytes and Langerhans 
cells in the dermal wound (Bruch-Gerharz, Ruzicka, & Kolb-Bachofen, 1998).  It has a 
very transient role in normal physiological conditions where it acts as a secondary 
messenger in cells. NO action can cause vasodilation of smooth muscles and increases 
blood flow into tissues, act as a neurotransmitter between neurons or as an acute toxin 
released by macrophages during inflammatory responses (Bruch-Gerharz et al., 1998).  
Nitric oxide is synthesised by two enzymes, nitric oxide synthase (NOS) and arginase 
using L-arginine as substrate and can be induced during inflammation by inducible 
NOS (iNOS). In normal wound healing NO is synthesised by NOS in the inflammatory 
phase and by arginase in the proliferative phase where arginine is converted to 
ornithine which in turn is converted to proline that is used to create collagen. In 
patients with diabetes who suffer from chronic venous ulcers; NOS, iNOS activity and 
arginase activity are upregulated and produce high levels of NO with iNOS being the 
dominant generator of NO. Excess NO generates free radicals, peroxynitrite and 
superoxide, that can cause apoptosis of cells. (Abd-El-Aleem et al., 2000; Jude, Boulton, 
Ferguson, & Appleton, 1999). Treatment with L-arginine to foot ulcers has been shown 
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to improve wound healing in diabetes (Arana, Paz, González, Méndez, & Méndez, 
2004).  
In vitro studies have shown excessive iNOS down regulates the expression of vascular 
cell adhesion molecule-1 (VCAM-1) that allows leukocytes to bind to the endothelial 
cell wall and migrate towards the wound and could possibly further delay the 
recruitment of monocytes in diabetic wound healing (Peng, Spiecker, & Liao, 1998).  
These findings are further corroborated in an in vivo study that showed delayed 
recruitment of macrophages in db/db mice was a result of a downregulation in mRNA 
levels for receptors in macrophage inflammatory protein 2 (MIP2) and macrophage 
chemoattractant protein 1 (MCP1) (Wetzler, Kampfer, Stallmeyer, Pfeilschifter, & 
Frank, 2000).  
Another feature of diabetic wounds is the lack of growth factors such as TGF-β and its 
isoforms. In healthy wounds TGF-β1 and TGF-β2 expression is increased at the early 
stages of wound healing whilst TGF-β3 is increased in the later stages of wound 
healing(Frank, Madlener, & Werner, 1996). Gene knockout of TGF-β1 in mice have 
shown to have delayed wound healing (Crowe, Doetschman, & Greenhalgh, 2000). 
Dermal gene knock out studies of TGF-β2 receptor in mouse models have shown that 
TGF-β is responsible for the recruitment of macrophages and scar formation as both 
were significantly reduced in the knockout mice. The study also showed that wound 
closure was mediated by accelerated re-epithelization and reduced granular tissue 
formation (Martinez-Ferrer et al., 2010).   Jude et al. (2002), have shown that TGF-β1 
expression was markedly reduced in wound biopsies of diabetic foot ulcers and diabetic 
skin while TGF-β3 levels were raised in both conditions. TGF-β2 levels were also 
significantly higher but lower than TGF-β3. They also showed that the receptors for 
TGF-β remained unchanged in diabetic skin and diabetic ulcers   (Jude, Blakytny, 
Bulmer, Boulton, & Ferguson, 2002). Low levels of TGF-β1 has been implicated in the 
increased activity of iNOS by macrophages and the overall raised levels of NO in 
diabetic foot ulcers (Jude et al., 1999).  
Another growth factor that is important in wound healing is platelet derived growth 
factor (PDGF). Almost all cells in the healing wound are sensitive to PDGF (Heldin & 
Westermark, 1999).  PDGF induces fibroblast proliferation (Pierce et al., 1994) and 
increases production of matrix proteins such as fibronectin (Blatti, Foster, 
Ranganathan, Moses, & Getz, 1988) and  hyaluronic acid (Heldin, Laurent, & Heldin, 
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1989). Pierce et al. (1995) have shown that PDGF was present in healthy healing wounds 
while non-healing wounds showed no expression of PDGF. Furthermore treatment 
with recombinant PDGF-BB (rPDGF-BB) improved wound healing as cells in the 
granulation tissue expressed high levels of the PDGF-BB receptor (Pierce et al., 1995). 
Wound fluid analysis of diabetic foot ulcers have shown very little mitogenic activity 
in diabetic foot ulcers and that samples taken post treatment with rPDGF-BB showed 
increased mitogenic activity (Castronuovo, Ghobrial, Giusti, Rudolph, & Smiell, 1998). 
Topical application of rPDGF-BB completed healed diabetic foot ulcers in conjunction 
with proper wound care (Castronuovo et al., 1998). PDGF levels are thought to be 
upregulated by TGF-β and this could possibly one of the reasons why PDGF levels 
remain low in diabetic wounds (Blakytny & Jude, 2006). Today PDGF-BB is the only 
commercially available growth factor on the market that is used to treat chronic 
wounds (Castronuovo et al., 1998).  
Other compounding factors that prevent diabetic wound closure are poor 
angiogenesis, hypoxia and the presence of matrix metalloproteinase in high quantities 
that maintain the wound in its inflammatory phase and do not let it progress any 
further. Studies have shown that monocytes express the receptor for VEGF, VEGFR1 
and high levels of VEGF are present in diabetic wounds; however their response to 
VEGF stimulation is impaired in diabetes. They do not produce other endothelial 
growth factors necessary for angiogenesis in response to hypoxia and allow hypoxia to 
prevail (Kolluru, Bir, & Kevil, 2012; Waltenberger, Lange, & Kranz, 2000). Wound 
biopsies of diabetic foot have shown increased metalloproteinase activity in patients 
with diabetes when compared to age-matched healthy controls. There were low levels 
of tissue inhibitor of matrix metalloproteinase (TIMP) in diabetics in comparison to 
controls (Lobmann et al., 2002). Matrix metalloproteinase degrade support proteins of 
the ECM and would prevent new ECM form being produced, thus impairing wound 
healing. 
 
1.5.2 Macrophage dysfunction 
Macrophages are central to the resolution of the inflammatory phase as they carryout 
wound debridement and are a source of growth factors and cytokines during early and 
late inflammatory phase (Samaan, 2011). Studies in adipocytes (3T3-L1) cultured in 
hypoxic medium have shown that adipocytes induce the expression of hypoxia-
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inducible factor-1α (HIF-1α), and produce increase expression of pro-inflammatory 
cytokines TNF- IL-6 and MCP-1 and down regulation of anti-inflammatory adipokine, 
adiponectin (Yu et al., 2011). Media transfer from hypoxic adipocytes to C2C12 
myotubes resulted in insulin resistance by elevating serine phosphorylation of IRS-1 
through JNK1 (Yu et al., 2011). Antibody neutralization of IL-6 and MCP-1 returned 
glucose homeostasis to normal as did heat inactivation of cultured media (Yu et al., 
2011). Trans well migration assays also showed that hypoxic adipocytes promoted 
migration of macrophages, suggesting adipose tissue hypoxia and subsequent 
recruitment of macrophages is a key step in the prognosis of type 2 diabetes in vivo (Yu 
et al., 2011). Infiltration of macrophages into white adipose tissue and subsequent 
formation of giant cells has been seen in both wild type and genetic (ob/ob) mouse 
models (Xu et al., 2003). Treatment with insulin sensitising drugs such as rosiglitazone 
reduces inflammatory gene expression in white adipose tissue. Inflammation was not 
observed in liver or muscle and therefore was thought to be adipose tissue specific 
suggesting that, in obesity inflammation first begins in adipose tissue  (Xu et al., 2003).  
Macrophages can be sub divided into 2 groups based on how they are activated; M1 
macrophages are activated in response to interferon (IFN- and lipopolysaccharides 
(LPS) and secrete pro-inflammatory cytokines such as TNF- and produce NO through 
iNOS activity; usually described as classical activation (Gordon & Martinez, 2010). On 
the other hand M2 macrophages are activated in response to IL-4 and IL-13 and secrete 
anti-inflammatory cytokines such as IL-10, upregulate arginase activity and down 
regulate iNOS activity; usually described as alternative activation  (Gordon & Martinez, 
2010; Samaan, 2011). It must be noted that there are several intermediator stages of 
macrophage differentiation as they can be affected by various stimuli that cause them 
to differentiate to varying degrees of M1/M2 and that M1 and M2 classification is just 
describing macrophages at the extreme polar opposite.  It was always thought that 
adipose tissue macrophages (ATM) would be of M1 phenotype as they significantly 
produce pro-inflammatory cytokines, however analysis of ATM by flow cytometry have 
shown that ATM have an M2 phenotype and that there is direct correlation between 
ATM presence and BMI (Zeyda et al., 2007). ATM have also been shown to have 
increased basal expression levels of both pro and anti-inflammatory cytokines when 
compared to peripheral blood monocytes, classically activated macrophages and 
alternatively activated macrophages (Zeyda et al., 2007).  
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IL-4 and STAT6 have been shown to improve insulin sensitivity in mouse hepatocytes 
by down regulation of peroxisome proliferator-activated receptor α (PAPR a nuclear 
receptor that promotes lipid oxidation during fasting conditions (Kersten et al., 1999; 
Ricardo-Gonzalez et al., 2010). This change in turn activates the nuclear hormone 
receptor, peroxisome proliferator-activated receptor (PAPR which promotes lipid 
uptake and adipogenesis. PAPR expression is increased in presence of IL-4 in 
macrophages. A deletion of PAPR in macrophages reduced the expression of M2 
macrophage markers such as Mrcl, Clec7a and Arg1 and these macrophages resembled 
M1 macrophages (Odegaard et al., 2007). The PAPR knock out mice also were insulin 
resistant, implicating the role of PAPR in alternative activation of macrophages. It also 
showed that alternative macrophage activation had a protective effect on obesity 
induced complications (Odegaard et al., 2007).  More recently macrophages present in 
diabetic wounds were found to have reduced levels and reduced expression of PAPR
and its receptor, CD36 and CPT-1 that are normally expressed in M2 on macrophages 
showing that wound healing had not progressed (Mirza et al., 2015). Myeloid knock 
out PAPR significantly delayed wound healing with prolonged expression of 
inflammatory cytokines like IL-1β, TNF-α and delayed expression of TGF-β, VEDGF and 
IGF-1. Treatment with PAPR agonist improved wound healing and showed promise 
as a mode of treatment for diabetic wounds (Mirza et al., 2015).  
These studies have shown the central role of the macrophage in metabolism and 
immunity; where altering the metabolic state of the macrophage can change its 
cytokine profile from pro-inflammatory (M1) to anti-inflammatory (M2) and improve 
clinical outcomes of type 2 diabetes (Bermudez et al., 2010; Ricardo-Gonzalez et al., 
2010). This has provided a new therapeutic target for the treatment of type 2 diabetes 
and other inflammatory diseases such as pancreatic cancer and arthrosclerosis 
(Panunti & Fonseca, 2006; Polvani, Tarocchi, Tempesti, Bencini, & Galli, 2016) .  A class 
of drugs known as thiazolidinediones have been shown to be potent agonist for 
PAPR of which pioglitazone (Actos) and rosiglitazone (Avandia) are currently used 
to treat type 2 diabetes (Bermudez et al., 2010; Panunti & Fonseca, 2006).  
 
1.6 Heat shock proteins and their role in diabetes 
Heat shock response was first observed and described in the 1960s in Drosophila by 
Ritossa in Naples (De Maio, Gabriella Santoro, Tanguay, & Hightower, 2012). The heat 
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shock response or cell stress response is a ubiquitous and highly conserved mechanism 
seen all cell types(Richter, Haslbeck, & Buchner, 2010). When faced with stress such as 
physical (heat, radiation) or pharmacological (heavy metals, xenobiotics) cells 
transcribe and produce heat shock proteins (HSP), molecular chaperones that bring 
help misfolded proteins regain their structure or direct these proteins to the ubiquitin 
proteasome pathway to be degraded (Whitley, Goldberg, & Jordan, 1999). This prevents 
the formation protein aggregates within the cell (Verghese, Abrams, Wang, & Morano, 
2012). HSP have been shown to inhibit apoptotic pathways and prevent the activation 
of caspase 3 and bring about cell survival (C Garrido et al., 1999; Carmen Garrido, 
Gurbuxani, Ravagnan, & Kroemer, 2001). This cyto-protective ability of HSP have also 
been implicated in tumour drug resistance in cancer where cancer cells have been 
shown to produce large amounts of HSP (Lianos et al., 2015) 
HSP have also been shown to have moonlighting functions when they are present 
outside the cells and acts as immune modulators that can bring about pro (Calderwood, 
Mambula, Gray, & Theriault, 2007) or anti-inflammatory responses (Van Noort, Bsibsi, 
Nacken, Gerritsen, & Amor, 2012). In diabetes the expression of inducible HSP72 was 
found to lower in patients with type 2 diabetes when compared to controls (Bruce, 
Carey, Hawley, & Febbraio, 2003; Kurucz et al., 2002). HSP 72 has been shown to have 
an anti-inflammatory effect by causing PBMC to secrete IL-10 and reduce the 
production of TNF-α (Detanico et al., 2004) This would suggest that the lack of HSP 
in type 2 diabetes would hinder the timely resolution of inflammation in a wound. This 
cyto-protective and anti-inflammatory nature of HSP has been the subject of current 
research in diabetes and researchers have used heat shock treatments to show that HSP 
acts on both IKK and JNK signal transduction cascades to bring resolution to the 
inflammation and improve insulin sensitivity (Chung et al., 2008; Kumar Sharma et 
al., 2011; W. Li et al., 2007; Morino et al., 2008).   
It is currently unclear what effects heat shock treatments would have on a diabetic 
wound and if heat shock treatments could improve cell migration of fibroblasts into 
the wound. The effect of heat shock on fibroblast migration was investigated in this 
study by means of a scratch assay. A scratch assay is an in vitro method that is used to 
measure cell migration on a 2 dimensional plane (Liang, Park, & Guan, 2007). 
Adherent cells are grown to confluence and a wound is made using a 200μl pipette tip 
to create a gap by scraping cells of the monolayer to form a wound. This process of 
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physically removing cells replicates wound in vivo conditions. Migration of cells into 
the gap is monitored through microscopy (Jonkman et al., 2014). A scratch assay was 
developed using WS1 cells used to test the effect of heat shock on fibroblast migration 
in response to heat shock treatments. 
Tissue macrophages have a central role to play in wound healing and inflammation. 
Recent studies have shown that heat shock treatments cause monocytes to secrete anti-
inflammatory cytokines (Simar et al., 2012). The study aimed to investigate if 
monocytic cell line U937 expressed GLUT4 and the effects of glucose transport on this 
cell line when treated with insulin, extremes of pH and membrane fluidizers using 
fluorescent glucose analogue 2NBDG.   
  
1.7 Aims 
 The aims of this thesis are as follows: 
 Development and optimization of a scratch assay  
 Test the effect of heat shock on cell migration 
 Optimise a glucose uptake assay and to determine the presence of GLUT4. 
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Chapter 2  Materials and Methods 
2.1  Materials 
2.1.1  Consumables 
 
Table 1: List of consumables used 
Consumable/ equipment Manufactured by Catalogue number 
0.6ml micro centrifuge tubes Star lab E1405-0600 
1.5ml micro centrifuge tubes Star lab S1615-5500 
15ml centrifuge tubes Star lab S1415-0200 
50ml centrifuge tubes Star lab E1450-0200 
Adhesive plate seals Fisher Scientific 11524794 
Microplate flat bottom 96 
well 
Fisher Scientific 11349163 
Microplate V bottom 96 well Fisher Scientific 12697745 
Microplate 12 well flat 
bottom, sterile with lid 
Fisher Scientific 10253041 
Microplate 24 well flat 
bottom, sterile with lid 
Fisher Scientific 10380932 
Microplate 96 well flat 
bottom, sterile with lid 
Fisher Scientific 10687551 
Tissue culture flask 25cm3 Fisher Scientific 10568482 
Tissue culture flask 75cm3 Fisher Scientific 10364131 
Coverslips Fisher Scientific 22-037-169 
Filter paper 3 qualitative Whatman 1003-917 
CooBlue max protein gel 
stain 
Interchim UPR2034A 
Interchim Protein 
quantification kit 
Interchim UP87542A 
Nitrocellulose membrane, 
0.45μm 
Bio-Rad 162-0115 
Nalgene Cryoware cryogenic 
vials 1.8ml 
Thermo Fisher Scientific 5000-0020 
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2.1.2  Sodium Dodecyl Sulphate Poly Acrylamide Del electrophoresis (SDS 
PAGE) and Western blots 
Table 2: List of reagent used for SDS PAGE and Western blot  
Reagent Manufactured by Catalogue number 
Acrylamide Fisher Scientific BP170-500 
N’N’-methylene bisacrylamide BDH 443003N 
(Hydoxymethyl)-methylamine (Tris-base) Fisher Scientific T/3710/60 
Glycine Sigma-Aldrich G7126-500G 
Sodium dodecyl sulphate (SDS) BDH 442444H 
Sucrose Anal R 102744B 
Bromophenol blue Fisons Scientific B/5630/44 
DL-Dithiotheritol Sigma-Aldrich D-0632 
Benzamidine Sigma-Aldrich B-6506 
Ethylene diamine tetra acetic acid (EDTA) Sigma-Aldrich E5134-100G 
Ammonium persulphate Sigma-Aldrich A3678-100G 
Triton X-100 Sigma-Aldrich T9284 
ɛ-Amino-n-caproic acid Sigma-Aldrich A7824 
Tween-20 Sigma-Aldrich P1379-500ML 
Sodium chloride Fisher Scientific S/3160/65 
Methanol Fisher Scientific M/4056/17 
N’N’N’N’Tetramethylethylenediamine 
(TMED) 
Sigma-Aldrich  
Bovine serum albumin (BSA) Fisher Scientific BP9700-100 
Precision Plus™ Western C™ Bio-Rad 1610376 
Precision Protein StrepTactin-Horseradish 
Peroxidase (HRP) Conjugate 
Bio-Rad 1610380 
Mem-PER Eukaryotic Membrane Protein 
Extraction Reagent Kit 
Thermo Fisher 
Scientific 
89826 
SuperSignal™ West Femto maximum 
sensitivity substrate 
Thermo Fisher 
Scientific 
34094 
CooBlue max Protein Gel Stain Interchim R2034A 
Uptima Cooassay Max 1L of Coomassie Max 
reagent 
Interchim UP87542A 
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2.1.3  Cell culture 
Table 3: List of reagent used for cell culture  
Reagent Manufactured by Catalogue number 
WS1 cell line European Collection of 
cell Culture 
88021104 
U937 cell line European Collection of 
cell Culture 
85011440 
MCF-7 cell line European Collection of 
cell Culture 
86012803 
MG-63 cell line European Collection of 
cell Culture 
86051601 
Eagle’s Minimal essential Medium 
(EMEM) with L-glutamine 
Lonza BE12-611F 
Roswell Park Memorial Institute 
(RPMI) 1640 with L-glutamine 
Lonza BE12-702F 
Dimethyl Sulfoxide (DMSO) hybrid 
max 
Sigma-Aldrich D2650-5x5ML 
Foetal bovine serum (FBS), E. U 
Approved, South American origin 
Life technologies 10270-106 
Mitomycin C from Streptomyces 
caespitosus 
Sigma-Aldrich M4287-2MG 
Trypsin-versene EDTA Lonza BE17-161E 
Non-Essential Amino Acid Solution 
(NEAA) 
Sigma-Aldrich M7145 
D-glucose solution (45%) Sigma-Aldrich G8769 
Trypan blue solution (0.4%) Sigma-Aldrich T-8154 
2-deoxy-2-[(7-nitro-2,1,3-
benzoxadiazol-4-yl)amino-D-
glucose (2NBDG) 
Sigma-Aldrich 72987-1MG 
Insulin solution from bovine 
pancreas 
Sigma-Aldrich I0516-5ML 
Culture inserts Ibidi 80209 
Platelet-Derived Growth Factor-BB 
(PDGF-BB) 
Sigma-Aldrich P3201-10UG 
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2.1.4  Antibodies 
Table 4: List of Antibodies used in this study 
Antibody Manufactured by Catalogue no: 
GLUT4 polyclonal Santa Cruz Biotechnologies SC-1608 
Mouse anti-goat IgG-FITC Santa Cruz Biotechnologies SC-2356 
GLUT4 (IF-8) Santa Cruz Biotechnologies SC-53566 
Anti mouse IgG FITC 
conjugate 
Sigma-Aldrich F-0257 
Anti mouse IgG peroxidase Sigma-Aldrich A5278-1ML 
 
2.1.5  Flow cytometry 
Table 5: List of reagents used for flow cytometry 
Reagent Manufactured by Catalogue no: 
1Dulbecco’s phosphate 
buffered saline (DPBS) 
without Ca2+ and MG2+ 
Lonza BE17-513f 
Paraformaldehyde Sigma-Aldrich 158127 
BD Cytofix/Cytoperm™ 
fixation and permeablization 
solution 
BD Biosciences 51-2090KZ 
Phenethyl Alcohol, Kosher Sigma-Aldrich W285811-SAMPLE-K 
Benzyl Alcohol Sigma-Aldrich 30,519-7 
 
2.1.6  Cell viability assays 
Table 6: list of reagents used for cell viability assays 
Reagent Manufactured by Catalogue number 
Propidium iodide Sigma-Aldrich P4170-25MG 
Phenazine Ethosulphate (PES) Santa Cruz Biotechnologies SC-215699 
CellTitre 96®Aqueous 3-(4,5-
dimethylthiazol-2yl)-5-(3-
carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium 
(MTS) Reagent Powder, 1g 
Promega G1111 
5 bromo-2’ deoxy uridine 
(BrdU) cell Proliferation  
(Enzyme-Linked 
Immunosorbent Assay) ELISA 
kit 
Abcam Ab126572 
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2.1.7  Equipment 
Table 7: List of equipment used  
Equipment Manufactured by Catalogue number 
Bio-Rad mini protean 3 gel 
electrophoresis system 
Bio-Rad 165-3301 
Bio-Rad Chemi doc XRS 
molecular imaging system 
Bio-Rad 170-8070 
Power pack Bio-Rad Power pack 1000 
EVOS auto FL microscope Thermo Fisher Scientific AMAFD1000 
EVOS auto FL onstage 
incubator 
Thermo Fisher Scientific AMC1000 
EVOS XL core Thermo Fisher Scientific AMEX1000 
Heraeus Multifuge x1 Thermo Fisher Scientific 75004210 
Hermle Z323K refrigerated 
centrifuge 
VWR International 5210221 
BD Accuri™ C6 flow 
cytometer 
BD Biosciences  
Bright-Line™ 
Haemocytometer 
Sigma-Aldrich Z359629 
Vortex mixer mini Thermo Fisher Scientific GBI-900-010E 
E100 Binocular Microscope Jencons Scientific 450-951 
Bio-Tek Synergy™ HT Multi-
Detection Microplate Reader 
Labtech International Ltd. SIAFR 
Sigma A 1-14 micro centrifuge Sigma-Aldrich 12084 
GXCAM 5 GX Optical ID1122 
TC120 heated circulating 
water bath 
Grant Instruments TC120-P5 
Trans-Blot®Turbo™ blotting 
system 
Bio-Rad 170-4155 
MSC-Advantage™ Class II 
Biological Safety Cabinet 
Thermo Fisher Scientific 51025411 
 
 
2.2  Buffers and solutions 
2.2.1 Cell culture 
All solutions used for cell culture we prepared under aseptic conditions. 
2.2.1.1 Complete culture medium for U937 cells 
To make complete culture medium for U937 cells 50ml of foetal bovine serum (FBS) 
was added to 1000ml of RPMI 1640 with L-glutamine.  The media bottle was labelled 
and stored at -20°C. 
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2.2.1.2 Complete culture medium for MG-63, MCF-7 and WS1 cells 
To make complete culture medium for MG-63, MCF-7 and WS1 cells 50ml of FBS and 
5ml of non-essential amino acid (NEAA) solution (100x) was added to EMEM with L-
glutamine. The media bottle was labelled and stored at -20°C.  
2.2.1.3 Heat inactivated media 
To make heat inactivated media 50ml of FBS was incubated in a water bath at 60°C for 
1h. This heat inactivated FBS was then added to EMEM containing 1% NEAA. The media 
was stored at -20°C. 
2.2.1.4 Freeze media 
To make freeze media 5ml of DMSO (hybrid max) was added to 45ml of FBS. The 
solution was then stored at -20°C.  
2.2.1.5 2NBDG stock solution 
A stock solution of 2NBDG was made by adding 1ml of DPBS 1mg of 2NBDG and stored 
at -20°C. A 1:10 dilution of this stock solution freshly prepared at the beginning of every 
experiment.  10μl of working dilution was used for all experiments.  
2.2.1.6 Mitomycin C stock solution 
To make mitomycin stock solution 4ml of EMEM supplemented with 10% FBS and 1% 
NEAA (complete medium) was added to 2mg of Mitomycin C to obtain a final 
concentration 500μg/ml. the solution was stored at -20°C. 
2.2.1.7 PDGF-BB stock solution 
To make PDGF-BB stock solution, 5ml of complete EMEM medium was added to 10μg 
of PDGF-BB to get a final concentration of 2μg/ml. 
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2.2.2 Cell extraction buffer 
Table 8: Cell extraction buffer recipe 
 
 
 
 
 
 
 
2.2.3 SDS PAGE buffers 
Table 9: Acrylamide solution 
 
 
 
The solution was then filtered and stored in the dark at 4°C 
 
Table 10: 1.5M Tris-HCl pH 8.8 buffer 
 
 
*pH was adjusted to pH 8.8 and topped up to 100ml with distilled water. 
 
Table 11: 0.5M Tris-HCl buffer pH6.8 
 
 
*pH was adjusted to pH6.8 and topped up to 50ml with distilled water. 
 
Reagent  Quantity (g) 
Tris base 0.315 
EDTA 0.004 
DL- dithiothreitol 0.01 
Distilled water 100 ml* 
 
*pH was adjusted to 7.4 and then the remaining reagents were 
added. 
 
Phenylmethylsulfonyl fluoride 0.035 
Benzamidine 0.016 
Amino-n-caproic acid 0.065 
Triton X100 100μl 
Reagent Quantity (g) 
Acrylamide 30 
N’N’Bismethylene Acrylamide 0.8 
Distilled water 100ml 
Reagent Quantity (g) 
Tris-Base 18.50 
Distilled water 80ml* 
Reagent Quantity (g) 
Tris-Base 3 
Distilled water 25ml* 
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Table 12: Electrode buffer pH 8.3 
 
 
 
*pH was adjusted to pH 8.3 and topped up to 900ml with distilled water 
 
 Table 13: Reducing sample buffer 
 
 
 
 
 
Table 14: Resolving gel (10% acrylamide) 
 
 
 
 
*10% ammonium persulphate and TMED were added after the gel was degassed 
making sure no bubbles were made. They were mixed into gel by gently swirling the 
flask. 
 
 
 
 
 
Reagent Quantity (g) 
Tris-Base 3.03 
Glycine 14.4 
10% SDS solution 10ml 
Distilled water 900 ml* 
Reagent Quantity (g) 
Sucrose 2.4 
Dithithreitol 0.1 
0.05% bromophenol blue 
solution 
0.4 ml 
0.5M Tris-HCl pH 6.8 2.0 ml 
10% SDS solution 2.0 ml 
Distilled water 9.10 ml 
Reagent Quantity (ml) 
Distilled water 6.05 
1.5M Tris-HCl pH 5.8 3.75 
10% SDS 0.15 
Acrylamie-bis (30%) 5 
Degas gel for 10min using a vaccum pump and then add the 
following 
*10% Ammonium persulphate 0.05 
*TEMED 0.0075 
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Table 15: stacking gel (3% acrylamide) 
 
 
 
 
 
 
*10% ammonium persulphate and TMED were added after the gel was degassed 
making sure no bubbles were made. They were mixed into gel by gently swirling the 
flask. 
 
2.2.4 Western blot buffers 
Table 16: Tween Tris buffered saline pH 7.5 (TTBS) 
 
 
 
*pH was adjusted to pH 7.5 and topped up to 2000ml using distilled water. 
Table 17: Blocking Buffer 
 
 
 
2.2.5 Flow cytometry solutions 
 2.2.5.1 Cell fixative – 4% Paraformaldehyde solution 
To make 4% paraformaldehyde solution 4g of paraformaldehyde was added to 80ml of 
Phosphate buffered saline pre heated and maintained at 60°C. Once all the 
formaldehyde was in suspension it was solubilized by adding small aliquots of 1M 
NaOH until solution became clear, pH was adjusted to 7.4 and the solution was made 
up to 100ml. The solution was stored at 4°C and used within a month. 
Reagent Quantity (ml) 
Distilled water 3.15 
0.5M Tris-HCl pH 6.8 1.25 
10% SDS 0.05 
Acrylamie-bis (30%) 0.5 
Degas gel for 10min using a vaccum pump and then add the 
following 
10% Ammonium persulphate* 0.05 
TEMED* 0.005 
Reagent Quantity (g) 
Tris base 4.84 
Sodium chloride 58.44 
Tween 20 1 ml 
Distilled water 1800ml* 
Reagent Quantity (g) 
BSA 1 
TTBS 100ml 
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2.2.6 Cell viability solutions 
2.2.6.1 PES stock solution recipe 
Phenazine ethosulphate (PES) stock solution was prepared by dissolving 0.0092g of 
PES in 10ml of DPBS. The solution was wrapped in foil and covered to prevent photo-
degradation and stored at -20°C 
2.2.6.2 MTS solution recipe 
MTS solution was prepared by dissolving 0.042g of MTS powder in 20ml of DPBS and 
the pH was adjusted to 6.5 by adding 1M HCl or 1M NaOH. The solution was then made 
to a final volume of 21ml by adding DPBS. MTS working solution was then made by 
adding 1 ml pf PES solution to 20ml of MTS. MTS solution was then stored as 1ml 
aliquots in micro-centrifuge tubes wrapped in foil and stored at -20°C. 
2.2.6.3 PI stock solution recipe 
A 1mg/ml of PI solution was prepared by weighing 10mg of PI and dissolving it in 100ml 
PBS. The stock solution was aliquoted in 1.6ml centrifuge tubes and wrapped in foil and 
stored at -20°C.  
2.2.6.4 Phosphate buffered saline (PBS) recipe 
PBS was prepared by adding NaCl 8g, KCl 0.2g, KH2PO4 0.24g and Na2HPO4 were 
added to 900ml of water and dissolved. The solution was made to 1000ml using 
distilled water.  
 
2.3. Methods  
2.3.1 Cell culture 
U937 cells were cultured in RPMI 1640 medium supplemented with 10% (v/v) foetal 
bovine serum (FBS) (complete culture medium). They were maintained by sub-
culturing a ratio of 1:10 every 3 to 4 days at and incubated at 37°C, 5% CO2 in a 
humidified environment. 
WS1 were cultured in EMEM supplemented 10% (v/v) FBS and 1% non-essential amino 
acids (complete culture medium). They were maintained by sub-culturing at a ratio 1:1 
every 3 to 4 days when they had reached a confluence of 75% or higher and incubated 
at 37°C, 5% CO2 in a humidified environment. They were a finite cell line and were used 
in experiments when they between 4 and 8 passages. 
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 MCF-7 cells were cultured in EMEM supplemented with 10% (v/v) FBS and 1% non-
essential amino acids (complete culture medium). They were maintained by sub-
culturing at a ratio of 1:1every 3 to 4 days when they had reached a confluence of 75% 
or higher and incubated at 37°C, 5% CO2 in a humidified environment.  
MG-63 cells were cultured in EMEM supplemented with 10% (v/v) FBS and 1% non-
essential amino acids (complete culture medium). They were maintained by sub-
culturing at a ratio of 1:3 every 3 to 4 days once they had reached a confluence of 75% 
or higher and incubated at 37°C, 5% CO2 in a humidified environment. 
All adherent cell lines were treated with trypsin EDTA to re-suspend cells in fresh 
medium for subculture as follows. Cell culture media was discarded and 2ml of trypsin 
EDTA was added to the flask to wash rinse the cells and remove any residual media. 
The trypsin was then discarded, a second 2ml aliquot of trypsin was added to the flask 
and incubated at 37°C for 3-5min. The flasks were observed under the microscope at 
1min intervals to assess detachment. Once the cells were in solution the reaction was 
stopped by adding 8ml of complete culture medium. The cells were aspirated using a 
pipette to obtain a homogenous solution. Cells were diluted into fresh flasks containing 
complete culture medium as described earlier. 
 
2.3.2  Counting viable cells using trypan blue exclusion. 
For all experiments cell counts of viable cells were carried out by diluting 100μl of cell 
suspension in trypan blue at a ratio of 1:1. The cell suspension and dye were aspirated 
using a pipette and 20μl of the cell/trypan blue suspension was used to count viable 
cells using a haemocytometer. Cells were counted in the central chamber of the 
haemocytometer. Cells that touched the top and right side of the central grid were 
ignored. Viable cells would not take up the dye and appear white while dead cells would 
take in the dye and appear blue. Two cell counts were performed and a mean cell 
density was obtained. This mean cell density was then multiplied by the dilution factor 
(x 2) to obtain the actual cell count. Cells were then diluted in complete culture 
medium to obtain the required cell density for the experiments.       
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2.3.3 Freezing cells for cryopreservation 
U937 cells were cultured until they reached a cell density of 5 x 105 viable cells/ml and 
the cells were centrifuged for 5min at 500g. The culture medium was discarded and 
the pellet was re-suspended in 1ml freeze media (10%DMSO in FBS). The pellet was 
gently suspended and aliquoted into labelled cryo-tubes. The cells were then incubated 
in the vapour phase of liquid N2 for a minimum of 2h after which they were stored in a 
designated location in the cryostat.     
All adherent cells were sub-cultured and grown until they reached a confluence of 50-
60%. The media was then removed and the cells were washed with 2ml of trypsin 
EDTA. 2ml aliquot of trypsin EDTA was then added to the flask and incubated at 37°C 
for 3 to 5min. The flask was examined at 1min intervals until the cells layer had 
dispersed. 8ml of complete culture medium was added to the cells and cell clumps were 
dispersed by gently aspirating the cells using a pipette. They cells were then centrifuged 
at 500g for 5min, the media was discarded and the pellet was gently re-suspended in 
1ml freeze media.  The cell suspension was then aliquoted into labelled cryo-tubes and 
incubated in the vapour phase of liquid N2 for a minimum of 2h and then stored in a 
designated location in the cryostat.  
 
2.3.4 Scratch assays 
2.3.4.1 Scratch assay using MCF-7 and MG-63 
MCF-7 and MG-63 cells were treated with trypsin EDTA as described earlier in section 
2.3.1 to form a homogenised cell suspension. The cells were counted using a 
haemocytometer and diluted to a cell density of 1 x 105 viable cells/ml. 1ml aliquots of 
the cell suspension was then added to each well of a 12 well plate. The cells were then 
allowed to adhere for 24h after which they were scratched manually using a 200μl 
pipette tip. The cells were washed twice in compete EMEM medium and pictures and 
gap measurements were taken at 24h time intervals, where n=3.  
2.3.4.2 General Scratch assay for WS1 cells  
A 25cm3 flask containing WS1 cells was rinsed with 2ml trypsin EDTA. The trypsin was 
then removed and a second 2ml aliquot of trypsin was added. The flask was incubated 
at 37°C for 3min and viewed under the microscope at 1min intervals until the cell 
monolayer had dispersed. After 3min, 8ml of complete EMEM was added to stop the 
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reaction. The cells were then aspirated using a pipette to obtain a homogenous cell 
suspension. Cells were counted using a haemocytometer and diluted to a cell density 
of 5 x 104 viable cells/ml. 1ml aliquots of the cells suspension were then used to fill each 
well of a sterile 12 well culture plate. The plate was incubated at 37°C, 5% CO2 in a 
humidified environment for 48h after which they had reached a confluence of 65-85%. 
After 48h the adherent cell layer was scratched using a 200μl pipette tip with a 
diameter of <1mm. The cells were washed twice with complete EMEM to remove cell 
debris and incubated in complete culture medium. Pictures and measurements were 
taken at hourly intervals at a pre-determined location marked by a marker on the 
underside of each well of the well plate. The plate was incubated at 37°C, 5% CO2 in a 
humidified environment for the duration of the experiment. The number of replicates 
used in each experiments was 3.  
2.3.4.3 The effect of PDGF-BB on WS1 cells 
WS1 cells were cultured onto 12 well plates as described in section 2.3.4.2. The cells 
were scratched and 2 media washes were carried out. After washes were completed 
control wells received complete EMEM medium while treatment wells received 
complete EMEM medium supplemented with 15ng/ml of PDGF-BB. Pictures and 
measurements were then taken at hourly intervals as described previously. 
2.3.4.4 The effect of HI media of WS1 cells 
WS1 cells were cultured onto 12 well plates as described in section 2.3.4.2. The cells 
were scratched. Control wells were washed and incubated with complete EMEM 
medium while treatment wells were washed and incubated with HI media. Pictures 
and measurements were taken at hourly intervals as described previously. 
2.3.4.5 The effect of PDGF-BB prepared in HI media on WS1 cells 
WS1 cells were cultured onto 12 well plates as described in section 2.3.4.2. The cells 
were scratched. Control wells were washed and incubated with complete EMEM 
medium while treatment wells were washed in HI media and incubated with HI media 
supplemented with 15ng/ml or 30 ng/ml of PFGF-BB. Pictures and measurements were 
taken at hourly intervals as described previously. 
2.3.4.6 The effect of location on gap closure 
WS1 cells were cultured onto a 12 well plate as described in section 2.3.4.2. The cells 
were then scratched and washes were carried out in complete EMEM medium. Cells 
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were incubated in complete EMEM medium. Measurements and pictures were taken 
at 3 locations on each well namely top, middle and bottom at hourly intervals.   
2.3.4.7 Testing commercial inserts 
 Commercially available inserts were purchased; here the inserts adhered to the bottom 
to the plate and when removed formed a scratch width of 500μm between cells. The 
insert was placed aseptically using sterile forceps into each well of a sterile 12 well cell 
culture plate and 70μl of WS1 cells at a concentration of 5x104 viable cells/ml was added 
to each well of the insert. 300μl of complete EMEM medium was added around the 
insert (Figure 2.1). The plate was then incubated under optimal culture conditions for 
48h. The scratch assay was started by simply removing the inserts. Control wells were 
washed and incubated with complete EMEM medium while treatment wells were 
washed and incubated with HI media. Pictures and measurements were taken at 2h 
intervals. 
 
 
Figure 2.1: A schematic of the culture insert used in the study. Culture inserts were placed 
aseptically into each well of a 2 well plate. l of WS1 cells were added to each well of the insert 
and l of culture medium was added around the insert (a). Once the cells had adhered the 
insert was removed and the cells were washed with media the gap left by the insert was 
approximately m as shown by the arrow (b). 
 
2.3.4.8 The effect of a recovery period after heat shock on WS1 gap closure 
WS1 cell were cultured on two 12 well plates as described in section 2.3.4.2. After 48h 
one plate of cells was incubated at 40°C, 5% CO2 in a humidified environment for 1h. 
The cells in the heat treated plate were then incubated at 37°C, 5% CO2 in a humidified 
environment for 2h to recover. The cells were then scratched and washed and 
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incubated in complete EMEM medium as described in 2.3.4.2. Pictures and 
measurements were then taken at hourly intervals. 
2.3.4.9 The effect of heat shock of WS1 cells. 
WS1 cells were cultured onto two 12 well plates as described in 2.3.4.2. Prior to 
commencing the scratch assay the heat treatment plate was incubated at either 39°C, 
40°C, 41°C, 42°C or 45°C with 5% CO2 in a humidified environment for 1h. The cells 
were then scratched, washed twice and incubated with complete EMEM medium. The 
plates were incubated at optimal culture conditions for the duration of the experiment. 
Measurements and pictures were taken at 2h intervals. 
2.3.4.10  The effect of 45°C incubation on WS1 cells   
WS1 cells were cultured onto two 12 well plates as described in 2.3.4.2. The cells were 
scratched, washed twice and incubated with complete EMEM medium. The heat 
treatment plate was incubated at 45°C, 5%CO2 in a humidified environment for the 
duration of the experiment whilst the control was incubated under optimal culture 
conditions. Measurements and pictures were taken at 2h intervals. 
2.3.4.11  The effect heat shock and HI media on WS1 cells measured using commercial 
inserts 
Inserts were placed aseptically onto the bottom of four 12 well plates as described in 
section 2.3.4.7. The 2 wells of each insert were inoculated with 70μl of WS1 cell 
suspension with cell density of 5 x 104 viable cells/ml. 300μl of complete EMEM culture 
medium was added to the surrounding area of the insert. The plates were incubated 
for 48h. 2 plates were then given a heat shock by incubating them at 39°C, 5% CO2 in 
a humidified environment for 1h. The plates were then put through the scratch assay 
by simply removing the insert.  The effect of heat shock and HI media were tested. One 
of the 2 control plates was washed and incubated in complete EMEM medium whilst 
the other was washed and incubated in HI medium. The heat treated plates were also 
treated in the same manner as the controls. Pictures and measurements were taken at 
0, 5.5, 8, 12, 24 and 30h. 
2.3.4.12 The effect of hyperglycaemia and mitomycin on WS1 cells 
WS1 cells were cultured on a 12 well plate as described in section 2.3.4.2. The cells were 
scratched and washed in complete EMEM medium. Control wells were incubated in 
complete EMEM medium whilst test wells received media containing 30mM glucose 
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or 10μg/ml of mitomycin C. Images were taken using an automated microscope with 
an onstage incubator where beacons (software generated markers) were placed at the 
centre of the scratch. 2 time lapse settings were used; for the first 7h images were taken 
at hourly intervals whilst for the remaining 5h images were taken at 0.5h intervals. The 
images were analysed using software TScratch. 
2.3.4.13  The effect of heat shock and hyperglycaemia on WS1 cells  
WS1 cells were cultured on a 12 well plate as described in section 2.3.4.2. The plate was 
then subjected to a heat shock treatment by incubating the plate at 40° with, 5%CO2 
in a humidified environment for 1h. The cells were then put through the scratch assay 
where control wells were washed and incubated with complete EMEM medium whilst 
treatment wells were washed in complete EMEM medium and incubated in complete 
EMEM medium supplemented with 30mM glucose. Images were taken using an 
automated microscope with an onstage incubator where beacons (software generated 
markers) were placed at the centre of the scratch. 2 time lapse settings were used; for 
the first 7h images were taken at hourly intervals whilst for the remaining 5h images 
were taken at 0.5h intervals. The images were analysed using software TScratch. 
2.3.4.14 The effect of longer heat shock treatment, mitomycin C and hyperglycaemia 
on WS1 cells 
WS1 cells were cultured on a 12 well plate as described in section 2.3.4.2. The plate was 
then subjected to a heat shock treatment by incubating the plate at 42° with, 5%CO2 
in a humidified environment for 3h. The cells were then put through the scratch assay 
where control wells were washed and incubated with complete EMEM medium whilst 
treatment wells were washed in complete EMEM medium and incubated in EMEM 
medium supplemented with 30mM glucose or complete EMEM medium 
supplemented 10μg/ml mitomycin C. Images were taken using an automated 
microscope with an onstage incubator where beacons (software generated markers) 
were placed at the centre of the scratch. 2 time lapse settings were used; for the first 7h 
images were taken at hourly intervals whilst for the remaining 5h images were taken at 
0.5h intervals. The images were analysed using software TScratch. 
 
2.3.5  Measuring Scratch widths using an eyepiece reticule. 
The scratches were monitored and measurements were taken at x4 magnification. To 
measure scratch widths, the eyepiece reticule was calibrated using a stage micrometre 
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at 4x magnification.  When aligned, 37 reticule units = 1mm on the stage micrometre 
thus the distance between each line on the reticule = 1000μm/37 =27.03μm. All 
measurements of the scratch were taken at the centre of the scratch (marked using a 
marker) and recorded as reticule units and converted to μm for analysis. As the 
scratches were made manually there was high variability between scratches. To 
minimise variation, scratches of similar size were always selected for analysis. Only 
images within 4 reticule units were chosen for analysis giving a tolerance of 108.11μm 
to ensure similar sized scratches were compared and reduced standard error. Pictures 
were taken at specific time intervals over a course of 12h. All experiments were repeated 
twice to ensure reproducibility of the assay. 
 
2.3.6 Automated image capture and image analysis 
Scratch assays were also carried out using an automated microscope (EVOS Auto FL) 
with an on stage incubator at x10 magnification. The plates were incubated at 37°C with 
5% CO2. Two time lapse settings were used in each experiment. Pictures were taken 
using phase contrast settings at 1h intervals for the first 7h and for the remaining 5h 
pictures were taken at 30min intervals. Each experiment lasted for 12h. Beacons were 
placed to mark the location of the centre of the scratch in each well. The microscope 
would automatically take pictures of all the wells at each time point dictated by time 
lapse setting. 
The images were analysed using a free image analysis software called TScratch. The 
software presents the area of the wound gap as a percentage of the total image. It 
automatically analyses the image and determines thresholds for the wound gap for 
each image (Gebäck, Schulz, Koumoutsakos, & Detmar, 2009).  
 
2.3.7  Western blots 
2.3.7.1 Heat shock treatment on U937 cells. 
U937 cells were cultured in a 75cm2 flask that was split at a ratio of 1:1 the day before 
to obtain cells in the log phase of growth. 2 such flasks were pooled and a cell count 
was determined using a haemocytometer and trypan blue s escribed in section 2.3.2. 
The cells were then diluted to a cell density of 1 x 106 viable cells/ml. 10 ml of cell 
suspension was centrifuged at 500g for 5min and the culture media was discarded and 
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re-suspended in 10ml of fresh media. For heat shock treatment, 10ml of this cell 
suspension was placed in a water bath at 42°C for 1h and then placed in a water bath at 
37°C for 2h while the control was incubated in the 37°C water bath for the entire 3h 
period.  
2.3.7.2 Extraction of proteins from cells 
 Following heat shock treatment, the cells were centrifuged and washed in DPBS twice 
to remove dead cells. The pellet was re-suspended in 1ml of ice cold cell extraction 
buffer and incubated at -20°C for 10min. The lysed cell suspension was then centrifuged 
at 13500g for 20min. The supernatant containing total cell proteins was removed and 
stored in a fresh micro-centrifuge tube and total protein concentration was determined 
using the Bradford assay (section 2.3.7.4). All samples were then diluted to the sample 
containing the lowest protein concentration to ensure equal protein loading during gel 
electrophoresis and stored at -80°C until required. For gel electrophoresis, a 1:1 dilution 
of the cell extracts was made with reducing sample buffer and the tube was placed in a 
water bath set at 85°C for 10 min. The samples were then stored on ice until they were 
loaded into gels. 
2.3.7.3 Membrane protein extraction 
Following heat shock treatment membrane protein extraction was carried out using 
the Mem-PER Eukaryotic Membrane Protein Extraction Reagent Kit. Membrane extractions 
was carried out on both the control and heat shock treatment. 10ml of cell suspension 
from each condition were transferred into centrifuge tubes and centrifuged at 850g for 
2min. The supernatant was discarded and the pellets were re-suspended 1ml PBS and 
transferred to micro-centrifuge tubes. The cells were centrifuged again at 850g for 
2min and the supernatant was discarded. 150μl of Reagent A was then added to each 
cell pellet and incubated for 10 min at 18°C and vortexed every 2min. The cell lysate 
was then placed on ice.  600μl of Reagent C and 300μl of Reagent B were mixed and 
450μl aliquot of this mix was added to each tube and placed on ice for 30min and were 
vortexed every 5min. The tubes were then centrifuged at 10000g for 3min at 4°C and 
incubated in a water bath at 37°C for 20min. The cells were then centrifuged at 10000g 
for 2min at room temperature to isolate the hydrophobic fraction. The top hydrophilic 
layer was then carefully removed into a separate tube and both fractions were stored 
at -20°C until required. They were then diluted at 1:1 ratio in reducing sample buffer 
and boiled at 85°C for 10min prior to being used for gel electrophoresis.   
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2.3.7.4 Braford assay 
Concentration of the protein samples for membrane extracts and protein extracts was 
measured using a colorimetric assay known as Bradford assay. A series of dilutions were 
made using 2mg/ml BSA as stock and cell extraction buffer as diluent as described in 
the table below. 
Table 18:   BSA standard curve dilutions 
Concentration of BSA (μg/ml) Volume of stock BSA 
solution (μl) 
Buffer volume (μl) 
2000 100 0 
1500 300 100 
1000 200 200 
750 150 250 
500 100 300 
250 50 350 
125 25 375 
25 5 395 
0 0 400 
 
10μl of standards and the cells extracts were added to wells of a 96 well plate in 
triplicate. 300μl aliquots of the CooAssay reagent was added to the wells and the well 
plate was agitated for 30 seconds. The plate was then incubated in the dark at room 
temperature for 10min after which the absorbance was measured at 595nm. A standard 
curve was then plotted for each BSA concentration against its mean absorbance and 
the concentrations of the cell extracts were interpolated from the curve. The samples 
were then diluted to the sample with lowest dilution to obtain equal protein 
concentrations. 
2.3.7.5 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS PAGE was carried out using Bio-Rad mini Protean 2 gel assembly kits. The 10% 
resolving gel was made as described in table 14. A layer of distilled water was overlaid 
on top of the gel by gently adding distilled water (dH2O) to the top of the gel to prevent 
excessive evaporation. The gel was allowed to polymerise for an hour. The layer of 
dH2O was then drained and the 3% stacking gel was layered on top as described in 
table 15.The combs were gently placed at the top of cast to form wells. The gel was 
allowed to polymerise for 1.5h after which the combs were removed. The fully formed 
gels were removed from the casting stand and assembled into the electrophoresis tank. 
Two gels could be run simultaneously so if only one gel was made a dam was used in 
place of a second gel. Electrode buffer was added to both the inner reservoir and into 
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to the outer tank. The Precision Protein Plus™ Western C standards (5μl) and samples 
(20μl) were loaded and the gel was connected to the power supply. Gels were initially 
run at 75V until the samples reached the resolving gel after which the voltage was 
increased to 150V and the gels were allowed to run until the dye front reached the 
bottom of the gel. The gels were removed and one gel was used for total protein stain 
whilst the second was used to transfer proteins onto nitrocellulose membrane for 
western blot analysis. 
2.3.7.6 Total protein gel stain 
The stacking gel was removed and the resolving gel was placed in a container and 
washed in 20ml of dH2O for 15min. The water was discarded and 10ml of CooBlue MAX 
protein gel stain was then added onto the gel and agitated for an hour to stain all the 
proteins. The gel was the washed in 20ml dH2O for 1h and water was changed every 
15min to remove excess stain. The gel was then photographed.    
2.3.7.7 Electro transfer and Immunoblotting 
A semi-dry transfer method was employed to transfer samples onto nitrocellulose 
membrane. The gels were dis-assembled and the stacking gel was removed. The 
transfer onto nitrocellulose was carried out using trans-blot turbo kits. The resolving 
gel was placed on top of the membrane and was covered with blotting paper on both 
sides. The entire sandwich was placed into the transfer cassette and run for 7min at 
2.5A up to 25V. Once the transfer was complete the nitrocellulose membrane was 
placed in 20ml blocking buffer (TTBS with 1% (w/v) BSA). The membrane was agitated 
for 1h after which the blocking buffer was discarded and the primary antibody diluted 
in blocking buffer was added. The membrane was agitated for 1h or incubated at 4°C 
overnight. This blocking buffer was then discarded and the membrane was washed 
with 10ml of TTBS 3 times with 5min of agitation per wash. The membrane was then 
probed with the appropriate secondary antibody conjugated to HRP diluted in blocking 
buffer at a dilution ratio of 1:25000 along with Precision Protein™ StrepTactin-HRP 
conjugate at a dilution of 1:10000 and incubated for 1h whilst being agitated. The 
Precision Protein™ StrepTactin-HRP bound to Strep-tagged proteins in the Precision 
Protein Plus™ Western C standards allow for visualisation of the ladder during chemi-
luminiscent imaging to aid determination of the size of the target protein with ease. 
The secondary antibody and Precision Protein™ StrepTactin were then discarded and 
the membrane was washed 5 more times in TTBS as described earlier. After the final 
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wash a 1:1 dilution of reagent A and reagent B of SuperSignal™ West Femto maximum 
sensitivity substrate was prepared and 400μl was added to the membrane. The 
membrane was agitated for 5min in the dark and placed in the Bio-Rad Chemi doc XRS 
molecular imaging system to establish the presence of target protein. 
 
2.3.8 Flow cytometry methods 
All experiments were performed on U937 cells that were in log phase of their growth 
cycle. To obtain cells in the log phase, 10ml of U937 cells growing in 25cm3 culture 
flasks were transferred into centrifuge tubes and centrifuged at 500g for 5 min. The 
supernatant was discarded and the pellets were re-suspended in 20ml complete RPMI 
medium. 10ml of the culture medium was transferred to two 25cm3 flasks and cells 
were incubated under optimal culture conditions overnight. 
2NBDG is a green fluorescent glucose analogue that is readily transported into cells by 
glucose transporters and can easily be detected using flow cytometry in live cells (Zou, 
Wang, & Shen, 2005). For the glucose uptake assay, 30.8μM of 2NBDG was used 
throughout this study. A 10μl aliquot of 0.1mg/ml of 2NBDG was added to U937 cells 
cultured in wells of a 96 well plate and incubated at 37°C for 2h. They were then washed 
twice in DPBS and analysed by flow cytometry. Fluorescence was detected on FL-1 
488nm laser and mean fluorescence of the viable population was recorded  
2.3.8.1 Determining the optimal incubation time for 2NBDG 
U937 cells growing in 25cm3 flasks prepared the day before were subjected to a cell 
count using trypan blue exclusion. The cells were then diluted in fresh culture medium 
to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl was then added to 
each well of a 96 well plate. A reverse time course was performed whereby 10μl of 
working dilution of 2NBDG was added to 3 test wells every hour over a period of 3h. 
Cells in 0h time point received 2NBDG but were not incubated while cells in the no 
stain condition received DPBS. At 0h cells were transferred to 96 v-bottomed well 
plates and centrifuged at 500g for 5min. the supernatant was discarded and cell pellets 
were re-suspended in Dulbecco’s Phosphate buffered saline without Ca2+ Mg2+ (DPBS). 
Cells were centrifuged at 500g for 5min and analysed by flow cytometry. Viable cells 
were gated using cells from the no stain condition and any fluorescence higher than 
the no stain was recorded (figure 2.2)  
 43 | P a g e  
 
 
 
Figure 2.2: Representation of the scatter plot and histogram of U937 cells treated with 2NBDG. 
Cells were plated out at a seeding density of 1 x 106cells/ml and incubated with 2NBDG for 2h. 
They were washed twice to remove excess 2NBDG and analysed by flow cytometry. 
 
2.3.8.2 Competitive inhibition of 2NBDG by glucose 
U937 cells growing in 25cm3 flasks prepared the day before (as described in 2.3.8) were 
subjected to a cell count using trypan blue exclusion. The cells were then diluted in 
fresh culture medium to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl 
was then added to each well of a 96 well plate. Plate was incubated overnight under 
optimal culture conditions. The cells were then transferred to a v-bottom plate and 
centrifuged at 500g for 5min.  Cells were then re-suspended in a range of glucose 
concentrations made in glucose-free culture medium ranging from 5mM to 100mM. 
10μl of working dilution of 2NBDG was added to all wells with the exception of cells in 
the no stain condition that received complete culture medium and 10μl of DPBS. The 
plate was incubated for 2h under optimal culture conditions. The cells were then 
centrifuged at 500g for 5min the supernatant was discarded and cell pellets were re-
suspended in DPBS. The cells were then washed once more in DPBS and analysed by 
flow-cytometry.   
2.3.8.3 The effect of insulin on 2NBDG uptake 
U937 cells growing in 25cm3 flasks prepared the day before (as described in 2.3.8) were 
subjected to a cell count using trypan blue exclusion. The cells were then diluted in 
fresh culture medium to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl 
was then added to each well of a 96 well plate. Plate was incubated overnight under 
optimal culture conditions. The cells were then transferred to a v-bottom plate and 
centrifuged at 500g for 5min.  The supernatant was discarded and cells were re-
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suspended in 100μl of complete culture medium containing a range of insulin. Control 
wells and no stain wells received 10μl of DPBS. 10μl of 2NBDG was then added to the 
cells and the plate was incubated for 2h under optimal culture conditions. The cells 
were then washed 2 times in DPBS and analysed by flow cytometry. 
2.3.8.4 The effect of pH on 2NBDG uptake   
U937 cells growing in 25cm3 flasks prepared the day before (as described in 2.3.8) were 
subjected to a cell count using trypan blue exclusion. The cells were then diluted in 
fresh culture medium to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl 
was then added to each well of a 96 well plate. Plate was incubated overnight under 
optimal culture conditions. The cells were then transferred to a v-bottom plate and 
centrifuged at 500g for 5min.  The supernatant was discarded and cells were re-
suspended in 100μl of complete culture medium whose pH had been adjusted by 
addition of acid (Hydrochloric acid HCl) or alkali (Sodium hydroxide NaOH). Cells in 
the control wells and in no stain wells received complete culture medium whose pH 
was not altered. 10μl of 2NBDG was then added to the cells and the plate was incubated 
for 2h under optimal culture conditions. The cells were then washed 2 times in DPBS 
and analysed by flow cytometry. 
2.3.8.5 The effect of membrane fluidizers on 2NBDG uptake 
U937 cells growing in 25cm3 flasks prepared the day before (as described in 2.3.8) were 
subjected to a cell count using trypan blue exclusion. The cells were then diluted in 
fresh culture medium to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl 
was then added to each well of a 96 well plate. Plate was incubated overnight under 
optimal culture conditions. The cells were then transferred to a v-bottom plate and 
centrifuged at 500g for 5min.  The supernatant was discarded and cells were re-
suspended in 100μl of complete culture medium supplemented with doubling dilutions 
of DMSO. The concentrations of the membrane fluidizers used in this study were based 
on those described by Dempsey, Ireland, Smith, Hoyle, & Williams, (2010). Cells in the 
control wells and in no stain wells received complete culture medium. 10μl of 2NBDG 
was then added to the cells and the plate was incubated for 2h under optimal culture 
conditions. The cells were then washed 2 times in DPBS and analysed by flow 
cytometry. 
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 2.3.8.6 GLUT4 detection using flow cytometry 
U937 cells growing in 25cm3 flasks prepared the day before (as described in 2.3.8) were 
subjected to a cell count using trypan blue exclusion. The cells were then diluted in 
fresh culture medium to obtain a cell density of 1 x 106 viable cells/ml. Aliquots of 100μl 
was then added to each well of a 96 well plate. Plate was incubated overnight under 
optimal culture conditions. The cells were then transferred to a v-bottom plate and 
centrifuged at 500g for 5min. The supernatant was discarded and the cells were re-
suspended in DPBS. The cells were then re-suspended in 70 l BD Cytofix/Cytoperm™ 
buffer to fix and permeabilise cells. This would allow for the detection of proteins 
within the cells. For membrane protein analysis 70μl of 4% paraformaldehyde was used 
to fix the cells. The plate was then incubated at 4°C for 20min in the dark. 70 l of DPBS 
was then added to dilute the buffer or paraformaldehyde. The cells were centrifuged at 
500g for 5min and re-suspended in 100 l blocking buffer (5% FBS in DPBS). The cells 
allowed to rest at 18°C for 5min and then the blocking buffer was removed by 
centrifugation at 500g for 5min. GLUT4 antibody dilutions (1:200 and 1:500) were 
made in blocking buffer and 50μl of the diluted antibody was used to re-suspend the 
pellets. The plate was then covered in foil and incubated at 4°C for 45min. 50μl of 
blocking buffer was added to the wells to dilute the antibody. The plate was then 
centrifuged at 500g for 5min, the supernatant was discarded. The secondary antibody 
(1:500 and 1:1000) was then diluted in blocking buffer and 50μl of the antibody was 
used to re-suspend the pellets.  The plate was sealed, covered in foil and incubated at 
4°C for 30min. 50μl of blocking buffer was added to the wells to dilute the antibody. 
The plate was then centrifuged at 500g for 5min, the supernatant discarded and the 
pellets were re-suspended in 100μl DPBS. The plates were then analysed by flow 
cytometry. 
 
2.3.9 Cell viability assays  
2.3.9.1 MTS assay 
The MTS assay measures cellular viability through the reduction of a tetrazolium 
compound (yellow) to a soluble formazan product which is only converted by viable 
respiring cells (Riss, Niles, & Minor, 2004). The assay gives an indication of cellular 
metabolism and changes in cellular metabolism equate to a change in absorbance. MTS 
is a negatively charged molecule that is impermeable to the cell membrane, thus a cell 
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permeable electron acceptor phenazine ethosulphate (PES) is added to the MTS 
solution.  
2.3.9.2 Optimizing the concentration of Mitomycin c for WS1 cells 
The media form a 25cm3 containing WS1 cells was removed. The flask was washed with 
2ml of trypsin EDTA followed by 2ml of trypsin being added to the flask. The flask was 
incubated under optimal culture conditions for 3min. at 1min intervals the flask was 
examined to see whether the monolayer of WS1 cells had dispersed. 8ml of complete 
EMEM media was then added to flask to stop the reaction. The cells were aspirated 
using a pipette to obtain a homogeneous cell suspension. The cell were then counted 
using a haemocytometer and trypan blue exclusion to determine viable cell density. 
The cells were then diluted to a cell density of 5 x 104 viable cells/ml. 100μl aliquots of 
this cell suspension were used to inoculate each well of a 96 well plate. To make dead 
cell control 500μl of cell suspension was aliquoted into a sterile micro centrifuge tube. 
The cells in the tube were then snap frozen by placing the tube in liquid N2 until all the 
media was completely frozen. The tube was then thawed using a water bath set at 37°C. 
This freeze thaw process was repeated a second time, following which the cells were 
plated out as dead cell control. 
The plate was then incubated for 48h under optimal cell culture conditions. The plate 
was then examined under the microscope to see if cells had adhered to the plate. Media 
from the wells was removed and complete EMEM culture medium supplemented with 
different concentrations of mitomycin C were added to wells in triplicate. Control wells 
received no mitomycin C. the plate was then incubated for a further 48h after which 
the plate was removed and 20μl of working MTS reagent was added to each well. The 
plate was then incubated for 2h and absorbance was measured at 490nm using a plate 
reader. 
A mitomycin C time course was also carried out to determine the optimal 
concentration of mitomycin C for the duration of the scratch assay. Here 4 plates were 
prepared as described initially and each plate was put through the MTS assay at specific 
time points. For 0h time point MTS assay was carried out immediately after the 
addition of mitomycin C.   
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2.3.9.3 Propidium Iodide (PI) assay 
PI is a fluorescent DNA binding dye that is impermeable to the cell membrane, thus 
heathy cells with an intact membrane do not take up the dye while dying cells or cells 
whose membrane integrity has been compromised readily take up the dye. 
The media form a 25cm3 containing WS1 cells was removed. The flask was washed with 
2ml of trypsin EDTA followed by 2ml of trypsin being added to the flask. The flask was 
incubated under optimal culture conditions for 3min. at 1min intervals the flask was 
examined to see whether the monolayer of WS1 cells had dispersed. 8ml of complete 
EMEM media was then added to flask to stop the reaction. The cells were aspirated 
using a pipette to obtain a homogeneous cell suspension. The cell were then counted 
using a haemocytometer and trypan blue exclusion to determine viable cell density. 
The cells were then diluted to a cell density of 5 x 104 viable cells/ml. 100μl aliquots of 
this cell suspension were used to inoculate each well of a 96 well plate. To make dead 
cell control 500μl of cell suspension was aliquoted into a sterile micro centrifuge tube. 
The cells in the tube were then snap frozen by placing the tube in liquid N2 until all the 
media was completely frozen. The tube was then thawed using a water bath set at 37°C. 
This freeze thaw process was repeated a second time, following which the cells were 
plated out as dead cell control. 
The plate was then incubated for 48h under optimal cell culture conditions. The plate 
was then examined under the microscope to see if cells had adhered to the plate. Media 
from the wells was removed and complete EMEM culture medium supplemented with 
different concentrations of mitomycin C were added to wells in triplicate. Control wells 
received no mitomycin C. The plate was then incubated for 48h under optimal culture 
conditions and then taken through the PI assay.  A working dilution of propidium 
iodide was made by making a 1:200 dilution of the 1mg/ml stock solution in phosphate 
buffered saline (PBS). Equal volume of the working dilution was added to each well on 
the well plate and incubated at 18°C in the dark for 20min. The fluorescence was then 
detected using a plate reader  
2.3.9.4 Cell proliferation assay 
Cell proliferation can be measured by treating cells with a thymine analogue called 5 
bromo 2 deoxy uridine (BrdU). Dividing cells would take up the analogue in the place 
of thymine and incorporate it into their DNA during DNA synthesis in the S phase of 
growth. BrdU can then be detected using a detecting antibody that binds to it. An 
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enzyme linked secondary antibody can then be used to quantify the amount BrdU 
present and assayed to determine if cell division has taken place as growing cells would 
incorporate large amounts of BrdU thereby generating a signal.  
In this study BrdU assay was carried out using a commercially available BrdU assay kit 
(BrdU cell Proliferation ELISA kit). It was used to determine if mitomycin C inhibited cell 
proliferation in the scratch assay. The media form a 25cm3 containing WS1 cells was 
removed. The flask was washed with 2ml of trypsin EDTA followed by 2ml of trypsin 
being added to the flask. The flask was incubated under optimal culture conditions for 
3min. at 1min intervals the flask was examined to see whether the monolayer of WS1 
cells had dispersed. 8ml of complete EMEM media was then added to flask to stop the 
reaction. The cells were aspirated using a pipette to obtain a homogeneous cell 
suspension. The cell were then counted using a haemocytometer and trypan blue 
exclusion to determine viable cell density. The cells were then diluted to a cell density 
of 5 x 104 viable cells/ml. 100μl aliquots of this cell suspension were used to inoculate 
each well of a 96 well plate. The cells were incubated under optimal culture conditions 
for 48h. Following incubation cell culture media was removed and replaced with 50μl 
of complete culture media containing 2x concentration of 5μg/ml, 10μg/ml and 
20μg/ml mitomycin C.  A 1:500 dilution BrdU was made in complete culture medium 
and 20μl was added to positive control and test wells. Concentrations of mitomycin C 
were brought to test concentrations by adding 30μl of complete culture medium to all 
wells treated with mitomycin C. Positive control received no mitomycin C but received 
BrdU and a negative control did not receive and BrdU or mitomycin were used. The 
plate was then incubated under optimal culture conditions for 12h. 
Following the 12h incubation all media from the wells was removed. Each well then 
received 200μl of fixing solution and was incubated at 18°C for 20mins. The fixing 
solution was then removed the plate was dried and sealed using a plate sealed and 
stored at 4°C overnight. A 1:50 dilution of wash buffer was prepared and 200μl was 
added to each well. The wash buffer was then discarded and the plate was washed 2 
more times in wash buffer. 100μl of ready mixed primary antibody was then added to 
all wells and the plate was incubated at 18°C for 1h. Following the 1h incubation the 
antibody was removed and the plate was dried onto paper towels. The plate was then 
washed 3 times in 1x wash buffer as before. A 1:2000 dilution of the secondary anti 
mouse IgG peroxidase was made in conjugate diluent and 100μl of this solution was 
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added to all wells. The plate was then incubated at 18°C for 30min. The plate was then 
washed 3 times in 1x wash buffer as described before. A 1:30 dilution of 
chemiluminescent substrate was prepared in reaction buffer and 100μl of the buffer 
was added to all wells. The plate was incubated for 10min at 18°C and luminescence 
was detected using a plate reader. 
 
2.4 Statistical analysis 
All data was analysed using GraphPad Prism™ 7 version 1.0 (GraphPad Software, Inc, 
San Diego, USA). All data are presented as mean ± Standard error of mean (SEM) and 
were analysed using either a one way ANOVA or a two way ANOVA with appropriate 
post hoc test. 
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Chapter 3  Optimization of the scratch assay 
 
3.1  Introduction 
As described in the introductory chapter, fibroblast migration is an important event in 
wound closure and wound healing. Wound closure maintains the integrity of the 
surface and prevents further exposure of sensitive tissue to the environment. The 
wound healing process can easily replicated in vitro through the use of a scratch assay. 
A scratch assay is an economical and easy method to measure cell migration in vitro 
(Liang et al., 2007). Cells can easily be cultured to confluence and a wound can be 
created using a 200μl pipette tip but this leaves a scratch/gap of varying widths. 
Creation of the scratch is intended to replicate wounds created in vivo and also causes 
cell stress. Migration of cells in closing the scratch has been shown to mimic their 
behaviour in in vivo models (Liang et al., 2007). The assay can easily be monitored and 
cell migration rates can be determined through microscopy (Jonkman et al., 2014). 
Wound healing in vivo occurs though cell migration and proliferation into the wound 
therefore an in vitro wound in the context of a scratch assay is composite of cell division 
and cell movement. This means that gap closure rates obtained would be through cell 
migration and division and not represent cell migration alone. The aim of this study 
was to look at the effect of various factors in cell movement, therefore the DNA 
synthesis inhibitor mitomycin C was used. Mitomycin C is an inhibitor of DNA 
synthesis (Verweij & Pinedo, 1990) and thus would inhibit cell proliferation. 
There are several ways in which an in vitro scratch assay can be modelled depending 
on the method of cell removal from a monolayer (Ashby & Zijlstra, 2012). These can 
broadly be divide into 2 categories are briefly described here 
3.1.1 Cell removal methods  
Here cells are removed through physical, chemical or electrical means. These are 
simple and easy to use methods and do not require much expertise. Cells are 
maintained in optimal culture conditions and limited specialist equipment is required. 
On the other hand they suffer from high variability and the mode of removal can 
damage the matrix coating used to coat the plate. Wounds can be made using a pipette 
tip, Teflon wedge or a spinning silicone tip (Kam, Guess, Estrada, Weidow, & Quaranta, 
2008). Specialist scratch making assays tools have also been developed to reduce 
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scratch variability and be used in throughput screening (Yarrow, Perlman, Westwood, 
& Mitchison, 2004).  
Electrical removal via electrical substrate cell impedance sensing (ECIS) methods have 
the advantage that they reduce errors and cells need not be taken out of the incubator 
to take measurements and can be monitored in real time; moreover it is a non-invasive 
technique. Here cells are grown to confluence in an electrode containing substrate and 
a circular gold chip of 250μm in diameter. Normal culture medium serves as the 
electrolyte. A current is passed through the culture medium and kills all the cells 
growing on the chip. As cells migrate into the wound changes in impedance are 
recorded (Keese, Wegener, Walker, & Giaever, 2004).   
Chemical removal is carried out using specialist fluidic devices where cells are grown 
on microfluidic plates to confluence and subjected to three fluid steams two of which 
contain culture medium and the middle one contains trypsin which disperses adherent 
cells and form a wound. The advantage of this system is that there is no damage to the 
plate coatings, however these systems employ specialist equipment and require 
specialist personnel to run (van der Meer, Vermeul, Poot, Feijen, & Vermes, 2010).   
3.1.2 Cell exclusion methods 
Cell exclusion methods compartmentalise cells by growing them in barriers. These 
barriers when removed create a reproducible cell free space in to which cells can 
migrate. Several types of barriers are available ranging from solids, semi-solids, liquid 
and gas. These methods can easily be applied to high throughput screenings, however 
the additional cost of these barriers can be expensive. Barrier removal can also damage 
the plate coating and inhibit migration of cells into the wound. Another problem with 
cell exclusion assays is that they are not representative of physiological conditions that 
generate a wound (Van Horssen & Ten Hagen, 2011). 
 
3.2 Aims 
The aim of this study was to develop and optimise a scratch assay with a view to 
investigate the effects of heat shock and hyperglycaemia on wound healing. Mitomycin 
C was optimised as a negative control in order to establish if wound closure occurred 
through cell proliferation and migration or cell migration alone. 
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3.3 Methods 
3.3.1 Scratch assay 
A scratch assay was performed using MCF-7, MG-63 and WS1 cells as described in detail 
the methods chapter 2 section 2.3.4.1 to 2.3.4.7 and 2.3.4.12. Briefly cells were grown to 
confluence and scratched using a pipette tip. Pictures of the scratches were taken at 
hourly, 2 hourly or specific time intervals as dictated by the experiment. Widths of the 
scratch were measured using a microscope reticule calibrated using a stage micrometre 
at x4 magnification as described in chapter 2 section 2.3.5. In later experiments image 
capture was automated and time lapse pictures were taken as described 2.3.6. Pictures 
of one well in each condition are shown over the duration of the time course. 
3.3.2 MTS assay 
MTS assay was carried out in accordance to the methods described in chapter 2 section 
2.3.9.2 
3.3.3 PI assay 
PI assay was carried out in accordance to the methods described in chapter 2 section 
2.3.9.3.  
3.3.4  BrdU cell proliferation assay 
BrdU assay was carried out using a commercially available kit in accordance to the 
methods described in chapter 2 section 2.3.9.4.  
 
3.4  Results 
3.4.1 Cell selection 
In order to confirm findings in the scratch assay 3 cell lines were tested MCF-7, MG63 
and WS1 (Figure 3.1).  For the scratch assay it was required to have cells that have a 
high migration rate and represent cells in vivo hence WS1 cells were chosen as they had 
a high migration rate and could completely close the wound gap in 12 to 14h. They also 
have a finite lifespan of 60 population doublings while MCF-7 and MG63 were cancer 
cell lines and took almost 72h to close with high variability. Moreover this cell line has 
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also been used by other research groups to study diabetic wound healing (Bizzarro et 
al., 2012). 
 
 
 
Figure 3.1: Scratches in three different cell lines MCF-7, MG63 and WS1. Cells were plated out 
onto cell culture plates at a seeding density of 1 x 105 viable cell/ml for MCF-7 and MG63 while 
WS1 were seeded at 5 x 104 viable cells/ml. The cells were allowed to adhere and become 
confluent. They were then subjected to a scratch assay and pictures were taken at two time 
points 0h and 24h. After 24h only WS1 cells had migrated into the scratch and hence were used 
further for optimization. Pictures for each cell line are from representative separate experiments 
and each cell line tested had three replicates. 
 
3.4.2 The effect of PDGF-BB on WS1 cell migration 
The effect of PDGF-BB was tested on WS1 wound closure (Figure 3.2). Platelet derived 
growth factor (PDGF-BB) is potent mitogen for fibroblasts and thus was chosen to 
provide the scratch assay with a positive control (Heldin & Westermark, 1999). 
Previous studies by Li et al., (2007) have shown that PDGF-BB at 15ng/ml would induce 
complete closure of the scratch after 16h, thus 15ng/ml of PDGF-BB was tested on WS1 
scratch assays (Figure 3.2 a & b). The cells began to close the wound after 2h and after 
6h (Figure 3.2a) wound closure progressed at a constant rate and by 12h they closed 
the gap by approximately 65% (Figure 3.2b.). Overall no significant difference was seen 
and PDGF-BB seemed to show no effect on WS1 cell movement into the gap (p = 0.915) 
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Figure 3.2: The effect of PDGF-BB on wound closure of WS1 cells. WS1 cells were cultured at a 
seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The cells were then 
scratched and control wells received culture medium whilst the rest received media 
supplemented with 15ng/ml of PDGF-BB. The widths of the scratch were measured and pictures 
were taken at hourly intervals (a). The data were normalized and presented as means ± SEM, 
n=3 (b). Mean percentage gap closure between controls and PDGF-BB treatment was analysed 
by a two way ANOVA with Sidak’s multiple comparison as post hoc test. The p values for the 
comparison between control and treated cells at each time point are shown table (c).  
 
A possibility was that the action of PDGF-BB was masked by growth factors present in 
the FBS used in culture medium, thus a scratch assay was performed to see if heat 
inactivated (HI) media had any difference on gap closure rates (Figure 3.3). The cells 
in HI media followed the same migration pattern as that of the control (p = 0.988) thus 
it was thought that concentration of PDGF-BB used in the experiment was too low. 
 
Sidak’s  multiple comparison test 
Time (h) p values (control vs PDGF-
BB) 
0 >0.9999 
1 0.9997 
2 >0.9999 
3 >0.9999 
5 >0.9999 
6 >0.9999 
7 >0.9999 
8 >0.9999 
9 >0.9999 
10 >0.9999 
11 >0.9999 
12 >0.9999 
13 0.9992 
13.5 >0.9999 
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Figure 3.3:  The effect of HI media on wound closure of WS1 cells. WS1 cells were seeded at 5 x 
104 viable cells/ml and allowed to adhere for 48h. The cells were then scratched, control wells 
were washed and incubated in complete medium while cells in the heat inactivated condition 
were washed and incubated in complete medium supplemented with heat inactivated serum. 
Width measurements and pictures were taken at hourly intervals (a). The data were normalized 
and presented as means ± SEM, n=3 (b). Mean percentage gap closure between controls and HI 
media treatment was analysed by a two way ANOVA with Sidak’s multiple comparison as post 
hoc test. The p values for the comparison between control and treated cells at each time point 
are shown table (c).  
 
 WS1 cells were then treated with 2 different concentrations of PDGF-BB prepared in 
HI media in the following experiment (Figure 3.4). The data show that there was no 
significant difference seen in gap closure rates of WS1 cells when treated with PDGF-
Sidak’s  multiple comparison test 
Time (h) p values (control vs HI 
media) 
0 >0.9999 
1 >0.9999 
2 >0.9999 
3 >0.9999 
4 >0.9999 
5 >0.9999 
6 >0.9999 
7 0.9128 
8 0.9087 
9 0.9650 
10 0.4664 
11 0.6439 
12 0.9994 
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BB (p = 0.973). It was concluded that PDGF-BB had no effect of WS1 cells at the 
concentrations tested. 
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Figure 3.4: The effect of PDGF-BB made in HI media on wound closure of WS1 cells. WS1 cells 
were cultured in wells at a seeding density of 5 x 104 viable cells/ml and were allowed to adhere 
for 48h. The cells were then scratched, control cells were washed and incubated in complete 
growth medium while cells while cells treated with PDGF-BB were washed in heat inactivated 
medium and incubated in heat activated medium supplemented with two different 
concentrations of PDGF-BB. Width measurements and pictures were taken at hourly intervals 
(a). The data were normalized and presented as means ± SEM, n=3 (b). Data were analysed by 
two way ANOVA with Tukey’s multiple comparison as post hoc test and the p values for the 
comparisons are shown in table (c). 
Tukey‘s multiple comparison test 
Conditions p values 
Control vs 15ng/ml PDGF-BB HI media >0.9999 
Control vs 30ng/ml PDGF-BB HI media >0.9999 
15ng/ml PDGF-BB  HI media vs 30ng/ml PDGF-BB  
HI media 
>0.9999 
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3.4.3 The effect of location on gap closure 
A second concern that was noted was that during the scratch assay that some parts of 
the scratches closed at a faster rate in comparison to the reference point. To ensure gap 
closure was constant throughout the scratch a scratch assay was performed and wound 
closure over time was measured at three reference points in each well namely top, 
middle and bottom (Figure 3.5).  Form the results it was noted that gap closure 
remained constant and the closure was more dependent on the size of the gap as no 
significant difference was found between scratch locations (p = 0.974). 
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Figure 3.5: Wound closure of WS1 cells at different locations in the well. WS1 cells were cultured 
at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The cells were then 
subjected to a scratch assay. Width measurements and pictures were taken at hourly intervals 
(a). The data were normalized and presented as means ± SEM, n=3 (b). The data was analysed 
by two way ANOVA with Tukey’s multiple comparison as post hoc test and the p values for the 
comparisons are shown in table (c).  
 
Tukey‘s multiple comparison test 
Conditions p values  
Top vs middle 0.9995 
Top vs bottom 0.8335 
Middle vs bottom 0.8178 
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3.4.4 Testing commercial inserts on WS1 scratch assay: physical removal vs 
cell exclusion 
WS1 scratch widths were found to be variable from experiment to experiment. In order 
to reduce variability commercial inserts form Ibdi were used. The cells were cultured 
in the wells of the insert and once they had adhered and grown to confluence the 
scratch assay could be started by simply removing the insert. The inserts would 
produce a scratch with a defined width of 500μm and so were tested to see how they 
compared to a previous experiment with heat inactivated media (Figure 3.6). It was 
found that gap closure took a similar amount of time to when cells were scratched 
using a pipette tip and was not significantly different when control and HI media were 
compared (p = 0.153) (Figure 3.6).   
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Figure 3.6: The effect of HI media on wound closure of WS1 cells cultured using commercial 
inserts. WS1 cells were seeded at 5 x 104 viable cells/ml, allowed to adhere for 48h. The assay 
was begun by removing the inserts. Control well were washed and incubated in complete 
culture medium while cells in the HI were washed in HI media and cultured in HI media. The 
widths of the scratch were measured and pictures were taken at 2h intervals and after 8h they 
were taken at hourly intervals (a). The data were normalized and presented as means ± SEM, 
n=3 in graph (b). Mean percentage gap closure between treatments was compared at each time 
point using a two way ANOVA with Sidak’s multiple comparison as post hoc test and the p 
values for the comparisons are shown in table (c). 
 
3.4.5 Optimization of mitomycin C for the scratch assay 
The use of Mitomycin C as an inhibitor of cell division was also optimised for the 
scratch assay using MTS assay. Initial testing showed that mitomycin C significantly 
reduced cell viability of WS1 cells after 48h. The data showed that cell viability was 
Sidak’s  multiple comparison test 
Time (h) p values (control vs HI 
media) 
0 >0.9999 
2 >0.9999 
4 0.8397 
6 0.6718 
8 0.4833 
9 0.2481 
10 0.1914 
11 0.3162 
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significantly reduced even at the lowest concentration tested in WS1 cells after 48h 
incubation (p<0.0001).  
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Figure 3.7: WS1 cell viability after 48h following mitomycin C treatment. WS1 cells were cultured 
in 96 well plates at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. 
The cell culture medium was removed and the cells were supplemented with media containing 
different concentrations of Mitomycin C and incubated for another 48h following which MTS 
assay was performed. Data are presented as means ± SEM, n=3 and compared to untreated 
0μg/ml mitomycin. Data were analysed by a one way ANOVA with Dunnett’s multiple 
comparison as post hoc test where ****(p = 0.0001). 
 
Mitomycin C concentration was lowered and cell viability was assayed by MTS and PI 
(Figure 3.8). The data showed that even at very low concentrations of g/ml 
mitomycin C was toxic to the cells (p<0.0001). Moreover cell death had occurred much 
earlier than 48h as there was no significant difference in PI (p=0.299). This meant that 
mitomycin C was causing cell death at much earlier time point.   
 
 
 
 
 
 
Dunnett's multiple comparisons test 
Comparisons p values 
0 vs. 10 0.0001 
0 vs. 20 0.0001 
0 vs. 30 0.0001 
0 vs. 40 0.0001 
0 vs. 50 0.0001 
0 vs. 60 0.0001 
0 vs. 70 0.0001 
0 vs. 80 0.0001 
0 vs. 90 0.0001 
0 vs. 100 0.0001 
0 vs. 110 0.0001 
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Figure 3.8: WS1 cell viability at 48h following treatment with mitomycin C. WS1 cells were 
cultured in two 96 well plates at a seeding density of 5 x 104 viable cells/ml and allowed to 
adhere for 48h. The cell culture medium was removed and the cells were supplemented with 
complete culture media containing different concentrations of mitomycin C and incubated for 
another 48h following which MTS assay (a) and PI assay (b) was performed. Data are presented 
as means ± SEM, n=3 and data were compared to 0. Data were analysed by a one way ANOVA 
with Dunnett’s multiple comparison as post hoc test where ****(p<0.0001)  
 
A mitomycin C time course was setup where cells were treated with mitomycin C and 
cell viability was assayed by MTS at specific time points (Figure 3.9).   The data showed 
that cell viability decreased with time and that after 24h viability was significantly 
reduced even at low concentrations of mitomycin C. From the data mitomycin C did 
not significantly affect cell viability until 16h (p = 0.999). An unpaired t-test was carried 
out between 0h and 16h for the concentration of 10μg/ml and 20μg/ml of mitomycin 
C and found that both concentrations had no significant difference on cell viability 
(p=0.629 for 10μ/ml and p=0.138 for 20μg/ml).  
Dunnett’s Multiple comparison 
test 
Comparisons p values 
0.0 vs. 2.5 0.0001 
0.0 vs. 5.0 0.0001 
0.0 vs. 10.0 0.0001 
0.0 vs. 20.0 0.0001 
Dunnett’s Multiple comparison 
test 
Comparisons p values 
0.0 vs. 2.5 0.8748 
0.0 vs. 5.0 0.3543 
0.0 vs. 10.0 0.1546 
0.0 vs. 20.0 0.5073 
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Figure 3.9: The viability of WS1 cells at different time points following treatment with 
mitomycin C. WS1 cells were plated out in 4 plates at a density of 5 x 104 viable cells/ml. Cells 
were allowed to adhere for 48h and then treated with doubling dilutions of mitomycin C and 
MTS assay was performed at 0, 16, 24 and 48h after treatment. Data are represented as means 
± SEM, n=3 (a).Data were analysed by two way ANOVA with and compared to 0h using Tukey’s 
multiple comparison as post hoc test (b). 
 
In order to confirm if 10μg/ml mitomycin C was sufficient to inhibit cell proliferation 
BrdU assay was performed to determine the extent by which cell proliferation was 
inhibited by mitomycin C (figure 3.10). The results showed that mitomycin C inhibited 
cell proliferation at all concentrations tested but there was no significant difference 
between 10μg/ml and 20μg/ml over the 12h time period.  Each concentration inhibited 
cell proliferation by 90.48% and 95.31% respectively, thus 10μg/ml mitomycin C was 
chosen and used as a control to determine if gap closure occurred through cell 
migration alone.  
 
 
 
 
 
 
 
Tukey‘s multiple comparison test 
Conditions p values  
0h vs 16h 0.9999 
0h vs 24h 0.0025 
0h vs 48h 0.0302 
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Figure 3.10: The inhibition of WS1 cell division by mitomycin C measured by BrdU assay. WS1 
cells were cultured on a 96 well plate at seeding density of 5 x 104 viable cells/ml and incubated 
at 37°C for 48h. Once the cells had adhered cell culture media was removed and 50μl of 2x 
dilutions of mitomycin C prepared in complete EMEM was added to test wells. Control wells 
received no mitomycin C. 20μl of BrdU was added to each well with the exception of wells in 
the no stain (NS) condition. 30μl of complete EMEM was then added to each well to bring 
mitomycin concentrations to final concentrations. Cells were then incubated for 12h under 
optimal culture conditions and then taken through the BrdU assay. Data were normalized 
presented as means ± SEM, n=3. Data were analysed by a one way ANOVA and means were 
compared to each other using Tukey’s multiple comparison as post hoc test. 
 
3.4.6 The effect of mitomycin C on wound closure of WS1 cells.  
A new microscope (EVOS Auto FL) was purchased with an on stage incubator (EVOS 
Auto FL onstage incubator) that could be set up to take time lapse images of the scratch 
at predetermined time points while simultaneously incubating the cells. Pictures of the 
cells were taken in phase contrast to allow for cell to be viewed in detail. The scratch 
assay was then carried out using this microscope. The effect of 10μg/ml of mitomycin 
C was tested. The scratches were analysed using a free software called TScratch. 
TScratch calculates the area of the scratch and shows it as a percentage of the whole 
image. Time lapse images can also be analysed once initial image capture has been 
carried out. Image analysis was used as it reduces human error and enables researchers 
to assess cell migration in terms of area as opposed to a single point. In order to test 
the image analysis software as scratch assay was setup to test the effects of mitomycin 
C on WS1 cells (Figure 3.11). The data showed that mitomycin C did not have a 
significant effect on WS1 gap closure (p = 0.587). This suggested that gap closure was 
not brought about by cell proliferation but through cell migration. The pictures shown 
Tukey’s multiple comparison test 
Comparisons p values 
0 vs. 5 <0.0001 
0 vs. 10 <0.0001 
0 vs. 20 <0.0001 
5 vs. 10 0.0002 
5 vs. 20 <0.0001 
10 vs. 20 0.6248 
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are of a well in each condition that was analysed by TScratch and depict wound gap as 
seen by the software.    
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Figure 3.11: The effect of mitomycin C on wound closure of WS1 cells. WS1 cells were cultured 
on well plates at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. Cells 
were then subjected to a scratch assay and pictures were taken using an automated microscope. 
Pictures were taken at hourly intervals for the first 7h and then at 30min intervals for the next 
5h. Images were analysed using TScratch software and migration at each time point was 
normalized. Data are presented as means ± SEM, n=3 and mean percentage gap closure was 
compared to control at each time point. Data were analysed by a two way ANOVA with Sidak’s 
multiple comparison as post hoc test.  
 
With the automated microscope the pictures were taken at exactly the same locations 
and at higher resolution for the software to pick up even minute movements of the 
cells. The microscope could also pick up individual movements of the cells throughout 
the time course. Unlike epithelial cells that move as sheets fibroblasts can bud off and 
migrate in to the wound site independently. This blebbing effect by the production of 
Sidak’s  multiple comparison test 
Time (h) p values (control vs Mitomycin 
C) 
0 >0.9999 
1 >0.9999 
2 >0.9999 
3 >0.9999 
4 >0.9999 
5 0.9987 
6 >0.9999 
7 >0.9999 
7.5 >0.9999 
8 >0.9999 
8.5 >0.9999 
11 >0.9999 
11.5 0.9997 
12 >0.9999 
12.5 0.9820 
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lamillopodia is promoted by -catenin and allows them to migrate swiftly to a wound 
site (Poon, Nik, Ahn, Slade, & Alman, 2009). WS1 cells showed these characteristics as 
they came off the monolayer they would randomly irrespective of their orientation 
move towards the other side of the scratch, but not always in the direction they began 
as shown in the figure below (Figure 3.11). The migration could also be in response 
chemotactic signals, but what they are exactly remains to be elucidated.  
 
 
  
 
 
 
 
 
 
Figure 3.12: WS1 cells migrate into the wound in random trajectories. The images are taken form 
an automated time-lase (8h-8.5h) to demonstrate that WS1 cells do not migrate into the scratch 
following a set trajectory pattern the arrows highlight a cell that is migrating into the gap but 
has changed its trajectory to lie parallel to the wound edge.  
 
A second aspect generated by the variability of the scratch has shown a correlation 
(p=0.036) in net movement of cells. If similar sized scratches were not compared, the 
net movement of cells in smaller scratches is lower than the net movement of cells in 
larger scratches over the same length of time (Figure 3.13). This would suggest that cell 
motility is governed by the presence of a chemotactic factor. Whether this factor is 
inhibitory (secreted when cells are in close proximity) or promotive (secreted when 
cells are further away) needs to be investigated. This effect was also observed during 
image capture of the cells in the scratch assay, where cells would bleb in random 
manner and not follow the orientation they began in (Figure 3.12).  
 
 68 | P a g e  
 
0 2 0 0 4 0 0 6 0 0 8 0 0
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
s c r a t c h  w i d t h  (  m )
n
e
t 
m
o
v
e
m
e
n
t 
o
v
e
r
 8
h
 (

m
)
Y  =  0 . 2 5 3 4 * X  +  3 9 . 7 2
R
2
=  0 . 7 0 8 8
 
Figure 3.13: The net movement of WS1 cells with varying widths over a period of 8h. WS1 
cells were cultured in 12 well plates at a cell density of 5 x 104 viable cells/ml. The cells 
were scratched using a pipette tip, washed twice and incubated in complete medium. 
Measurements and pictures were taken at 2h intervals. Each point represents cells in a 
single well and their net movement over a period of 8h. 
 
3.5 Discussion 
Previous studies have used MCF-7 (Guttilla et al., 2012), MG-63 (Ziyan, Shuhua, 
Xiufang, & Xiaoyun, 2011), and WS1 cells (Bizzarro et al., 2012; Zungu, Mbene, Hawkins 
Evans, Houreld, & Abrahamse, 2009) to investigate cell migration. Each of these cells 
were tested in a scratch assay evaluated for suitability to study wound healing (Figure 
1).  A working scratch assay has been developed and optimized using WS1 cells with the 
purpose of investigating wound healing in diabetes. WS1 cell were chosen as they were 
fibroblasts and had a finite life span similar to cells in vivo. Fibroblasts are one of the 
first cells that move into the wound bed following infiltration of monocytes and 
macrophages where they carry out the important task of synthesising ECM proteins 
and growth factors (Guo & Dipietro, 2010). Fibroblast at the wound edge have been 
shown to differentiate into morphologically distinct myofibroblasts and help in 
contraction of the wound (Darby et al., 2014). As the study aimed to investigate the 
effects of cell migration into the wound, fibroblasts were the ideal candidate to develop 
a scratch assay. 
The advantage of a scratch assay is that it allows for the simulation of wound conditions 
in vitro and enables quantitative analysis on cell migration to be performed (Jonkman 
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et al., 2014; Liang et al., 2007). It also allows the researchers to investigate the effects 
of conditions such as hyperglycaemia on cell migration and to assess the efficacy of 
treatments or drugs that enhance wound closure by fibroblasts via promotion of cell 
migration. Scratch assays have been used as a high throughput screening method to 
screen for anticancer drugs that inhibit cancer metastasis (Hulkower & Herber, 2011). 
The method can easily be automated with a suitable microscope, however a scratch 
assay cannot simulate all the complications that can arise in a chronic diabetic wound. 
For instance the assay used in this study could not account for pre-existing 
inflammatory conditions and complications that arise as a result of insulin resistance 
in peripheral tissue such as neuropathy. The scratch assay also cannot account for the 
local wound environment found in a diabetic ulcer.  
The effect of PDGF-BB was tested on WS1 gap closure (Figure 3.2). The data was found 
to be inconsistent with the results published in other studies as PDGF-BB had no effect 
on WS1 cell migration (W. Li et al., 2007). One reason for this could be attributed the 
presence of growth factors that would mask the stimulatory effects of PDGF-BB. To 
address this issue a scratch assay was performed on WS1 cells using heat inactivated 
(HI) media (Figure 3.3) and no significant difference was seen. A scratch assay was then 
performed using 2 different concentrations of PDGF-BB in HI media (figure 3.4) and 
found to have no significant difference in gap closure of WS1 cells. Pierce et al., (1995) 
have previously shown that fibroblasts in the wound bed have receptors for PDGF-BB 
and recommended that recombinant, rPDGF-BB be used to treat chronic wounds 
where the relative concentration of PDGF-BB is low. The group also identified that 
fibroblasts in the wound usually produce large quantities of the long isoform of PDGF 
called PDGF-AAL in both chronic and acute wounds which could be another reason 
why PDGF-BB has no effect on WS1 cells; moreover the action of PDGF-BB can only 
occur if the cells have receptors for PDGF-BB (Heldin, Laurent, & Heldin, 1989). PDGF-
BB binds to its receptor PDGF-β which is expressed on mature granulation tissue 
including wound fibroblasts and perivascular cells (Pierce et al., 1995) which could 
mean that WS1 cells possibly do not express the receptor PDGF-β; however the 
presence of PDGF-β was not tested in this study.  
One observation was that some locations on the scratch seemed to close at a faster rate 
than the reference point and so a scratch assay was carried out and gap measurements 
were taken at the centre and extremes of the well (Figure 3.5). No significant difference 
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was found in gap closure between locations suggesting that the cells moved into the 
scratch at a steady rate across the scratch. Commercial inserts were also were also 
tested to see if there was a difference in migration when using mechanical or cell 
exclusion methods (Figure 3.6). No difference was seen in gap closure when either 
method was applied. The advantage of the cell exclusion method was that it required 
very few cells to form a monolayer, produced consistent gap width and could be used 
for large experiments, but their lack of reusability and cost offset their advantage. 
Another advantage for using commercial inserts is that they do not damage ECM 
components that are coated onto the plate to ensure cell adhesion (Jonkman et al., 
2014), however in this study uncoated plates were used. 
In order to ascertain that gap closure in this study occurred as a result of cell migration 
and not as a result of cell proliferation, mitomycin C was optimised using MTS assay. 
The doubling time for WS1 was 44h and so cells were treated with mitomycin and 
incubated for 48h. Mitomycin C was found to be acutely toxic to the cell even at low 
concentrations of 10μg/ml as detected by MTS assay (Figure 3.7). Reducing the 
concentration to 2.5μg/ml was still found to be toxic to WS1 cells (Figure 3.8). In order 
to circumvent this issue cell viability was assayed at various time points and showed 
that cellular viability did not reduce significantly after 16h when treated with 10μg/ml 
and 20μg/ml of mitomycin C (Figure 3.9).  
A BrdU assay was performed in order to test which concentration would be most 
suitable to use in the scratch assay. The assay showed that there was no significant 
difference between either concentration as they inhibited cell proliferation by 90.48% 
and 95.31% respectively. 10μg/ml was therefore chosen as it inhibited cell proliferation 
and would be less cytotoxic to cells.  Once image capture of the scratch had been 
automated this concentration of mitomycin C was tested on a scratch assay to see if 
gap closure occurred through cell proliferation or migration. No significant difference 
was seen between untreated control and cells treated with mitomycin C. This showed 
that gap closure in this study occurred through cell migration alone (Figure 3.10). The 
effect of an inhibitor of cell migration will be investigated in the near future. 
In this study only similar sized scratch widths were measured and analysed, however a 
correlation was found when scratches of different sizes were compared to each other. 
The net movement of cells in smaller scratches was lower than the movement of cells 
in larger scratches over the same length of time (figure 3.13). This would suggest that 
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cell migration is not dependant on gap width and orientation alone and is regulated by 
other factors. What these factors are remains to be discovered and how can they 
influence wound closure both in vivo and in vitro remains to be seen. WS1 did not seem 
to migrate in a defined trajectory when observed through time-lapse images (figure 
3.12) this could be regulated by these promotive or inhibitory factors that would cause 
cells to move toward them a faster or slower rate. 
In this study gap width measurements at specific time points were measured for most 
of the experiments and in later experiments area measurements were used primarily to 
compare whether area measurements offered better accuracy. Image analysis on earlier 
experiments could not be carried out as they were of poorer quality and generated high 
variability. When area measurements of the scratch was attempted TScratch at times 
would consider areas where no cells are present as the edge of the scratch and give very 
high percentage cover rates. TScratch recommends using phase contrast pictures as 
opposed to pictures taken in bright field which were used in earlier experiments 
(Gebäck et al., 2009). Fibroblasts and keratinocytes are the first cells to move into the 
wound and initiate proliferative phase of wound healing and hence prove to be ideal 
candidates to investigate the effects of a treatments such as heat shock in a diabetic 
wounds where the migration of fibroblasts is reduced (Hehenberger, Heilborn, 
Brismar, & Hansson, 1998).  
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Chapter 4  Investigating the effect of heat shock in in 
vitro wound healing 
 
4.1  Introduction 
Impaired wound healing is a common problem in diabetes and is caused by underlying 
chronic inflammation (Magill et al., 2010).  Pre-existing neuropathic conditions bring 
about a loss of feeling in the lower limbs, produce foot deformities and the formation 
of chronic wounds in the lower limbs that do not heal (Brem & Tomic-Canic, 2007). 
Delayed by the lack of cell migrating into the wound exposes the wound to the 
environment and possible infection which may eventually lead to amputation. 
Impaired wound healing is one of the leading causes of patient mortality in diabetes. 
Migration of fibroblasts into the wound is an important aspect of wound healing and 
thus a scratch assay was developed to investigate cell migration in the wound and the 
effect of hyperglycaemia and heat shock on cell migration.    
The response of cells to thermal stress induces the expression of cell stress proteins or 
heat shock proteins (HSP). These proteins act as molecular chaperones that unfold 
thermally damaged proteins, direct irreparable proteins for degradation and down 
regulate the expression of apoptotic genes to ensure cell survival (Verghese et al., 2012). 
The induction of these proteins is highly conserved in all organisms and is collectively 
called the heat shock response. In diabetes this response is impaired (Kondo et al., 
2014; Magill et al., 2010). 
Induction of HSP has been shown to inhibit activation of caspases in cells and reduce 
reactive oxygen species (C Garrido et al., 1999). They also been shown to inhibit JNK 
activity and confer protection from apoptosis (Park, Lee, Huh, Seo, & Choi, 2001). 
Recent studies in mice and humans have shown that induction of HSP by heat shock 
coupled with mild electrical stimulation improves insulin sensitivity (Kondo et al., 
2014). Topical application of HSP proteins have also shown to improve wound healing 
in mice (W. Li et al., 2007). Taken together these studies have shown that heat shock 
stimulates wound healing and improves insulin sensitivity. However the mechanisms 
by which this occurs remains poorly understood. Moreover how heat shock specifically 
affects cell migration is unknown. The effect of heat shock on cell migration was tested 
in this chapter using an in vitro scratch assay. 
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4.2 Aims 
To investigate the effect of heat shock on WS1 cell migration and to further investigate 
the effect of cell migration under hyperglycaemic conditions. 
4.3 Methods used in this chapter 
4.3.1 Scratch assay 
A scratch assay was performed using WS1 cells as described in detail the methods 
chapter 2 sections 2.3.4.2. Details for the methods for the experiments described in this 
chapter can be found in sections 2.3.4.8 to 2.3.4.14. All data described here have a 
sample number of 3.  
 4.4 Results  
4.4.1 Is a recovery period essential for wound closure? 
Following heat shock treatment a recovery period was given to cells in order to produce 
cell stress proteins (Figure 4.1). The results showed that heat shock of 40°C had no 
effect on cell migration in WS1 cells (p=0.5443). As cells were incubated under optimal 
cell culture conditions following heat shock treatment (i.e. 37°C and 5% CO2), a 
recovery period may not be necessary. 
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Figure 4.1: The effect of heat shock at 40°C for 1h followed by a 2h recovery period on wound 
closure of WS1 cells. WS1 cells were cultured at a seeding density of 5 x 104 viable cells/ml and 
allowed to adhere for 48h. They were then placed in an incubator at 40°C for 1h and then 
incubated for a further 2h at 37°C and put through a scratch assay. Width measurements and 
pictures were taken at hourly intervals (a). The data were normalized and presented as means 
± SEM, n=3 (b). Mean percentage gap closure between treatments was compared at each time 
point using a two way ANOVA with Sidak’s multiple comparison as post hoc test (c).  
 
To ensure a recovery period was not necessary WS1 cells were given a heat shock 
treatment at 40°C and where immediately used for a scratch assay (Figure 4.2). The 
data showed that heat shock treatment at 40°C had no significant effect on the 
migration of WS1 cells (p=0.80), thus the following experiments no recovery period 
was used. 
 
 
 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs 40°C 2h recovery) 
0 >0.9999 
1 >0.9999 
2 0.9987 
3 >0.9999 
4 >0.9999 
5 0.9983 
6 >0.9999 
7 0.9999 
8 >0.9999 
9 0.4329 
11 >0.9999 
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Figure 4.2: The effect of heat shock at 40°C for 1h with no recovery period on wound closure of 
WS1 cells. WS1 cells were cultured at a seeding density of 5 x 104 viable cells/ml and allowed to 
adhere for 48h. The cells in the heat shock condition were subjected to a heat shock of 40°C for 
1h following which they were scratched. Width measurements and pictures were taken at 2h 
intervals (a). The data were normalized and presented as means ± SEM, n=3 (b). Mean 
percentage gap closure between treatments was compared at each time point by a two way 
ANOVA with Sidak’s multiple comparison as post hoc test (c). 
 
4.4.2 Heat shock treatment for 1h at various temperatures 
 WS1 cells were given a heat shock of 1h at 39°C (Figure4.3) (p=0.205), 41°C (figure 4.4) 
(p=0.8905), 42°C (Figure4.5) (p=0.6541) and 45°C (figure4.6) (p=0.560). The data 
showed that there was no significant difference between in cell migration between 
controls and heat shock treatments.  
 
 
 
Sidak’s multiple comparison test 
Time (h) p values (37°C vs 40°C no 
recovery) 
0 >0.9999 
2 >0.9999 
4 0.9247 
6 >0.9999 
8 0.9960 
10 0.7395 
12 0.9728 
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Figure 4.3: The effect of heat shock at 39°C for 1h on wound closure of WS1 cells. WS1 cells were 
cultured at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. Treatment 
plate was placed in an incubator at 39°C for an hour while the control plate was incubated at 
37°C. The cells were scratched immediately after heat shock treatment. Width measurements 
and pictures were taken at 2h intervals (a). The data were normalized and presented as means 
± SEM, n=3  (b) Mean percentage gap closure between treatments was compared at each time 
point by a two way ANOVA with Sidak’s multiple comparison as post hoc test (c). 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat 
shock 39°C) 
0 >0.9999 
2 >0.9999 
4 0.7889 
6 0.6553 
8 0.2626 
10 0.6276 
12 >0.9999 
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Figure 4.4: The effect of heat shock at 41°C for 1h on wound closure of WS1 cells. WS1 cells were 
cultured at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The 
treatment cell culture plate was then placed in an incubator at 41°C for an hour and put through 
a scratch assay whilst the control was incubated at 37°C. Width measurements and pictures 
were taken at 2h intervals (a). The data were normalized and presented as means ± SEM, n=3 
(b). Mean percentage gap closure between treatments was compared at each time point by a 
two way ANOVA with Sidak’s multiple comparison as post hoc test (c). 
 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat shock 
41°C) 
0 >0.9999 
2 >0.9999 
4 0.9995 
6 0.9601 
8 >0.9999 
10 0.9728 
12 0.9998 
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Figure 4.5: The effect of heat shock at 42°C for 1h on wound closure of WS1 cells. WS1 cells were 
cultured at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The cells 
in the heat shock condition were subjected to a heat shock of 42°C for 1h while the controls 
were incubated at 37°C. The cells were then subjected to a scratch assay. Width measurements 
and pictures were taken at 2h intervals (a). The data were normalized and presented as means 
± SEM, n=3 (b). Mean percentage gap closure between treatments was compared at each time 
point by a two way ANOVA with Sidak’s multiple comparison as post hoc test (c).  
 
 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat 
shock 42°C) 
0 >0.9999 
2 0.9995 
4 0.9909 
6 0.9982 
8 0.9997 
10 >0.9999 
12 0.9923 
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Figure 4.6: The effect of heat shock at 45°C for 1h on wound closure of WS1 cells. WS1 cells were 
cultured at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The cells 
in the heat shock condition were subjected to a heat shock of 45°C for 1h while the controls 
were incubated at 37°C. The cells were then subjected to a scratch assay. Width measurements 
and pictures were taken at 2h intervals (a). The data were normalized and presented as means 
± SEM, n=3 (b) Mean percentage gap closure between treatments was compared at each time 
point by a two way ANOVA with Sidak’s multiple comparison as post hoc test (c). 
 
As heat shock treatments at the temperatures tested seemed to have no significant 
effect on gap closure the effect of incubation at high temperatures was tested. A scratch 
assay was performed where control scratches were incubated at 37°C and the test 
scratches were incubated at 45°C (Figure 4.7).  The data showed that incubation at 
45°C had a significant effect on WS1 cells (p=0.0047) and inhibited their migration. 
After 5h there is a significant difference (p<0.0001) in gap closure between control cells 
and cells incubated at 45°C. The cells begin to appear morphologically different after 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat shock 
45°C) 
0 >0.9999 
2 0.9990 
4 0.9970 
6 0.8231 
8 0.7668 
10 0.9999 
12 >0.9999 
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3h and the change in morphology is very clear at 6h. This is because incubation at such 
a high temperature would cause cell death.  
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Figure 4.7: The effect of 45°C incubation for 10h on wound closure of WS1 cells. WS1 cells were 
cultured at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. The cells 
were then subjected to a scratch assay. Cells in the control wells were incubated at 37°C while 
cells in the incubation condition were incubated at 45°C. The widths of the scratch were 
measured and pictures were taken at hourly intervals (a). The data were normalized and 
presented as means ± SEM, n=3 and significance is indicated where ‘****’ indicates p<0.0001 
(b). Mean percentage gap closure between treatments was compared at each time point by a 
two way ANOVA with Sidak’s multiple comparison as post hoc test (c). 
  
4.4.3  Testing commercial inserts on WS1 scratch assay: physical removal vs 
cell exclusion 
The effect of heat shock at 39°C for 1h was tested using commercial inserts to see if 
there was any difference in cell migration of WS1 cells and determine whether cell 
exclusion or cell removal were better modes by which the scratch assay should be 
performed (Figure 4.8). The data and pictures showed that there is no significant 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat shock 
42°C) 
0 >0.9999 
1 >0.9999 
2 0.9998 
3 0.6078 
5 <0.0001 
6 <0.0001 
7 <0.0001 
8 <0.0001 
10 <0.0001 
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difference between gap closure between control and heat shock treatment at 39°C for 
an hour (p=0.171). 
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Figure 4.8: The effect of heat shock at 39°C for 1h on wound closure of WS1 cells using 
commercial inserts. WS1 cells were cultured in inserts at a seeding density of 5 x 104 viable 
cells/ml and allowed to adhere for 48h. Test well plate was incubated at 39°C for 1h and the 
scratch assay was started by removing the inserts. The widths of the scratch were measured and 
pictures were taken at 3, 6, 9, 12 and 26h intervals (a). The data were normalized and presented 
as means ± SEM, n=3 (b). Mean percentage gap closure between treatments was compared at 
each time point by two way-ANOVA with Sidak’s multiple comparison as post hoc test (c). 
 
The effect of compounding stresses heat shock and HI media were tested on WS1 gap 
closure (Figure 4.9). No significant difference was seen (p=0.471).  
 
Sidak’s multiple comparison test 
Time 
(h) 
p values (37°C vs  heat shock 
39°C) 
0 >0.9999 
2 0.9985 
5.5 >0.9999 
9 0.9637 
10 0.0025 
12 0.3332 
26 >0.9999 
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c 
Dunnett’s multiple comparison test 
Test conditions p values 
37°C vs 37°C HI media 0.9983 
37°C vs Heat shock  39°C 0.5917 
37°C vs Heat shock 39°C  Hi media 0.5563 
 
Figure 4.9: The effect of heat shock at 39°C for 1h and HI media on wound closure of WS1 cells. 
WS1 cells were cultured in inserts at a seeding density of 5 x 104 viable cells/ml in two well plates 
and allowed to adhere for 48h.  The test plate was incubated at 39°C for 1h. The inserts were 
then removed to start the scratch assay. Cells in control conditions were washed with complete 
culture medium and incubated in complete culture medium. Cells in the heat inactivated 
condition were washed and incubated with heat inactivated media.  Data are represented as 
means ± SEM, n=3 (b). Mean percentage gap closure between treatments was compared to 
control by two way ANOVA with Dunnett’s multiple comparison as the post hoc test (c).  
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4.4.4 The effect of hyperglycaemia on WS1 cells   
Following on from the automation of image capture of the scratch assay in chapter 3 a 
control experiment was setup to assess the effect of high glucose on the scratch assay. 
(Figure 4.10). The data showed that 30mM glucose had no effect on wound closure 
(p=0.516).  
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Figure 4.10: The effect of hyperglycaemia on wound closure of WS1 cells. WS1 cells were cultured 
on well plates at a seeding density of 5 x 104 viable cells/ml and allowed to adhere for 48h. Cells 
were then put through a scratch assay. Control wells received complete culture medium while 
hyperglycaemic wells received complete culture medium supplemented with 30mM glucose. 
Time lapse pictures were taken at hourly intervals for the first 7h and then at 30 min intervals 
for the remaining 5h (a). Cell migration was analysed using TScratch software and migration at 
each time point was normalized. Data are represented as means ± SEM, n=2 (b). Mean 
percentage gap closure between treatments was compared at each time point using a two-way 
ANOVA with Sidak’s multiple comparison as a post hoc test.  
 
Sidak’s multiple comparison test 
Time (h) p values (control vs 30mM 
glucose) 
0 >0.9999 
1 >0.9999 
2 >0.9999 
3 >0.9999 
4 >0.9999 
5 >0.9999 
6 >0.9999 
7 >0.9999 
8 >0.9999 
8.5 >0.9999 
11 0.9996 
11.5 0.9974 
12 >0.9999 
12.5 0.9975 
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In the following experiment the effect of heat shock and hyperglycaemia were tested 
(figure 4.11).  The data showed that there was no significant difference in cell migration 
of WS1 cells when under heat shock and hyperglycaemic conditions (p=0.188).  
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Figure 4.11: The effect of heat shock at 40°C for 1h and hyperglycaemia on wound closure of WS1 
cells. WS1 cells were cultured in inserts at a seeding density of 5 x 104 viable cells/ml and allowed 
to adhere for 48h. The cells were incubated at 40°C for 1h and then put through the scratch 
assay. Control wells received complete culture medium while hyperglycaemic wells received 
complete culture medium supplemented with 30mM glucose. Time lapse pictures were taken 
at hourly intervals for the first 7h and then at 30 min intervals for the remaining 5h (a). Cell 
migration was analysed using TScratch software and migration at each time point was 
normalized and data are represented as means ± SEM, n=2. Mean percentage gap closure 
between treatments was compared at each time point using a two-way ANOVA with Sidak’s 
multiple comparison as a post hoc test. 
 
As all other heat shock treatments did not show a significant difference on wound 
closure it was thought that the length of heat shock was too small to show any 
significant difference in cell migration. A scratch assay was then setup where the cells 
Sidak’s multiple comparison test 
Time (h) p values (40°C heat shock vs 40°C 30mM 
glucose) 
0 >0.9999 
1 >0.9999 
2 >0.9999 
3 >0.9999 
4 >0.9999 
5 >0.9999 
6 0.9833 
7 0.8300 
7.5 0.9185 
8 0.9116 
8.5 0.3593 
9 0.5549 
9.5 0.5658 
10 0.9484 
10.5 0.9892 
11 >0.9999 
11.5 0.9995 
12. 0.9988 
12.5 >0.9999 
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were incubated at 42°C for 3h and then put through the scratch assay (Figure 4.20). 
The effect of high glucose and mitomycin C were also tested so data could be compared 
between experiments. The data showed that there was no significant difference 
between control, hyperglycaemia and mitomycin C on wound closure (p=0825). The 
experiment also showed that movement of cells into the gap was a result of cell 
migration alone. 
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 Tukey’s multiple comparison test 
Comparisons p values 
Control heat shock 42 3h vs. 30mM glucose heat shock 42 3h 0.7629 
Control heat shock 42 3h vs. 10mg/ml Mitomycin heat shock 42 3h 0.9640 
30mM glucose heat shock 42 3h vs. 10mg/ml Mitomycin heat shock 42 3h 0.6170 
 
Figure 4.12: The effect of heat shock at 42°C for 3h, hyperglycaemia and Mitomycin C on wound 
closure of WS1 cells. WS1 cells were cultured on well plates at a seeding density of 5 x 104 viable 
cells/ml and allowed to adhere for 48h. Cells were then incubated at 42°C for 3h and then put 
through a scratch assay. Control wells received complete culture medium while hyperglycaemic 
wells received complete culture medium supplemented with 30mM glucose and cells in the 
mitomycin condition received complete culture medium supplemented with 10μg/ml 
mitomycin C. Time lapse pictures were taken at hourly intervals for the first 7h and then at 30 
min intervals for the remaining 5h (a). Cell migration was analysed using TScratch software and 
migration at each time point was normalized and data are represented as means ± SEM, n=3 
(b). Mean percentage gap closure between treatments was compared using a two-way ANOVA 
with Tukey’s multiple comparison as post hoc test.  
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Although gap closure had only progressed to 50% at the end of 12h when data is 
compared to control conditions the relationship is not significant. Comparing all the 
conditions to 37°C showed no significant difference between them (Figure 4.13). The p 
values for the two way ANOVA are depicted in the table 18. 
Table 18: The effect of hyperglycaemia and heat shock on WS1 cell migration.  
Two way ANOVA 
Comparisons P values 
37°C vs Heat shock 40°C 1h 0.971 
37°C vs Heat shock 42°C 3h 0.590 
37°C vs Heat shock 40°C 1h 30mM glucose 0.412 
37°C vs Heat shock 42°C 3h 30mM glucose 0.259 
37°C vs Heat shock 42°C 3h Mitomycin C 0.345 
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Sidak’s multiple comparison test 
Time 
(h) 
37°C vs Heat shock 
40°C 1h 
0.0 >0.9999 
1.0 >0.9999 
2.0 >0.9999 
3.0 0.9996 
4.0 0.9987 
5.0 0.9753 
6.0 >0.9999 
7.0 >0.9999 
7.5 >0.9999 
8.0 >0.9999 
8.5 >0.9999 
11.0 0.9937 
11.5 >0.9999 
12.0 0.9840 
12.5 0.9821 
Sidak’s multiple comparison test 
Time 
(h) 
37°C vs Heat shock 
42°C 3h 
0.0 >0.9999 
1.0 >0.9999 
2.0 >0.9999 
3.0 >0.9999 
4.0 >0.9999 
5.0 0.9992 
6.0 >0.9999 
7.0 >0.9999 
7.5 >0.9999 
8.0 >0.9999 
8.5 >0.9999 
11.0 0.9975 
11.5 0.9897 
12.0 >0.9999 
12.5 0.9950 
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Sidak’s multiple comparison test 
Time (h) 37°C vs 30mM 
glucose heat shock 
40°C 1h 
0.0 >0.9999 
1.0 >0.9999 
2.0 >0.9999 
3.0 >0.9999 
4.0 >0.9999 
5.0 >0.9999 
6.0 >0.9999 
7.0 0.8964 
7.5 0.9844 
8.0 0.9294 
8.5 0.3956 
11.0 0.8210 
11.5 0.9417 
12.0 0.3393 
12.5 0.7718 
Sidak’s multiple comparison test 
Time (h) 37°C vs 30mM 
glucose heat shock 
42°C 3h 
0.0 >0.9999 
1.0 >0.9999 
2.0 >0.9999 
3.0 >0.9999 
4.0 >0.9999 
5.0 0.9958 
6.0 0.9982 
7.0 0.9519 
7.5 0.5474 
8.0 0.6198 
8.5 0.6140 
11.0 0.4489 
11.5 0.2387 
12.0 0.9377 
12.5 0.4467 
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Figure 4.13: Comparing individual conditions to 37°C.  37°C vs heat shock 40°C for 1h (a) 37°C 
vs heat shock at 42°C for 3h (c) 37°C vs 30mM glucose heat shock 40°C 1h (d) 37°C vs heat shock 
42°C 3h (e) 37°C vs mitomycin C heat shock 42°C for 3h.  Data are represented as means ± SEM, 
n=3 and mean percentage gap closure between treatments was compared at each time point. 
Data were analysed by two way ANOVA with Sidak’s multiple comparison as post hoc test. 
 
4.5 Discussion 
The study aimed to investigate the role of heat shock on wound closure in vitro. WS1 
cells were initially given a 2h recovery to induce HSP prior to being scratched as it was 
considered that they were being subjected to compounding stresses (Figure 4.1). To 
test if this was indeed the case, WS1 cells were put through the scratch assay without a 
recovery period (Figure 4.2). No difference in wound closure was seen and so a recovery 
period was deemed unnecessary. WS1 cells were treated with heat shock at range of 
temperatures for 1h and then scratched (39°C to 45°C).  It was shown that migration of 
fibroblasts remains unaffected under heat shock treatments (Figures 4.2 to 4.6). WS1 
cells were then incubated at 45°C for the duration of the scratch assay. High 
temperature incubation significantly reduce cell migration (Figure 4.7) as it invariably 
caused cell death. 
The commercial inserts from Ibidi were also tested on heat shock at 39°C treatments 
and found to have no effect on wound closure (Figure4.8). No difference was found in 
wound closure rates. Moreover the size of gap the inserts generated and size of scratch 
that was generated using a pipette tip were similar. Following heat shock treatment, 
Sidak’s multiple comparison 
test 
Time 
(h) 
37°C vs 10μg/ml 
mitomycin hs42°C 3h 
0.0 >0.9999 
1.0 >0.9999 
2.0 >0.9999 
3.0 >0.9999 
4.0 0.9997 
5.0 0.9477 
6.0 0.9722 
7.0 0.9868 
7.5 0.9380 
8.0 0.9347 
8.5 0.9603 
11.0 0.9768 
11.5 0.9731 
12.0 >0.9999 
12.5 0.9623 
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WS1 cells were incubated in complete culture medium. The growth factors from FBS 
could have assisted in cell migration. A lack of growth factors would inhibit cell 
migration into the gap. Heat shock coupled with heat inactivated medium was then 
tested (Figure 4.9) and no significant difference was seen in cell migration.  
Once image capture had been automated the effect of hyperglycaemia was tested on 
wound closure of WS1 (Figure 4.10). Hyperglycaemia had no effect on the wound 
closure of WS1 cells. WS1 cells were then subjected to heat shock and hyperglycaemia 
and here too no difference was seen (Figure 4.11).     
It was thought that heat shock treatment for 1h was too short and so longer heat shock 
treatment period of 3h was tested. The effect of mitomycin C was also tested in the 
same experiment (Figure 4.12) no significant difference was seen.  The effect of a 2h 
heat shock has not been tested and would be looked into in the near future. All the 
heat shock experiments coupled with hyperglycaemia and mitomycin C were then 
compared to 37°C and found to have no significant differences between them (figure 
4.13). This implied that over a period of 12h cell migration seen in this study was an 
effect of cell movement alone.    
These results shown in this study indicate that hyperglycaemia (30mM) has no effect 
on cell migration. These results are in disagreement with (Xuan et al., 2014) who used 
human foreskin fibroblasts and showed that 30mM glucose inhibits fibroblast 
migration. One reason why they have seen this effect could be because they cultured 
their fibroblast in 0.35% FBS for their assay which would not be representative of in 
vivo as serum starvation has been  shown to induce morphological changes and the 
Warburg effect in human foreskin fibroblast cells (Golpour et al., 2014). The Warburg 
effect shows that cells prefer anaerobic respiration and produce lactate even under 
favourable aerobic conditions and therefore would cause fibroblasts to produce lactate. 
High lactate levels in diabetic wounds have been shown to inhibit fibroblast migration 
in vitro (Hehenberger et al., 1998). Commercially available human foreskin fibroblasts 
from ATCC recommend 15% FBS for complete culture medium.  
Lamers et al., (2011) show that cell migration rates of CHO, NIH-3T3 and mouse 
embryonic fibroblast are reduced in presence high glucose conditions (25mM), but 
does not describe how the wound healing assay was carried out or show pictures of the 
scratch assay. (Lamers, Almeida, Vicente-Manzanares, Horwitz, & Santos, 2011). The 
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data also shows that cells took 3 days for closure including mouse embryonic 
fibroblasts, while the data here indicates that complete closure of fibroblasts occurs in 
less than 24h. This could possibly be because the fibroblasts were primary cells from 
mice and are likely to behave differently compared to the embryonic fibroblasts used 
in this study.   
In the last few years whole body hyperthermia treatments have been shown to improve 
insulin sensitivity animal models (Chung et al., 2008; Gupte, Bomhoff, Swerdlow, & 
Geiger, 2009; Morera, Basirico, Hosoda, & Bernabucci, 2012; Sanz Fernandez et al., 
2015). Some studies have used heat shock coupled with mild electrical stimulation to 
show improvements in insulin sensitivity (Kondo et al., 2012; Matsuyama et al., 2014; 
Morino et al., 2008). These studies all have concluded that induction of HSP72 
improves insulin sensitivity through inhibition of JNK and NF B in liver, muscle and 
adipose tissues and improving overall glucose homeostasis even when given a high fat 
or high glucose diet.  Data presented in this chapter used heat shock treatment and 
hyperglycaemia to see if heat shock improved wound closure in a model of a diabetic 
wounds. Heat shock treatment was found to have no effect on cell migration in the 
WS1 wound healing model with the exception of incubation at high temperatures 
where it caused cell death.  Thus impaired wound healing in diabetes may not be 
caused by poor cell migration into the wound but could possibly be a result of other 
factors that would inhibit cell migration such as poor wound debridement by resident 
macrophages and neutrophils, a lack of growth factors, high levels of NO, chronic 
hypoxia and inflammatory cytokines in the wound site (Blakytny & Jude, 2006).  
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Chapter 5   Assays for glucose uptake and GLUT4 in 
U937 cells 
 
5.1 Introduction  
Diabetes is usually diagnosed by a measuring for circulating levels blood glucose. The 
oral glucose tolerance test (OGTT) is currently the gold standard to diagnose diabetes, 
however the test requires the patient to fast overnight and is labour intensive and so 
not used routinely. The reproducibility of the test in repeat tests is poor as well.  Other 
alternative tests require either prompt process sample processing and can be 
influenced by short term lifestyle changes as in random blood glucose testing and 
capillary blood glucose but do not indicate long term glycaemic control (Echouffo-
Tcheugui, Ali, Griffin, & Narayan, 2011). Recently testing for raised levels glycated 
haemoglobin (HbA1c) has been shown to identify glycaemic control over a long period 
and indicate possibility of diabetic complications in patients. The test however, is 
expensive and needs to be standardized for ethnicity and age as they produce varying 
levels of other interfering haemoglobin molecules (Weykamp, 2013). These test are also 
indirect measures to assess glycaemic control in diabetes and rely on insulin resistance 
and other factors to diagnose type 2 diabetes.  
One aspect of diabetes in the development of chronic low grade inflammation which 
occurs much before any glucose intolerance or insulin resistance occurs. This can easily 
be seen in monocytes and macrophages that infiltrate adipose tissue at the onset of 
obesity (Hasty, 2008). Monitoring monocyte and macrophage activity in blood could 
provide insights in to the level of glycaemic control within the body much before 
insulin resistance occurs. Monocytes and macrophages play a central role in insulin 
resistance and inflammation and could provide a more effective way to see if treatment 
is effective  (Koh & DiPietro, 2013; Samaan, 2011). 
In the preceding chapter the effects of heat shock and hyperglycaemia on cell migration 
were investigated; and here the same stresses were used to see the effects on monocyte 
glucose transport and cytokine profiles. In order to test the effect of heat shock on 
glucose uptake and expression in monocytes, a glucose uptake assay using a fluorescent 
glucose analogue (2-n(7-nitrobenz-2-oxa-1,3diazol-4-yl)amino)-2-deoxyglucose 
(2NBDG) was developed in U937 cells. The assay was previously described to measure 
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glucose uptake in human CD14 monocytes (Dimitriadis et al., 2005). A monoclonal 
antibody for GLUT4 was purchased and optimised with an aim to be used to assess 
GLUT4 expression in U937 cells   
 
5.1.1 Aims 
 To optimize a glucose uptake assay in U937 monocytes using the fluorescent 
glucose analogue 2NBDG.  
 To test the assay under cell stress conditions such as changes in pH and 
membrane fluidization. 
 To optimize an assay to study GLUT4 expression in U937 cells under conditions 
of membrane fluidization and hyperglycaemia  
5.2 Methods 
5.2.1 2NBDG glucose uptake assay 
Glucose uptake assay was carried out as described in chapter 2, section 2.3.8.1 to 2.3.8.5. 
5.2.2 GLUT 4 flow cytometry 
 The presence of GLUT4 is described in chapter 2, section 2.3.8.6.  
5.3 Results 
5.3.1 Determining the number of washes to remove excess 2NBDG   
The first step was to determine the number of washes required to remove excess 
2NBDG from cells and ascertain that the fluorescence that would be recorded would 
just come from 2NBDG that was internalized by the cells. This was done by adding 
2NBDG to the cells and incubating them for 1h and performing washes in DPBS. The 
supernatant was collected and its fluorescence was determined using a plate reader 
(figure 5.1). Supernatant taken immediately after incubation had the highest 
fluorescence which was significantly higher than the untreated cells (p<0.001).  After 
one wash fluorescence was reduced by 89.4%  (p<0.01) and after two washes 
fluorescence was not significantly different from untreated supernatant, therefore two 
washes were sufficient to remove excess 2NBDG from cells (Figure 5.1). 
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Figure 5.1: Number of washes required to remove excess 2NBDG from medium post treatment. 
U937 cells were cultured at seeding density of 1 x 106 viable cells/ml and treated with 10μl of 
2NBDG and incubated at 37°C for 1 h following which they were centrifuged at 500g for 5 min, 
the supernatant was stored and cells were re-suspended in DPBS. The process was repeated 3 
times to produce 3 supernatant samples whose fluorescence was detected using a plate reader. 
Data are presented as means ± SEM, n=3 and were compared to untreated cells. Data were 
analysed by a one way ANOVA with Dunnett’s as post hoc test where, * (p<0.05) and **** 
(p<0.0001). 
 
5.3.2  Determining the optimal incubation time of 2NBDG  
The optimal incubation time for 2NBDG uptake was then determined by a time course 
(Figure 5.2). 2NBDG was added to U937 cells every hour for 3h  following which they 
were wash twice and analysed by flow cytometry (Figure 5.2 a & b). Fluorescence 
significantly increased every hour and after 2h there was no significant difference in 
fluorescence therefore, a 2h incubation was chosen.  
 
 
 
 
 
 
Dunnett’s multiple comparison test 
Comparisons  p values 
untreated vs. 0 0.0001 
untreated vs. 1 0.0072 
untreated vs. 2 0.9997 
untreated vs. 3 0.9250 
untreated vs. media 0.9998 
untreated vs. DPBS 0.9362 
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Figure 5.2: Optimal incubation time for 2NBDG. U937 cells were cultured at a seeding density 
of 1 x 106 viable cells/ml in 96 well plate. 10μl of 2NBDG was added to three wells every hour 
over a period of 3h. The cells were then washed twice in DPBS and analysed using flow 
cytometry. Data are presented as means ± SEM, n=3. Data was analysed by a one way ANOVA 
with Tukey’s multiple comparison as post hoc test (a). A representative scatter plot of the viable 
cells and the mean fluorescence of unstained cells (blue) and cells that have been treated with 
2NBDG (yellow) is shown (b). 
 
5.3.3 Competitive inhibition of 2NBDG by glucose 
The effect of increasing glucose concentrations was tested to see if fluorescence could 
be competitively inhibited (Figure 5.3).  The data showed that fluorescence was highest 
when glucose was not present. The fluorescence of 5mM glucose was significantly 
lower than the fluorescence of glucose free media (p<0.01) while the remaining 
Tukeys’s multiple comparison 
test 
Comparisons p values 
0. vs. 1. 0.0061 
0. vs. 2. <0.0001 
0. vs. 3. <0.0001 
1. vs. 2. 0.0014 
1. vs. 3. <0.0001 
2. vs. 3. 0.0779 
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dilutions were even more significantly lower (p<0.001) in comparison, indicating 
glucose inhibited 2NBDG fluorescence in a competitive manner. 
 
 
 
Figure 5.3: The effect of glucose concentrations on 2NBDG uptake. U937 cells were seeded at 
cell density of 1 x 106 viable cells /ml. The cells were subsequently washed and re-suspended in 
media containing varying concentrations of glucose made in glucose free media. Control wells 
received glucose free media without any supplementation. Each well received 10μl of 2NBDG 
and the plate was incubated for 2h. The cells were then washed and analysed by flow cytometry. 
Data are presented as mean ± SEM, n=3 and compared to 0mM glucose. Data were analysed by 
one way ANOVA with Dunnett’s as post hoc test where significance ** (p<0.01) and **** (p= 
0.0001). 
 
5.3.4 Determining the effect of insulin on glucose uptake 
The effect of insulin was then tested on 2NBDG fluorescence (Figure 5.4). The data 
showed that insulin had no effect on glucose uptake (p=0.192).  
 
 
 
 
Dunnett’s Multiple comparison 
test 
Comparisons p values 
0. vs. 5. 0.0017 
0. vs. 10. 0.0001 
0. vs. 15. 0.0001 
0. vs. 25. 0.0001 
0. vs. 30. 0.0001 
0. vs. 35. 0.0001 
0. vs. 40. 0.0001 
0. vs. 55. 0.0001 
0. vs. 60. 0.0001 
0. vs. 65. 0.0001 
0. vs. 70. 0.0001 
0. vs. 75. 0.0001 
0. vs. 85. 0.0001 
0. vs. 90. 0.0001 
0. vs. 95. 0.0001 
0
1
0
2
0
3
0
4
0
5
0
6
0
7
0
8
0
9
0
1
0
0
1
1
0
1 2 0 0 0
1 4 0 0 0
1 6 0 0 0
1 8 0 0 0
2 0 0 0 0
2 2 0 0 0
g l u c o s e  c o n c e n t r a t i o n  ( m M )
2
N
B
D
G
 (
M
F
I)
* * * ** *
 99 | P a g e  
 
0
1
0
- 9
1
0
- 8
1
0
- 7
1
0
- 6
1
0
- 5
1
0
- 4
1
0
- 3
1
0
- 2
1
0
- 1 1
0
5 0 0 0
1 0 0 0 0
1 5 0 0 0
i n s u l i n  ( I U / m l )
2
N
B
D
G
 (
M
F
I)
 
 
Figure 5.4: The effect of insulin on 2NBDG uptake. U937 cells were plated out at cell density of 
1 x 106 cells/ml, centrifuged at 500g to remove media and re-suspended in media containing 
insulin ranging from 1 x 10-9 IU/ml to 1IU/ml and 30.8μM of 2NBDG. Following a 2h incubation 
cells were washed twice in DPBS and analysed by flow cytometry. Data are presented as mean 
± SEM, n=3. The data were analysed by a one way ANOVA and compared 0 using Dunnett’s 
multiple comparison as the post hoc test. 
 
5.3.5 The effect of pH on glucose uptake 
The effect of pH was investigated on glucose uptake in U937 cells (Figure 5.5). Mean 
fluorescence of 2NBDG was not significant until pH 4.5 (p<0.05). However extremes 
of pH had significant effect on cell viability pH 4.5 (p<0.001), pH5.5 (p<0.001), pH 
8(p<0.001), pH 9 (p<0.001) and pH 9.5 (p<0.001) when compared to pH 7. 
 
 
 
 
 
 
 
 
 
Dunnett’s Multiple comparison 
test 
Comparisons p values 
0 vs. 10-9 0.9968 
0 vs. 10-8 0.9999 
0 vs. 10-7 0.8375 
0 vs. 10-6 0.7004 
0 vs. 10-4 0.5943 
0 vs. 10-3 0.9918 
0 vs. 10-2 0.9575 
0 vs. 10-1 0.9919 
0 vs. 1 0.8619 
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Figure 5.5: The effect of pH on glucose uptake in U937 cells. U937 cells were cultured in 96 well 
plates at a cell density of 1 x 106 cells/ml. they were centrifuged at 500g for 5 min to remove 
media. The cell pellets were then re-suspended in media with pH ranging from 4.5 to 9.5 and 
2NBDG was added. Following a 2h incubation the cell were washed twice and analysed by flow 
cytometry. The graphs show mean 2NBDG fluorescence (a) and percentage viability (b). Data 
are represented as means ± SEM, n=3 and were compared to pH7. Data were analysed by a one 
way ANOVA with Dunnett’s multiple comparison as post hoc test *(p<0.05), ***(p<0.001 and 
****(p<0.0001).  
 
5.3.6  The effect of membrane fluidizers on glucose uptake  
The effect of dimethyl sulfoxide (DMSO) on 2NBDG uptake was tested as DMSO 
changes membrane polarity and can affect cellular transport in cells (Figure 5.6). 
DMSO also causes cells to differentiate. Overall 2NBDG fluorescence remained 
insignificant until 0.781% where it became significant. At this concentration cell 
viability showed high variability. 2NBDG fluorescence significantly decreased 
Dunnett’s multiple comparison 
test 
Comparisons  p values 
7.0 vs. 4.5 0.0356 
7.0 vs. 5.0 0.9994 
7.0 vs. 5.5 0.2519 
7.0 vs. 6.0 0.9539 
7.0 vs. 6.5 0.9243 
7.0 vs. 7.5 0.9868 
7.0 vs. 8.0 0.9995 
7.0 vs. 9.0 0.4836 
7.0 vs. 9.5 0.0804 
Dunnett’s multiple comparison 
test 
Comparisons p values 
7.0 vs. 4.5 0.0001 
7.0 vs. 5.0 0.0001 
7.0 vs. 5.5 0.3267 
7.0 vs. 6.0 0.5727 
7.0 vs. 6.5 0.6445 
7.0 vs. 7.5 0.9999 
7.0 vs. 8.0 0.9996 
7.0 vs. 9.0 0.0002 
7.0 vs. 9.5 0.0001 
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corresponding to a decrease in cell viability from 3.125% (p<0.0001). This could be 
because DMSO inhibited 2NBDG uptake at low dilutions. As concentrations of DMSO 
increased and membrane integrity of cells was compromised and 2NBDG began to leak 
corresponding to an increase in fluorescence. Higher concentrations of DMSO 
significantly reduced cell viability with a corresponding decrease in 2NBDG 
fluorescence (Figure 5.8). 
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Figure 5.6:  The effect of DMSO on glucose uptake in U937 cells. U937 cells were cultured in 96 
well plates at a cell density of 1 x 106 cells/ml. They were centrifuged at 500g for 5 min to remove 
media. The cell pellets were then re-suspended in media with supplemented with DMSO 
concentrations ranging from 0.098% to 50%. The cells were then assayed for glucose uptake 
using 2NBDG and incubated for 2h. The cells were washed and re-suspended in DPBS and 
analysed by flow cytometry showing mean fluorescence (a) and percentage viability (b) Data 
are presented as means ± SEM, n=3 and were compared to 0% DMSO. Data were analysed by a 
one-way ANOVA with Dunnett’s multiple comparison as post hoc test where *(p<0.05), ** 
(0.01) and ***** (p<0.0001). 
 
The effect of membrane fluidizer benzyl alcohol and phenethyl alcohol was tested on 
glucose uptake was tested (Figure 5.9). Membrane fluidizers denature cell membranes 
Dunnett’s multiple comparison 
test 
Comparisons p values 
0 vs. 0.098 0.8881 
0 vs. 0.195 0.6489 
0 vs. 0.391 0.5225 
0 vs. 0.781 0.0291 
0 vs. 1.563 0.9967 
0 vs. 3.125 0.4075 
0 vs. 6.25 0.0001 
0 vs. 12.5 0.0001 
0 vs. 25 0.0001 
0 vs. 50 0.0001 
Dunnett’s multiple comparison test 
Comparisons p values 
0 vs. 0.098 0.0014 
0 vs. 0.195 0.0014 
0 vs. 0.391 0.0021 
0 vs. 0.781 0.1553 
0 vs. 1.563 0.6284 
0 vs. 3.125 0.0001 
0 vs. 6.25 0.0001 
0 vs. 12.5 0.0001 
0 vs. 25 0.0001 
0 vs. 50 0.0001 
 102 | P a g e  
 
and therefore affect transport of substances across cell membranes. The data show that 
2NBDG fluorescence did not change significantly over the times tested (0h p=0.361; 2h 
p=0.431).  
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Figure 5.7: The effect of membrane fluidizer benzyl alcohol (ba) and phenethyl alcohol (pha) 
on glucose uptake. U937 cells were plated out at cell density of 1 x 106 cells/ml in 2 96well plates, 
centrifuged at 500g and re-suspended in media containing membrane fluidizers. At each time 
point a plate was assayed for glucose uptake by adding 30.8μM of 2NBDG and incubated for 2h. 
The cells were washed and re-suspended in DPBS and analysed by flow cytometry. The graphs 
show mean fluorescence at 0h (a) and 2h (b) and were compared to control. Data are presented 
as means ± SEM where n=3. Data were analysed by a one way ANOVA with Dunnett’s multiple 
comparison as post hoc test.  
 
5.3.7 Determining the presence of GLUT 4 on U937 membranes 
Monocytes have been shown to be sensitive to insulin as they express the insulin 
sensitive glucose transporter GLUT4 (Dimitriadis et al., 2005; Maratou et al., 2007). 
Dunnett's multiple comparisons test 
Comparisons  p values 
Control vs. ba 5mM 0.9977 
Control vs. ba 10mM 0.9108 
Control vs. pha 2.5mM 0.9999 
Control vs. pha 5mM 0.9994 
Control vs. ba 5mM +Pha 
2.5Mm 
0.9977 
Control vs. ba 10mM +Pha 
2.5mM 
0.9939 
Control vs. ba 5mM +Pha 5mM 0.9979 
Control vs. ba 10mM +Pha 
5mM 
0.3670 
Dunnett's multiple comparisons test 
Comparisons  p values 
Control vs. ba 5mM 0.9977 
Control vs. ba 10mM 0.9108 
Control vs. pha 2.5mM 0.9999 
Control vs. pha 5mM 0.9994 
Control vs. ba 5mM +Pha 
2.5mM 
0.9977 
Control vs. ba 10mM +Pha 
2.5mM 
0.9939 
Control vs. ba 5mM +Pha 5mM 0.9979 
Control vs. ba 10mM +Pha 
5mM 
0.3670 
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Therefore the presence of GLUT4 was tested by Western blotting using a monoclonal 
antibody where GLUT4, a 50-63KDa protein was found to be retained in the 
hydrophilic regions and detected in whole cell extract (Figure 5.8). No signal was found 
in the hydrophobic region because the antibody (IF8) used in this study only recognises 
the hydrophilic C terminus of GLUT4. Moreover the hydrophobic region had a lot of 
detergent contamination and did not run properly on the gel forming a smear.  
  
 
 
Figure 5.8: Western blot showing the presence of GLUT4 50-63KDa protein on U937 cell 
extracts and membrane extracts. 10% gels were cast and loaded with the following: Lane 1 
ladder, Lane 2 whole cell extract, Lane 3 hydrophobic membrane fraction, Lane 4 hydrophilic 
membrane fraction.  15.23μg of protein was loaded into each well and the membrane was 
exposed for 120s 
 
The antibody was also tested using flow cytometry to test the presence of GLUT4 on 
both the membrane using fixed cells and inside the cell using fixed and permeabilised 
cells (Figure 5.9). Fixed cells did not show a high presence of GLUT4 while fixed and 
permeabilised cells showed high presence of GLUT4. This suggested that GLUT4 was 
retained in intracellular vesicles as cells were not treated with insulin. The secondary 
antibody in the absence of primary antibody at both dilutions was not significantly 
different when compared to no stain suggesting that the washing steps were sufficient 
and non-specific binding was negligible. Higher dilutions of primary antibody 
produced a better signal with a lower dilution of secondary overall across both 
conditions and thus primary antibody dilution of 1:200 and secondary antibody 
dilution of 1:1000 was chosen (Figure 5.9). 
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Figure 5.9: Detection of GLUT4 on membrane and intracellular fracti1ons of U937 cells. 
Membrane and cellularU937 cells were plated out at a cell density of 1 x 106 cells/ml. They were 
then either fixed (a) or fixed and permeabiliszed (b) and probed for GLUT4 using a mouse anti-
glut4 monoclonal antibody. A FITC tagged anti-mouse secondary antibody was used to detect 
the primary antibody using flow cytometry. The mean fluorescence of viable cells is shown and 
was compared to no stain. Data are represented as means ± SEM, n=3 and were compared to no 
stain.  Data was analysed by a one way ANOVA with Dunnett’s multiple comparison as post hoc 
test where * (p<0.05), ** (p<0.01) and **** (p<0.0001).    
 
Dunnett’s multiple comparison test 
Comparisons p values 
No stain vs. 11:200 21:500 0.0022 
No stain vs. 11:200 21:1000 0.0009 
No stain vs. 11:500 21:500 0.0888 
No stain vs. 11:500 21:1000 0.0294 
No stain vs. 21:500 0.9981 
No stain vs. 21:1000 0.9999 
Dunnett’s multiple comparison test 
Comparisons p values 
No stain vs. 11:200 21:500 0.0001 
No stain vs. 11:200 21:1000 0.0001 
No stain vs. 11:500 21:500 0.0001 
No stain vs. 11:500 21:1000 0.0001 
No stain vs. 21:500 0.4967 
No stain vs. 21:1000 0.9998 
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5.4 Discussion 
A glucose uptake assay has been optimised in this study to test the effects of 
hyperglycaemia and heat shock on monocytes. The protocol has been developed to 
measure GLUT4 in the cells and on the cell membrane. The number of washes required 
to remove excess 2NBDG was determined (Figure5.1). Two washes reduced 
fluorescence in the supernatant and so was used throughout the study. The optimal 
incubation for 2NBDG was determined and found to be 2h as further incubation was 
found to not significantly enhance the fluorescence signal as 2NBDG fluorescence 
(Figure 5.2) declined over time. These results were similar to a study of 2NBDG HepG2 
human hepatocarcinoma cells and L6 rat skeletal muscle cells where the fluorescence 
of 2NBDG began to plateau after 1h incubation (Zou et al., 2005). This is because, once 
2NBDG is taken up by cells is immediately phosphorylated and broken down to a non-
fluorescent metabolite (Yoshioka et al., 1996). 2NBDG fluorescence was also shown to 
be competitively inhibited by glucose confirming that it is taken up into cells through 
their glucose transporters (Figure 5.3).   
The glucose uptake assay used in this study found no effect of insulin on 2NBDG 
fluorescence (Figure 5.4). The reason for this could be attributed to the short half-life 
of insulin which is estimated to be between 4 to 6min as it is degraded by insulin 
degrading enzyme (IDE) that is ubiquitously expressed in all cells (Qiu & Folstein, 
2006); however this half-life is measured in blood. The half-life of insulin in culture 
may be different and was not tested. IDE is a Zn metalloprotease present in the 
cytoplasm and is inhibited by 10-phenanthroline (Hulse, Ralat, & Wei-Jen, 2009). This 
could be why such a short time course of 650ms was used to in their study. Even so 
Dimitriadis et al., (2005) and Maratou et al., (2007) did not wash their cells prior to 
measurement and therefore as demonstrated in this thesis, they may have been 
recording residual fluorescence rather than glucose uptake in response to insulin and 
could possibly have compromised their data. The use of a metalloprotease inhibitor 
would be used in the future to determine whether U937 cells express GLUT4 in 
response to insulin. Another difference from Dimitriadis et al., (2005) and Maratou et 
al., (2007)  study was that they carried out their experiments at 22°C which not 
representative of the condition of monocytes in vivo.  
In this study glucose uptake was also tested in conditions that compromise membrane 
integrity and cell viability such as pH and membrane fluidizers (DMSO, benzyl alcohol 
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and phenethyl alcohol).  Extremes of pH would create large ionic gradients across 
membranes which would affect proton dependent membrane transporters and 
uniporters such as GLUT transporters. Low pH would bring about conformational 
changes in proteins that denature them (Nishimura et al., 1993). Glucose uptake at 
pH4.5 was found to be significantly lower than at other pH values whereas extremes of 
pH were shown to significantly reduce cell viability (Figure 5.5).   
Membrane fluidizers were used in this study as they are potent inducers of heat shock 
proteins. Studies using the membrane fluidizer Bimoclomol, have shown that 
membrane fluidizer activates the transcription factor, heat shock factor 1 (HSF-1) and 
brings about the induction of heat shock proteins (Hargitai et al., 2003). Another study 
in diabetic mouse models has shown that gavage feeding of membrane fluidizer, BGP-
15 for 15 days  significantly, reduced levels of phosphorylated JNK, and improved insulin 
sensitivity through the induction of HSP72 (Chung et al., 2008). The effect of DMSO 
on glucose uptake was not significant until 0.78% of DMSO where it was decreased 
significantly. Fluorescence then became non-significant before declining rapidly with 
increasing concentrations of DMSO. This decline in fluorescence was attributed to the 
substantial decline in cell viability with increasing concentrations of DMSO (Figure 
5.6). This could be because as the viable cell population began to die and release 
2NBDG into the solution which was seen as an increase in fluorescence. Benzyl alcohol 
and phenethyl alcohol were 2 other fluidizers used in this study and were shown to 
have no significant effect on glucose uptake. It is possible that the concentrations 
tested in this study were too low to show an effect on glucose uptake and needs to be 
investigated. Dempsey et al. (2010) have previously shown that treatment of Jurkat 
cells with 5mM benzyl alcohol and 2.5mM phenethyl alcohol translocated HSP72 and 
HSP60 to the membrane and induce HSP synthesis as intracellular HSP levels declined. 
This reduction in intracellular HSP levels sensitized the tumour cells to sub-lethal 
levels of cytotoxic drugs and showed that combinatorial treatment cancer cells with 
membrane fluidizers is a plausible approach for the treatment of drug resistant 
tumours. In diabetes where there is lack of HSP expression (Bitar, Farook, John, & 
Francis, n.d.); treatment with membrane fluidizers could be used to induce HSP 
expression and thus bring about resolution to inflammation brought about by immune 
cells in insulin sensitive tissue.  
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The presence of insulin sensitive glucose transporter 4 (GLUT4) has been shown in 
U937 cells through flow cytometry and western blot analysis in this study (Figure 5.7 
and 5.8). These data are in agreement with previous studies that have showed the 
presence of GLUT4 in monocytes (Dimitriadis et al., 2005; Maratou et al., 2007; Simar 
et al., 2012). The assay could be used to monitor GLUT4 expression in monocytes when 
treated with heat shock and/or hyperglycaemia to obtain an insight into the glucose 
metabolism in these cells when subjected to such stresses. Recently Simar et al., (2012) 
have shown that monocytes isolated from obese individuals showed insulin resistance 
with no change in glucose transporter GLUT4 levels. Heat shock treatment at 42°C for 
2h improved insulin sensitivity measured by a reduction in phosphorylated IRS-1, JNK 
and IKKβ (Simar et al., 2012).  
Monocytes and macrophages are key regulators of inflammation in wound healing and 
diabetes. Their dysfunction in diabetic wound healing is brought about by several 
mechanisms acting together such as oxidative stress, excess inflammatory cytokines, 
hypoxia and impaired glucose homeostasis (Samaan, 2011). Heat shock has been shown 
to improve and alleviate inflammatory responses in these cells and bring about 
resolution (Simar et al., 2012). They are an ideal target for therapeutic intervention in 
order to reduce inflammation in diabetes. The assays optimized here could be used to 
test the effects of hypoxia, heat shock and drug treatments and assess whether insulin 
sensitization occurs by the upregulation of GLUT 4. Moreover further development 
could be done to monitor insulin sensitivity or resistance from monocytes isolated from 
insulin resistant patients and gage glucose tolerance in real time.     
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Chapter 6  Discussion and future work 
The study described here aimed to develop an in vitro scratch assay to investigate the 
effects of various factors on cell migration in isolation such as, heat shock and 
hyperglycaemia and use the data to gain an insight into diabetic wound healing. WS1 
cells were chosen as they were a fibroblast cell line with a finite life. They were found 
to migrate quickly to ‘close the wound’ when subject to an artificial scratch, in a very 
reproducible manner. Their migration was shown to be an effect of cell movement 
alone as the rate of scratch closure was not significantly different over time when in 
the presence of DNA synthesis inhibitor, mitomycin C. Mitomycin C was used as an 
inhibitor of cell proliferation to see if wound closure occurred through cell migration 
or through migration and cell proliferation. Mitomycin C was found to be acutely toxic 
to WS1 cells as even 2.5μg/ml. A BrdU assay was used to determine that 10μg/ml 
mitomycin C was sufficient to inhibit WS1 cell division by 90.48% over a period of 12h. 
Doubling the concentration only increased inhibition to 95.31%.     
The effect PDGF-BB was also tested to determine if it would promote cell migration; 
however PDGF-BB had no significant effect on cell migration. Cell migration was also 
shown to occur in the presence of heat inactivated media showing that WS1 cell 
migration was not being promoted by growth factors present in FBS used in the culture 
medium. The use of commercial inserts (Ibidi) was also tested to ascertain if the varying 
gaps being produced through physical removal were significantly different from the 
uniform gaps created by the inserts. No significant difference was seen as the gap 
created by inserts were similar to the average sizes of the gaps measured in this study, 
and migration was not significantly different over time between the two methods.  
The effect of heat shock at a range of temperatures (39°C to 45°C) for 1h also showed 
no significant difference on cell migration. Cell migration, however was shown to be 
significantly reduced when WS1 cells were incubated at 45°C showing that prolonged 
heat treatment was detrimental to cell migration as it caused cell death. Combinatorial 
stresses of heat shock and heat inactivated media using commercial inserts were also 
carried out and shown to have no effect on cell migration. The image capture of the 
scratch assay was automated using a microscope with an onstage incubator, and image 
analysis software TScratch was used to measure area wide cell migration of the scratch. 
The effect of hyperglycaemia (30mM glucose) was tested using this system. No 
significant difference between control and hyperglycaemic conditions was seen. Heat 
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shock coupled with hyperglycaemia also had no significant difference on cell 
migration. It was thought that a 1h heat shock treatment was short and so a heat shock 
treatment time of 3h was used and found that hyperglycaemia and mitomycin C had 
no significant effect on cell migration. In this study serum starvation was not used as 
serum starvation has been shown to induce morphological changes within cells and 
promote the Warburg effect (Golpour et al., 2014). The data described in this thesis 
with regards to cell migration under hyperglycaemic conditions is in contrast with 
other studies as they used serum starvation which would not be similar to cells in vivo 
(Xuan et al., 2014). Another reason they observed an inhibitory effect could be that 
high lactate levels are produced by cells under serum starvation and has been shown 
to inhibit wound healing  (Hehenberger et al., 1998). Heat shock was used to induce 
the production of HSP and see if HSP would improve cell migration of WS1 cells but 
no stimulatory effect was seen. From the data it can be concluded that heat shock has 
no effect on migration of fibroblast.  
The effects of hypoxia on WS1 could be tested in the near future. Acute hypoxia has 
been shown to be a potent inducer of cell division of fibroblasts (Alaluf, Simon, Muir-
Howie, Heng-Long, Evana, & Green, 1998; Hong et al., 2014; W. Li et al., 2007) while 
chronic hypoxic conditions have been shown to inhibit TGF-β secretion (Hong et al., 
2014). Under hypoxic conditions, the transcription factor, hypoxia inducible factor-1 
(HIF-1) is stabilized and carries out transcription of its target genes for VEGF that 
promotes angiogenesis (Hong et al., 2014). Myeloid knockouts of HIF-1 regulatory 
subunit HIF-1α have shown to reduce macrophage, motility, aggregation and 
bactericidal activity (Cramer et al., 2003). Our group has recently acquired a hypoxia 
chamber and the effects of hypoxia on WS1 migration could easily be carried out.     
The scratch assay can also be used to test the effects of inflammatory cytokines on cell 
migration. Cell lines established for gingival fibroblasts (H-CL and F-CL) have been 
shown to produce IL-6 when treated with various inflammatory cytokines. TNF-α and 
IL-1α caused the greatest increase in IL-6 production was found to be 100 times more 
potent than LPS in inducing IL-6 (Kent, Rahemtulla, Hockett, Gilleland, & Michalek, 
1998). It would be beneficial to investigate the effect of anti-inflammatory cytokine 
treatment on cell migration as fibroblasts in diabetic wounds are often reduced in 
number, found to be apoptotic, and subjected to pro-inflammatory conditions (Desta, 
Li, Chino, & Graves, 2010).   IL-6 has been shown induce apoptosis in neutrophils and 
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promote the expression of M-CSF receptor on monocytes and therefore has been 
thought to contribute to the resolution of inflammation (Scheller, Chalaris, Schmidt-
Arras, & Rose-John, 2011). Media transfer from activated monocytes treated with LPS 
could be carried out to investigate the effects of pro-inflammatory cytokine production 
on cell migration. 
Co-culture experiments with macrophages could be carried out and their responses to 
the scratch assay could be investigated. Recently a novel compartmental model was 
developed for the co-culture of macrophages with fibroblasts in vitro and could be used 
to investigate the response of fibroblast and macrophage migration into the wound gap 
under various stress conditions (Zhou, Loppnow, & Groth, 2015). 
The study described in this thesis only assayed the effects of acute hyperglycaemia on 
cell migration while fibroblasts isolated from diabetic wounds have been exposed to 
chronic hyperglycaemia. Ex vivo culture studies have shown that fibroblasts isolated 
form ob/ob mice had reduced migration rates, on fibronectin and collagen coated 
plates, increased matrix metalloproteinase 9 levels and reduced production of VEDGF 
under hypoxic conditions when compared to wild type mice. Moreover fibroblasts 
isolated from new-born mice were similar to wild type mice suggesting that the onset 
of diabetes altered fibroblast behaviour. (Lerman et al., 2003). Culturing WS1 cells 
under hyperglycaemic conditions for a longer period and then assessing cell migration 
using the scratch assay coupled with heat shock treatment could provide information 
for the impaired fibroblast dysfunction described.  
The study described in this thesis also optimized a glucose uptake assay in U937 cells 
using the fluorescent glucose analogue (2NBDG). The effects of glucose competition, 
pH and membrane fluidizers was also tested to gain an understanding of glucose 
transport in U937 cells. A working protocol has also been developed for the insulin 
stimulated glucose transporter GLUT4. Ethical approval from the Faculty of Research 
Ethics Committee (FREC) was obtained to test these assays on PBMC isolated form 
healthy subjects. 2NBDG uptake was used to assay the glucose uptake of PBMCs 
isolated form healthy subjects at fasting and 30min post prandial consumption of a 
sugary meal. The assay revealed that there was no difference in glucose uptake of PBMC 
under either conditions (data not shown). The glucose uptake assay has been used in 
other studies to show the presence of GLUT4 on monocytes. However when they tested 
to see if insulin produced promote glucose uptake they did not wash their cells and so 
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could have measured fluorescence in the buffer (Dimitriadis et al., 2005; Maratou et 
al., 2007).   
The GLUT4 protocol has since been used to optimize the concentration of insulin 
required to translocate GLUT4 to membrane in U937 cells (data not shown). The 
presence of GLUT4 and its translocation upon treatment with insulin has been tested 
on PBMCs and found that only monocytes (CD14+) had GLUT4 present on their 
membranes (data not shown). Monocytes were then purified from healthy and 
overweight subjects at fasting and 30min post prandial using a monocyte purification 
kit. Purified monocytes were then treated with 1nM insulin to see if they translocated 
GLUT4 to the membrane. Monocytes isolated from subjects with high BMI showed 
lower levels of GLUT4 on their membrane when compared to monocytes isolated form 
healthy controls (data not shown). This would suggest that expression of GLUT4 within 
these cells was altered. Moreover membrane bound GLUT4 remained unchanged in 
monocytes isolated from both healthy and overweight subjects when treated with 
insulin. This indicated that concentration of insulin used needed to be optimized for 
monocytes was not comparable to the concentration of insulin optimized using U937 
cells. Simar et al. (2012), have recently shown that GLUT4 expression is unaffected in 
obese individuals following an oral glucose tolerance test when compared to healthy 
controls. They further demonstrated that monocytes from obese individual showed 
increased levels of phosphorylated IRS-1, phosphorylated JNK and phosphorylated 
IKKβ and that heat shock treatment of the monocytes by incubating them at 42°C for 
2h reduced the levels of phosphorylated kinases and IRS-1 thereby improving insulin 
sensitivity. They demonstrated that heat shock induced HSP72 and HSP27 reduced 
JNK phosphorylation and IKKβ  (Simar et al., 2012). Our initial data are in agreement 
with Simar et al. (2012). Future work could be carried out to see if macrophages express 
GLUT4 on their membranes and if induction of HSPs could alter their phenotype in 
diabetes as macrophages isolated from adipose tissues show M2 phenotype but are still 
capable of producing large amounts of inflammatory cytokines (Zeyda et al., 2007). 
In the last few years peroxisome proliferator-activators have garnered a large interest 
as PAPR has been shown to induce sensitivity in adipose tissue and bring about 
adipogenesis. PAPR (Evans, 2004). Recently the role of PAPR in diabetic wounds 
has been demonstrated and shows that a lack of PAPR delays wound healing and 
allows inflammation to progress (Mirza et al., 2015).  Moreover PAPR has been shown 
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to promote M2 phenotype in tissues improve insulin sensitivity (Odegaard & Chawla, 
2013). This makes PAPR a target of therapeutic interest not just for diabetes but other 
inflammatory conditions such as atherosclerosis (Neve, Fruchart, & Staels, 2000)  and 
arthritis .   
The role of HSP in improving cell survival and reducing inflammation in diabetes has 
been demonstrated by several groups in both human and animal models (Bitar et al., 
n.d.; Chung et al., 2008; W. Li et al., 2007; Morera et al., 2012; Park et al., 2001). Several 
studies have also demonstrated the reduced induction of HSP in diabetes and leads to 
the paradigm that a lack of cell stress response prolongs inflammation which in turn 
prolongs insulin resistance (Hooper & Hooper, 2009).  Atalay et al. (2004),  have 
shown that endurance training in streptozotocin induced diabetic mice improved 
HSP72 expression but the expression was much lower than that of control and HSF-1 
induction was also reduced (Atalay et al., 2004). Another study has shown that a lack 
of HSP72 expression was correlated to heme-oxygenase, and was inversely correlated 
to intramuscular triglyceride suggesting that diabetic patients are more susceptible to 
oxidative stresses (Bruce et al., 2003). Heat shock transcription factor has been shown 
to be inactivated by sequential serine phosphorylation at Ser307 by MAP Kinase, serine 
303 by glycogen synthase kinase (GSK3) and at Ser363 by PKC at 37°C (Chu, Zhong, 
Soncin, Stevenson, & Calderwood, 1998). These kinases are upregulated in insulin 
resistance thus impairing heat shock protein induction. Investigating ways to reduce 
inflammatory signalling cascades (JNK, IKK-NF B) through the induction of HSP 
within immune cells would bring about long term insulin sensitivity. This approach 
could then be extended to other inflammatory diseases such arthrosclerosis and 
rheumatoid arthritis.     
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